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SUMMARY  
 
Mental disorders and cardiovascular diseases (CVDs) are among the leading contributors to the 
global burden of disease, making them a major public health problem. Mental disorders and 
CVDs are common conditions, which very often co-occur, and influence each other’s etiology. 
Individuals with cardiac diseases experience higher rates of mental disorders such as 
depression, anxiety and posttraumatic stress disorder (PTSD) than the general population. 
Likewise, these mental illnesses are associated with both onset and progression of cardiac 
diseases. A growing body of evidence has documented the independent association between 
depression and onset of cardiac disease, morbidity and mortality. There is also compelling 
evidence that the co-occurrence of depression and cardiac disease leads to worse health-related 
quality of life (HRQL). However, less is known about the influence of anxiety and PTSD on 
cardiac outcomes and HRQL. The American Heart Association (AHA) has recommended 
routine depression screening in cardiac patients and guidelines for cardiac rehabilitation (CR) 
include that attention is paid to the diagnosis and treatment of mental disorders, yet the uptake 
of these recommendations remains limited. This situation is expected to be aggravated in low-
income countries (LICs) like Palestine, which is affected by the political conflict and rates of 
CVDs and mental disorders are on a rapid rise. However, mental disorders are stigmatized, and 
thus not recognized nor treated. The evidence base to promote mental health services is 
currently lacking. This is the first contribution to assess the relationship between mental 
disorders and cardiac diseases in Palestine.  
     This PhD project the “CARMEN Study” was carried out in collaboration between Swiss 
Tropical and Public Health Institute, (Swiss TPH) and An-Najah National University. The 
following dissertation is based on three interrelated studies and sought to study the 
epidemiology and contributions of depression, anxiety, PTSD among cardiac diseases in a 
xvi 
population-based sample of Palestinian adults. This dissertation provides evidence to fill the 
knowledge gaps to inform treatment and guide optimum management of these comorbid 
conditions.  
Study I used a cross-sectional design to investigate the prevalence of depression and anxiety 
symptoms among Palestinian cardiac patients. Among the 1022 patients assessed, 54% were 
categorized as having severe depressive symptoms, while 19% exhibited severe anxiety 
symptoms. The study also found PTSD symptoms, low level of self-esteem, high somatic 
symptoms, low physical and mental health component scores, active smoking, physical 
inactivity, and longer disease duration to be independently associated factors with both 
depressive and anxiety symptoms. Patients with depressive and anxiety symptoms also reported 
poor social support and lower resilience and were more prevalent among females and less 
educated patients. 
Study II revealed that women were more likely to suffer from depression than men (28.7% vs. 
18.8%). When assessing which characteristics mediate the effect of gender on depression using 
structural equation modeling (SEM), our results showed that there was no direct effect of gender 
on depression; however, indirect effects showed that female gender was associated with lower 
resilience, self-esteem and quality of life, education, prevalence of smoking and physical 
activity and higher PTSD symptoms, comorbidities, somatic symptoms and smoking.  
Study III found 27% of the overall sample at baseline exhibits moderate-to-high PTSD 
symptoms and at one year follow-up, patients with PTSD reported an approximate 20% lower 
HRQL. In addition, when assessing the longitudinal association of PTSD with HRQL after one 
year, the findings suggest this relationship was largely mediated by depression and anxiety.  
The overall conclusions drawn from this thesis support the essential need for integrating mental 
health care into CR in Palestine from disease onset and onwards, considering the alarming rates 
xvii 
of depression and anxiety symptoms in this Palestinian patient population. Depression, anxiety 
and PTSD should be considered important risk factors for cardiac diseases as much as other 
traditional cardiac risk factors. To deliver effective treatments for depression, anxiety and 
PTSD, assessment of the impact of psychological interventions on cardiac outcomes is needed. 
For clinical practice, future research should apply a more holistic approach in treating both 
physical and psychological recovery among cardiac patients. Finally, our findings can be 
considered as first steps to the translational approach of innovation, validation and application, 
where we can use the current cardiac sample as an entry door to pursue family members of 
diseased patients whom also could be at risk of onset and progression of cardiac diseases. This 
could potentially lead to a national mental health program that could be generalizable to similar 
health care systems in the Middle East region.  
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DEFINITIONS  
 
 
Anxiety: an unpleasant emotion that is triggered by anticipation of future events and memories 
of past events, and it could manifest in different forms (panic disorder, phobic anxiety, 
generalized anxiety, anxiety reactions, and chronic anxiety). 
Atherosclerosis: Atherosclerosis is a disease in which plaque builds up inside your arteries. 
Arteries are blood vessels that carry oxygen-rich blood to your heart and other parts of your 
body. 
Cardiac Rehabilitation (CR): a multi-factorial intervention recommended for cardiac 
patients, which aims at improving patients’ overall quality of life, as well as reducing the 
detrimental psychological, emotional and physical burden of cardiac diseases. 
Major depressive disorder (MDD): is defined by the presence of depressed mood and/or 
lack of interest/pleasure in activities, every day for a period of at least two weeks or more, 
along with the presence of additional symptoms including: significant weight loss/gain; 
increased/decreased appetite, hypersomnia/insomnia, agitation, fatigue or loss of energy, 
feelings of worthlessness, difficulty with concentration, presence of suicidal thoughts. 
(American Psychiatric Association [DSM-IV-TR], 2000). 
Mental disorders: clinically significant behavioral or psychological set of symptoms, which 
are commonly associated with distress, pain, disability or loss of freedom and interferes with 
ability to function effectively and with interpersonal relationships.  
Posttraumatic stress disorder (PTSD): Posttraumatic stress disorder is an anxiety disorder 
initiated by an exposure to a traumatic event, such as combat, natural disaster, or sexual 
assault, and is characterized by symptoms such as re-experiencing the traumatic event (e.g., 
intrusive thoughts, nightmares), cognitive or behavioral avoidance of reminders of the event, 
and physiological hyper arousal. 
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1 
 
 
INTRODUCTION 
  
 
1.1 Non-communicable diseases (NCDs) 
In the last century, the world has witnessed an “epidemiologic transition” from infectious 
disease and nutritional deficiencies to non-communicable diseases (NCDs). As a result of 
mainly the demographic aging of the population, as well as social detriments of health and 
globalization, NCD rates are drastically increasing posing major concerns for global health and 
health care systems around the world (WHO, 2014). According to the World Health 
Organization (WHO), among the 56 million deaths globally in 2012, 38 million (68%) were 
due to NCDs, of which 16 million were premature deaths under the age of 70 (WHO, 2014). 
The Global Burden of Disease (GBD) Study 2015, stated that NCDs contributed to the highest 
burden measured in disability-adjusted life years (DALYs) (Forouzanfar et al., 2016). 
Previously, high NCD mortality rates have affected high-income countries (HICs). However, a 
new trend is emerging as NCDs are rapidly increasing in low- and middle-income countries 
(LMICs) (Rahim et al., 2014). In 2012, 74% of NCD-related global deaths occurred in LMICs 
(WHO, 2014).  
     In recent years, the WHO has focused on the four major NCDs: cardiovascular diseases 
(CVDs), cancer, chronic respiratory diseases and diabetes. However, the focus has now 
expanded to a five-by-five approach to also include mental disorders, as the co-occurrence of 
mental health conditions and NCDs is on a tremendous rise (Stein et al., 2019).  
     NCDs are now hindering the progress towards the 2030 Agenda for Sustainable 
Development, which is aimed at reducing NCD-related premature deaths by one-third by 2030. 
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In response to the NCD epidemic, the WHO is supporting efforts to tackle NCDs through 
policies and programs that target prevention of NCDs, increase early detection, and ensure 
sustainable and universal access to appropriate and quality health care (WHO, 2018). 
 
1.2 Global burden of cardiovascular diseases (CVDs) 
CVD is an umbrella term comprising a group of disorders of the heart and blood vessels. The 
main types of CVDs include coronary heart disease (CHD), cerebrovascular disease (e.g. 
stroke), peripheral vascular disease, and other cardiac-related diseases including rheumatic 
heart disease, congenital heart disease, heart failure (HF), valvular heart disease, 
cardiomyopathies (disorders of the heart muscle) and atrial fibrillation (AF) (WHO, 2018) . 
CVDs are a key contributor to the rise of NCD-related deaths worldwide, accounting for nearly 
50% (Mendis et al., 2011). In 2015, CVDs were responsible for over 17 million deaths globally 
(Figure 1.2), making them the leading cause of death and loss of DALYs in the world (Yusuf 
et al., 2001, Roth et al., 2017). CHD, also known as ischemic heart disease (IHD) or coronary 
artery disease (CAD) is projected to be the leading cause of death in the developing world by 
2020 (Denollet et al., 2006). The most common clinical manifestations of CHD are stable 
angina, unstable angina and myocardial infarction (MI). MI is also a major cause of morbidity 
and mortality worldwide, and it is estimated that more than seven million people suffer from 
MI each year (White and Chew, 2008). The percentage of premature CVD deaths ranges from 
4% in HICs to 42% in low-income countries (LICs) and the rate of CVDs worldwide is 
predicted to increase as the prevalence CVD risk factors rises in LMICs. Currently, 80% of 
CVD mortality occurs in LMICs, and is expected to be the major cause of mortality by 2020, 
overtaking infectious diseases (Perk et al., 2012).  
     The major traditional risk factors associated with cardiac diseases are hypertension, diabetes, 
hyperlipidemia, obesity, sedentary lifestyles (e.g. physical inactivity, smoking, poor dietary 
habits, alcohol consumption), age, gender and family history. It has been established that age, 
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gender, diabetes and hypertension are greatly contributing to cardiac events such as MI, cardiac 
readmission, and cardiac death (Stahli et al., 2019, Cole et al., 2019). The WHO states that over 
75% of premature CVD is preventable and tackling risk factors can help reduce the increasing 
CVD burden on both populations and healthcare systems (WHO, 2014). 
Figure 1.2. Global distribution of CVD mortality rates in 2015 (Roth, G.A. et al. J Am Coll Cardiol.2017; 
70(1):1–25)  
 
 
1.3 Global burden of mental disorders  
Similar to CVDs, mental disorders also pose a great challenge to the world’s health problems, 
in both HICs and LMICs. According to the GBD study, mental disorders made up 56.7% of 
global DALYs in 2010, accounting for the fifth leading cause of DALYs and the number one 
leading cause of years lived with disability (YLD) (Ferrari et al., 2013). Previous research has 
found that 14.3% of deaths worldwide or eight million deaths each year are related to mental 
disorders and most of these deaths have been linked to having a co-occurring NCD. Depression 
and anxiety constitute as two of the most common mental disorders globally, and like CVDs 
occur at high frequencies in the general population. In 2010, depressive disorders accounted for 
40.5% of DALYs, while anxiety disorders accounted for 14.6% of DALYs (Whiteford et al., 
2013). The lifetime prevalence rate of depression has been estimated at 14.6% in HICs and 
11.1% in LMICs (Bromet et al., 2011), and lifetime incidence rates are approximately 12% and 
20% in men and women, respectively (2008, Kessler et al., 2003). The lifetime prevalence of 
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anxiety disorders is 33.7% (Mensah and Collins, 2015, Ormel et al., 2007). Depression and 
anxiety have been associated with poor quality of life (Baumeister et al., 2005), increased 
morbidity and mortality (Rugulies, 2002) and economic burden on society (Ormel et al., 1998). 
Depression, in particular has a significant impact on psychological (e.g. anxiety, fear, 
hopelessness), physical and social functioning (e.g. social isolation) (Khawaja et al., 2009) and 
has been linked to brain damage, cardiac events and poor health-related behaviors (Kessler et 
al., 2003, Kapfhammer, 2011, Roshanaei-Moghaddam et al., 2009). Posttraumatic stress 
disorder (PTSD), which is considered a type of anxiety disorder also constitutes as a serious 
health consequence, and has an estimated lifetime prevalence of 0.3% to 8.7% in HICs (Kessler 
et al., 1996). PTSD symptoms and clinical PTSD have also been associated with lower quality 
of life, impaired functioning, short and long-term disability and suicide attempts (Johansen et 
al., 2007, Sareen et al., 2007). If not treated, these disorders could follow a chronic course, be 
recurrent and lead to increasing disability over time (Solomon et al., 2000, Andrews, 2001). 
Diagnostic criteria for depression, anxiety and PTSD according to the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-V), 5th edition are outlined in Figure 1.2 (de Val D’Espaux 
et al., 2011).  
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Figure 1.3. Diagnostic criteria for depression, anxiety and PTSD  
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1.4 Comorbid mental disorders and CVD 
Mental disorders, such as anxiety disorders and depression are highly prevalent among chronic 
diseases. In particular, mental disorders very often coexist with CVDs and share common 
features (Hare et al., 2014, Pozuelo et al., 2009, Halaris, 2009). First, they are both chronic 
conditions in which persist over time and require ongoing management and monitoring over 
the course of the disease. Second, they arise from a combination of biological, psychosocial, 
behavioral, and social factors. Likewise, their co-existence of physical and mental morbidity 
negatively affects the course and outcome of both conditions, and thus results in significant 
levels of illness, disability and an overall increased burden of disease. This in turn reduces 
economic productivity, income and socioeconomic opportunities for patients, families and 
communities (Pozuelo et al., 2009, Halaris, 2009). Comorbid mental and cardiac diseases are 
associated with noncompliance of treatment, poorer prognosis, poor health-related quality of 
life (HRQL), and rising medical costs for healthcare systems (Egede, 2007, Dickson et al., 2012, 
Mensah and Brown, 2007). Additionally, mental disorders result in poor sedentary lifestyles 
such as reduced physical activity, poor dietary habits, smoking, increased alcohol consumption 
and increased stress levels (Chaddha et al., 2016).   
     A body of literature has documented that mental disorders, specifically depression and 
anxiety are important risk factors for both onset and prognosis of CVD, cardiac morbidity and 
mortality, independent of traditional cardiac risk factors (Januzzi et al., 2000, Rutledge et al., 
2009a, Whooley et al., 2008, Gan et al., 2014, Lichtman et al., 2014b). Patients suffering from 
mental disorders are even at higher risk for cardiac morbidity and mortality than are their 
counterparts in the general population (Sowden and Huffman, 2009). The lack of recognition 
of mental disorders in the development and progression of cardiac disease could explain why 
they remain the leading causes of death in most countries. This thesis will mainly focus on three 
mental disorders among cardiac patients; namely depression, anxiety and PTSD. 
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1.5. Epidemiology, etiological effects, and prognostic implications of DEPRESSION and 
cardiac disease 
Among all mental disorders, depression has received the most attention in the CVD literature 
given that it is the most prevalent mental illness in patients with CVD, and can tremendously 
impact treatment and successful management of CVD. The association between depression and 
CVD has been recognized since the end of the 19th century. An extensive amount of literature 
has documented the bidirectional relationship between depression and CVD (Katon, 2011, 
Mensah and Collins, 2015), indicating, depression as a risk factor for CVD and CVD as a risk 
factor for depression (Mosovich et al., 2008, Chaddha et al., 2016). Interestingly, depression is 
associated with an increased incidence of new CVD (etiology) and worse outcomes in 
established CVD (prognosis) (Colquhoun et al., 2013).  
 
1.5.1 Epidemiology  
Depression is highly prevalent among cardiac patients in particular. Approximately, 31% to 
45% of patients with CAD including those with unstable angina, MI, and stable CAD suffer 
from some level of depression (Carney and Freedland, 2003, Lesperance et al., 2000, 
Lesperance and Frasure-Smith, 2000, Thombs et al., 2006, Rudisch and Nemeroff, 2003). The 
prevalence of MDD among CAD patients ranges from approximately 10% to 30% (Carney and 
Freedland, 2008, Thombs et al., 2008, Thombs et al., 2006), which is three-fold higher than in 
the general population (Kessler et al., 2003). Patients with HF, AF, and those undergoing 
implantable cardioveter-defribrillator (ICD) placements are also at increased risk for elevated 
depressive symptoms and MDD. A meta-analysis of HF patients found prevalence rates of 36% 
for increased depressive symptoms and for MDD (Rutledge et al., 2006). Among patients 
undergoing coronary artery bypass graft (CABG) surgery, 30 to 40% of patients met criteria for 
minor or major depression and 15% of patients met full MDD criteria (Tully and Baker, 2012). 
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In the EUROASPIRE III study which investigated over 8500 CHD patients the proportion of 
men with depression varied form 8.2% to 35.7% and 10.3% to 62.5% in women (Cooney et al., 
2013). 
     There are also established risk factors for depression in cardiac patients. Studies suggest that 
among CVD patients, younger age, female gender and patients with a history of depression are 
more likely to have depression (Shanmugasegaram, 2012, Mallik et al., 2006, Caro et al., 2012). 
Among MI patients, social isolation, prior history of MI, and comorbid diabetes may also 
increase the risk of depression (Spijkerman et al., 2005). In CABG patients, depression is 
predicted by female gender, younger age, living alone, anxiety and less education (Dunkel et 
al., 2009). Depression is also associated with many other traditional cardiac risk factors 
including diabetes, hypertension, smoking, sedentary lifestyle (e.g. physical inactivity, 
unhealthy diet) and smoking (Huffman et al., 2013).  
 
1.5.2 Etiology  
Previous studies have established depression is independently associated with an increased risk 
of development of CAD in healthy individuals (Wulsin and Singal, 2003). According to a meta-
analysis which comprised of 36,000 patients, depression was found to be an independent risk 
factor for the development of some type of cardiac disease with a relative risk of 1.64 (95% CI: 
1.41-1.90), among healthy individuals (Rugulies, 2002). Janszky et al. reported in their study 
that healthy individuals with depression are at 2.9 (95% CI: 1.8-4.9) times higher risk of having 
an MI (Janszky et al., 2007). A Danish longitudinal study demonstrated that depression 
predicted a 70% increase in MI after a 10-year period and a 60% increase in all-cause mortality 
after a 17-year period (Barefoot and Schroll, 1996).  
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 1.5.3 Prognosis  
On another note, a recent meta-analysis found that among patients with already established 
cardiac disease, depression is associated with a 1.6 to 2.6-fold  increased risk of future major 
adverse cardiac events (MACE), cardiac mortality and all-cause mortality. For example, 
patients who have acute coronary syndrome (ACS; an umbrella term for MI and unstable 
angina) and depression have double the risk for future MACE, a rate similar to traditional risk 
factors such as reduced left ventricular ejection fraction (LVEF) and diabetes (Rozanski et al., 
2005), while post-MI patients have a 2.4-fold (95% CI = 1.76–3.22) increased risk for all-cause 
mortality (Meijer et al., 2011). Subsequently, the American Heart Association (AHA) has 
recently recommended that development of depression after an MI should be raised to the status 
of a risk factor for poor prognosis, as evidence also supports its association to reduced 
secondary prevention behaviors (e.g. smoking, physical activity and CR) and cardiac-mortality 
(Meijer et al., 2011) (Lichtman et al., 2014a, Frasure-Smith et al., 1995, Barth et al., 2004). 
Similarly, among patients with unstable CAD, a meta-analysis found MDD to be associated 
with all-cause mortality (HR= 1.76 [95% CI = 1.27–2.43], two years following a cardiac event, 
even after adjustment for other risk factors (Barth et al., 2004). Depression also appears to have 
a detrimental effect on cardiac outcomes in patients with other cardiac diseases. Among HF 
patients, depression is linked to more frequent hospitalizations, increased heath care costs and 
utilization and a two-fold increase in mortality risk (Rutledge et al., 2006). Likewise, among 
CABG patients, depression has been associated with poor functional outcomes, preoperative 
complications, higher rates of re-hospitalizations, reduced HRQL and progression of 
atherosclerotic disease (Wellenius et al., 2008, Morone et al., 2010). In addition, depression 
among cardiac patients is associated with poor compliance to cardiac risk factors and 
compliance to medication and treatment regimens (Hare et al., 2014).   
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1.6 Epidemiology, etiological effects, and prognostic implications of ANXIETY and 
cardiac disease 
Anxiety disorders are strongly correlated with depression among cardiac populations. However, 
in contrast to depression, less research has focused on the association of anxiety with cardiac 
diseases. Anxiety is highly prevalent in patients with cardiac diseases, including those with 
CAD, MI and those participating in CR (Frasure-Smith and Lesperance, 2008, De Schutter et 
al., 2011).  
 1.6.1 Epidemiology  
The most common type of anxiety associated with cardiac diseases is generalized anxiety 
disorder (GAD), with an 11% point prevalence and 26% lifetime prevalence in CAD patients. 
The prevalence of elevated symptoms of anxiety in cardiac patients has been reported to be, 
approximately 30% (Pajak et al., 2013). These rates are higher than the 3-7% lifetime 
prevalence of GAD in the general population (Tully and Cosh, 2013, Kessler et al., 2005). 
Among ACS patients, 20 to 30% of patients experience elevated symptoms of anxiety, with 
symptoms persisting up to one-year after the cardiac event, suggesting that anxiety remains 
chronic over the course of heart disease (Hanssen et al., 2009). In a recent meta-analysis of 38 
studies, 32% of HF patients experience elevated symptoms of anxiety, while 13% met criteria 
for an anxiety disorder. Furthermore, anxiety affects 20% of patients with advanced HF and 20 
to 40% of patients who have undergone implantation of an ICD (Easton et al., 2016, Magyar-
Russell et al., 2011).  
 1.6.2 Etiology  
Anxiety is known to be a normal response to a stressful situation or experience, such as cardiac 
events. A handful of studies have found anxiety to be associated with the development of 
cardiac disease (Frasure-Smith and Lesperance, 2008, Phillips et al., 2009, Martens et al., 
11 
2010). In a 2010 meta-analysis by Roest et al. including 20 studies and 250,000 patients, anxiety 
was associated with a 26% (HR = 1.26; 95% CI: 1.15–1.38) increased risk of CAD and a 48%  
(HR = 1.48; 95% CI: 1.14–1.92) increased risk of cardiac mortality, independent of socio-
demographic and traditional cardiac and lifestyle factors (Roest et al., 2010a). However, this 
meta-analysis did not adjust for depression, which is highly comorbid with anxiety. A 
prospective national study conducted on men in the military revealed that an anxiety diagnosis 
was strongly associated with incident CHD (HR= 2.17; 95% CI: 1.28–3.67) and MI (HR= 2.51; 
95% CI: 1.38–4.55) over a follow-up of 37 years (Janszky et al., 2007). Additionally, in a large 
retrospective study among 236,000 patients free of cardiac disease, anxiety disorders increased 
the risk of HF (HR = 1.19; 95% CI: 1.10–1.28) (Garfield et al., 2014).  
1.6.3 Prognosis   
Among patients with existing cardiac diseases, a three-year cohort study found anxiety to be 
independently associated with increased risk of all-cause mortality (HR= 1.83, 95% CI: 1.18-
2.83) in CHD patients, particularly in the presence of comorbid depression (Watkins et al., 
2013). Additionally, anxiety among cardiac patients has been associated with lower quality of 
life in patients with MI (Van Beek et al., 2016). Anxiety has also been associated with MACE 
(OR = 1.71; 95% CI: 1.31–2.23; p < 0.001) and cardiac mortality (OR = 1.23; 95% CI: 1.03–
1.47; p = 0.02) (Roest et al., 2010b). Similarly, in a 10-year follow-up study by Van Dijk et al. 
on patients with existing CAD, the prevalence of anxiety was 27% and anxiety was associated 
with an increased risk for all-cause mortality (HR = 1.50; 95% CI: 1.14–1.98) (van Dijk et al., 
2016). In a prospective study of 158 patients undergoing CABG surgery, GAD was associated 
with incident MACE over a five-year period. The associations between GAD and HF outcomes 
have not yet been investigated (Tully et al., 2015).  
 
1.7 Epidemiology, etiological effects, and prognostic implications of PTSD and cardiac 
disease 
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 1.7.1 Epidemiology  
PTSD symptoms and clinical PTSD also are common in patients with cardiac diseases. Cardiac 
events including cardiac surgery can be potentially traumatic experiences which could lead to 
the development of PTSD. PTSD symptoms are present in 10% to 25% of patients with ACS, 
which is comparable to PTSD rates among those exposed to other traumatic events and the 
general population (Vilchinsky et al., 2017, Edmondson et al., 2011, Levine et al., 2014). 
Across other cardiac populations, approximately 20% of patients with ICD and 19% to 38% 
who have had cardiac arrest suffer from elevated levels of clinical PTSD symptoms (Ladwig et 
al., 2008, Spindler and Pedersen, 2005, Gamper et al., 2004).  
1.7.2 Etiology  
It has been established PTSD that occurs as a result of a trauma in non-medical settings is 
independently associated with increased risk of developing some type of cardiac disease, even 
after controlling for traditional cardiac risk factors such as smoking, hypertension and diabetes 
(Edmondson et al., 2013, Edmondson and Cohen, 2013). A meta-analysis evaluating PTSD in 
healthy individuals found that PTSD was associated with a 27% increased risk for CHD or 
cardiac-related mortality (HR=1.27,95% CI:1.08-1.49), even after adjusting for confounders, 
including depression (Edmondson et al., 2013). Another study conducted on twins over a 13-
year period found that the incidence of CHD was twice as high among those with PTSD, 
compared with those without PTSD (22.6% vs 8.9%; p<0.0001), after adjustment for 
depression, lifestyle factors and cardiac risk factors (Vaccarino et al., 2013).  
1.7.3 Prognosis  
Among patients with clinical PTSD symptoms due to ACS, there is a two-fold increased risk 
of having another cardiac-related event or mortality within one to three years compared with 
cardiac patients with no PTSD symptoms (Edmondson et al., 2012a). In a recent Swiss study 
among MI patients, findings suggest there was a 42% increased risk of ACS recurrence 
associated with higher levels of PTSD symptoms (von Kanel et al., 2011). Further, the presence 
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of PTSD due to an ACS has been associated with increased cardiac-related hospitalizations, 
lower treatment adherence, and lower quality of life. Among patients undergoing CABG, PTSD 
occurs in approximately 15% of patients (Tully and Baker, 2012) and 18 to 37% among patients 
with an ICD. Among these subgroups of patients, a recent trial on CABG patients found that 
those with PTSD also had concomitant depression (Dao et al., 2010, Ladwig et al., 2008).  
 
1.8 Mechanisms linking depression, anxiety and PTSD with cardiac diseases  
 
Mental disorders including depression, anxiety and PTSD share similar biological, behavioral 
and psychosocial mechanisms in their contribution to the increased risk and prognosis of 
cardiac diseases (Figure 1.8a, 1.8b). Knowledge of these common mechanisms between the 
aforementioned mental disorders and CHD could help improve prevention and treatment of 
these comorbid conditions.  
 
 
Figure 1.8a Etiological mechanisms linking depression, anxiety and PTSD with onset of 
cardiac disease 
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Note. BMI= body mass index; HPA= hypothalamic–pituitary–adrenal; HRV= heart rate variability; PTSD= 
posttraumatic stress disorder; SES= socioeconomic status. 
 
 
1.8.1 Biological mechanisms 
Depression, anxiety and PTSD have been associated with several biological mechanisms which 
are involved in the development and progression of atherosclerosis including, autonomic 
nervous system (ANS) dysfunction, hypothalamic-pituitary adrenal (HPA) axis dysregulation, 
inflammation and increased platelet reactivity (Rozanski et al., 1999). This, in turn leads to the 
onset or adverse course of cardiac diseases. 
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Autonomic nervous system (ANS) dysfunction 
 
The ANS is divided into two systems, the sympathetic and parasympathetic systems that serve 
to control heart rate, blood pressure and other critical functions. Depression in particular tends 
to cause activation of the sympathetic system causing increases in heart rate and blood pressure, 
while affecting the coronary blood flow and increasing the risk of CHD. Another marker of 
ANS dysfunction is decreased heart rate variability (HRV) which is caused by increased 
sympathetic tone or decreased parasympathetic tone and is known to be an independent risk 
factor for cardiac mortality and growing risk of incident CHD (Adibfar et al., 2016, Whooley 
and Wong, 2013). Several studies have documented that lower HRV has been more frequent 
among depressed patients compared to non-depressed patients and is associated with increased 
mortality among depressed patients (Gehi et al., 2005, Kim et al., 2005). Reductions in HRV 
have also been observed among those with concurrent anxiety (Kemp et al., 2012).  
 Hypothalamic-pituitary adrenal (HPA) axis dysregulation 
Another biological mechanism is the elevated cortisol levels from enhanced activity of the HPA 
axis (Dinan, 1994). HPA hyperactivity and elevated levels of cortisol have been documented 
among patients with depression, anxiety and PTSD (Fiedorowicz, 2014, Whooley and Wong, 
2013). Meanwhile, depression has been found to cause the stress induced activation of the HPA 
axis, which causes an increase in levels of glucose, hyperlipidemia and visceral fat mass, 
ultimately increasing the risk of CHD (Bjorntorp and Rosmond, 2000).  
Inflammation  
Inflammation which involves endothelial dysfunction has also been established as a causal 
pathway responsible for depression, anxiety and PTSD leading to an increased risk of CHD, 
unstable angina and MI through the development of atherosclerosis (Frasure-Smith and 
Lesperance, 2005). Stress, which is very common in patients with major depression, has been 
shown to promote endothelial dysfunction, an early sign of cardiac deterioration (Lerman and 
Zeiher, 2005). Patients with these mental disorders have been found to have elevated levels of 
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inflammatory markers (e.g. C-reactive protein (CRP); inflammatory cytokines), which have 
been associated with poor CHD outcomes (Poole et al., 2011, Miller et al., 2002). In a large 
study of health individuals, higher levels of CRP were found among those with elevated levels 
of anxiety (Pitsavos et al., 2006).  
Increased platelet activity  
MDD has been associated with increased platelet activity and aggregation, which can cause 
thrombus generation, a process involved in atherosclerotic diseases, including CHD. These 
elevated platelet levels promote clotting. Depressed patients with cardiac disease have been 
found to have higher platelet activation levels and endothelial dysfunction compared to non-
depressed patients (Kim et al., 2014, Spiliopoulos and Pastromas, 2015, Seligman and 
Nemeroff, 2015, Pozuelo et al., 2009). Similarly, greater levels of platelet aggregation are more 
frequent among patients with anxiety and PTSD, increasing the risk of cardiac events among 
these patient populations (Bedi and Arora, 2007, Garvey et al., 1995).  
 
 
 
 
 
 
 
 
 
Figure 1.8b Prognostic mechanisms linking depression, anxiety and PTSD with adverse 
course of cardiac disease 
17 
HPA= hypothalamic–pituitary–adrenal; HRV= heart rate variability; MACE= major adverse cardiac events; 
PTSD= posttraumatic stress disorder 
 
1.8.2 Behavioral mechanisms  
It is equally likely that behavioral mechanisms also explain the association between depression, 
anxiety and PTSD and cardiac diseases. Previous studies suggest that these mental disorders 
are associated with poor dietary habits, smoking, physical inactivity, obesity and alcohol 
consumption. These behavioral factors are associated with inflammatory activity, release of 
inflammatory cytokines, and increased activity in the HPA, which in turn are important drivers 
in the process of atherosclerosis and can increase the chance of developing cardiac disease and 
increase the risk of cardiac morbidity and mortality in CHD patients (Bonnet et al., 2005, Berk 
et al., 2013, Brumpton et al., 2013). Depression, anxiety and PTSD are associated with higher 
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rates of smoking, leading to three times higher rates of MI among smokers than non-smokers 
(Berk et al., 2013, Aubin et al., 2012, Chaddha et al., 2016). People with depression and anxiety 
are also at greater odds of becoming obese and not being physically active. Additionally, 
hypertension, diabetes, and cholesterol and obesity tend to be present among patients with 
depression or anxiety, and may be associated with the progression of CHD and poor cardiac 
outcomes in patients with established cardiac disease and onset of cardiac disease in those 
without established cardiac disease (Chaddha et al., 2016). Further, and most importantly, there 
is evidence suggesting depression and anxiety predict poor adherence among CHD patients 
whom are less likely to adhere to medication and treatment regimens, follow cardiac 
rehabilitation programs and lifestyle recommendations or practice self-management (e.g. 
monitor weight and food intake), all of which increase the incidence of cardiac disease and lead 
to adverse outcomes in those with established cardiac disease. Patients with severe depression 
and CHD are three times more likely not to take their medication compared to patients that had 
minor or no depressive symptoms (Fiedorowicz, 2014, Seligman and Nemeroff, 2015, 
Ziegelstein et al., 2000, Carney et al., 1995). Furthermore, among patients who do not follow 
behavioral recommendations there is a 10-fold increased risk of MI, compared to those who do 
(Chaddha et al., 2016).  
 1.8.3 Psychosocial mechanisms  
Additionally, psychosocial factors like social support, social isolation, chronic life stressors, 
coping styles as well as care giving have been related to depression and anxiety and may play 
a role in the onset and/or course and outcomes of cardiac diseases (King, 1997, Allman et al., 
2009, Kessler, 1997). Evidence indicates that low social support increases the onset and 
prognosis of CHD in males and females with a relative risk of 1.5 to 2.0 (Khayyam-Nekouei et 
al., 2013, Lett et al., 2005). Chronic life stressors such as low socio-economic status (SES) and 
unemployment (e.g. low income) as well as gender have been known to mediate the relationship 
between depression and onset of cardiac diseases. Individuals with low SES are more likely to 
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experience cardiac risk factors, are at higher risk for incidence of CHD, and are more likely to 
suffer from adverse cardiac outcomes than those with a higher SES (Golden et al., 2007, Vieweg 
et al., 1998). In addition, low SES is linked to poor living conditions (e.g. healthy lifestyles, 
lack of important resources), which can lead to cardiac risk factors such as overweight, obesity, 
hyperlipidemia or hypertension, ultimately leading to the development of atherosclerosis 
ultimately leading to the onset or progression of cardiac disease (Vieweg et al., 1998). Further, 
Chida et al. found that personality traits such as hostility and anger have been associated with 
onset of cardiac disease and poorer prognosis in CHD patients (Chida and Steptoe, 2009).   
     Future research should address the role of negative mood, personality traits and other 
psychosocial factors increasing the risk of CHD in those with mental disorders, in order to 
develop effective prevention and treatment strategies. 
1.9 Screening of co-morbid mental and cardiac diseases 
    There is evidence that treating depression and anxiety improves quality of life and daily 
functioning in cardiac patients (Ormel et al., 2007), thus there needs to be more understanding 
about the nature of these mental disorders in this population. Unfortunately, health systems 
around the world have not yet adequately responded to the increasing burden of mental 
disorders in the cardiac population. As a consequence, there is a gap between the need for 
treatment and its provision around the world, despite the availability of effective treatments for 
depression and anxiety in cardiac patients (Collins et al., 2013). Screening and treatment of 
depression in particular by cardiology physicians continues to be limited due to poor symptom 
recognition and lack of desire to treat perceived primary care conditions in cardiology practice. 
Furthermore, physicians often do not consider depression or other mental illness as a risk factor, 
underestimating their negative effects (Collins et al., 2013, Tesio et al., 2017, Lichtman et al., 
2014b). 
      The AHA has recommended routine screening of cardiac patients for depression using 
screening instruments as a potential way to improve detection of depression in this patient 
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population (Huffman et al., 2013). In western countries, the two-item Patient Health 
Questionnaire (PHQ-2), the PHQ-9 and the Cardiac Depression Scale short  form (CDS-SF) 
have all been recommended as simple and effective depression screening tools in patients with 
heart disease (Lichtman et al., 2014b, McManus et al., 2005). Thus, it is important for 
psychiatrists, social workers, mental health experts, and cardiologists to be educated about the 
bi-directional association between mental disorders and cardiac diseases and about the 
symptoms and risk factors occurring in the course of both conditions (De Hert et al., 2009, 
Goldston and Baillie, 2008).  
Regardless of the recommendations from the AHA, evidence from settings in HICs points to 
the fact that even in the context of well-funded health care systems, less than 15% of patients 
admitted for acute MI are diagnosed for comorbid depression (Lichtman et al., 2014b). 
Evidence from settings in European and North-American countries, including results from 
intervention studies, point to the gains in chronic disease outcomes and quality of life obtained 
from the provision of depression care at different levels. Multiple intervention studies have 
attempted to examine whether improving psychosocial function improves cardiac outcomes. A 
Cochrane meta-analysis reported benefits of psychotherapy on CVD outcomes among 
depressed adults (Whalley et al., 2011, Linden et al., 2007). The evidence stimulated the 
establishment of guidelines such as the National Institute for Health and Care Excellence 
(NICE) in the United Kingdom for the treatment of depression at different severity stages in 
patients with chronic physical conditions (NICE, 2012).  
     Debates still remain about the optimal screening tools for depression in light of the 
potentially transient nature of symptoms as well as the optimal disease management of heart 
disease patients with depression and its associated long-term effect (Ski et al., 2017). There is 
also controversy whether routine screening for depression alone in cardiac patients in fact, 
improves patient outcomes. With regard to the management of mental disorders, results from a 
Cochrane review point to collaborative care being more effective than usual care for depression 
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and anxiety treatment in general. Collaborative care is delivered by non-medical case managers 
working with the patient’s physicians (e.g. their primary care physician) and with mental health 
specialists (psychiatrist/psychologist) (Coventry et al., 2015).   
 
1.10 Management strategies for cardiac patients with depression, anxiety and PTSD 
1.10.1 Cardiac rehabilitation (CR) 
International guidelines strongly recommend the integration of mental health interventions, 
including diagnosis and treatment into cardiac rehabilitation (CR), yet the uptake of these 
recommendations remains limited (Anderson et al., 2016, Hare et al., 1995). CR is an important 
phase to implement psychological interventions in order to stimulate psychological well-being, 
disease acceptance, and to reduce depressive or anxiety symptoms. There is rich literature 
which supports CR including psychosocial therapies improving quality of life and health 
outcomes after an MI. (Oldridge et al., 1988, West et al., 2012). According to a meta-analysis 
on the effect of CR programs, findings suggest CR programs reduced mortality and hospital 
readmissions in patients with CAD (Clark et al., 2005). In addition, a home-cased CR program 
has demonstrated to reduce both depression and anxiety symptoms among patients recovering 
from CAD (Lewin et al., 1992). CR has also shown to improve prognosis, heart functioning, 
and HRQL among cardiac patients (Iqbal et al., 2010). More specifically, among all 
components in CR programs, exercise training has been strongly recommended to improve 
quality of life and reduce depression in patients with CVD (van Tol et al., 2006, Taylor et al., 
1986).  
1.10.2 Exercise programs  
It has been well-established that exercise programs in a group setting could be an alternative 
treatment for those with depression, and appear to have the same effect on reduction of 
depression as anti-depressant medications. In the HF-ACTION trial, it was found that the 
exercise group had lower levels of depression at three and 12 months and mortality and 
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hospitalization rates were 10% lower for the exercise group, after adjusting for other relevant 
variables (Blumenthal et al., 2012).  
1.10.3 Cognitive behavioral therapy (CBT) 
Cognitive behavioral therapy (CBT) has been the most studied psychotherapy in patients with 
cardiac disease. CBT aims to treat psychological disorders that arise from negative feelings, 
thoughts and behaviors which occur due to stress. It has been well established that CBT for 
CHD or HF patients has led to major improvements and reduction in depressive or anxiety 
symptoms, compared to other types of care (Cully et al., 2010, Dekker et al., 2012). Further 
studies have suggested that CBT can have a major effect on reduction of depression in cardiac 
patients in combination with other management strategies such as exercise programs and anti-
depressants (Berkman et al., 2003, Gary et al., 2010, Gulliksson et al., 2011).  
1.10.4 Pharmacotherapy and antidepressant medications  
Antidepressants are the most commonly used treatments for depression and a variety of anxiety 
disorders including GAD and PTSD. Selective serotonin reuptake inhibitors (SSRIs), have been 
found to be the most commonly used and effective for the management of depression, GAD 
and PTSD in cardiac patients (Berkman et al., 2003).  
 
1.11 Background in the context of Palestine  
 
 
In Palestine, health is influenced by political, economic and social determinants (Giacaman et 
al., 2003). The historical Palestinian-Israeli war, which began with the Nakba (“catastrophe” in 
Arabic) in 1948, has caused much suffering and distress for the Palestinian population and has 
been continuously affecting their lives physically, mentally, emotionally, and economically. 
Until now, this conflict continues to cause instability and fragmentation throughout the country 
including the healthcare system (Keelan, 2016, Marie et al., 2016). The Palestinian health care 
system is controlled by Israel in terms of healthcare budgets, border crossings, and entry 
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permits. In addition to the occupation, inefficient and underfunding of the existing Palestinian 
healthcare system has been linked to the lack of skilled health professionals as well as 
inadequate healthcare services and affordable medicines, all of which raise challenges in 
tackling the NCD epidemic across the country. Moreover, health care in Palestine including 
hospitals is very basic in comparison to Israeli and other international health care services. 
Restriction of movement across the West Bank has resulted in lack of access to quality 
healthcare to the most vulnerable populations, especially those in rural communities and 
refugee camps, whom are the most marginalized population and have higher rates of NCDs and 
associated risk factors (Keelan, 2016) (Husseini et al., 2009). 
 1.11.1 CVD epidemiology in Palestine 
  
Palestine, a LIC and the focus of this thesis, has been facing the surging burden of NCDs in the 
past several decades causing an epidemiological shift in the health status of the Palestinian 
population (Abu-Rmeileh et al., 2012). In particular, CVDs have become highly prevalent in 
Palestine accounting for 29.5% of all deaths in 2014, making them the largest proportion of 
disease burden on the population (Murray et al., 2012). Approximately 80% of the ministry of 
health’s (MOH) financial expenses is put to fight NCDs. In 2010, IHD contributed to 40% of 
all deaths in the Gaza Strip and 36.7% of all deaths in the West Bank (Mosleh et al., 2018). 
Moreover, Palestine has high rates of CVD-related risk factors: 19.3% for smoking, 46.5% for 
physical inactivity and 26.8% for obesity (Rahim et al., 2014). These numbers are predicted to 
increase in the coming decades, ultimately continuing to increase the prevalence of CVDs 
(Husseini et al., 2009).   
 
1.11.2 Mental health in Palestine  
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The ongoing-conflict in combination with the violence and continued humiliation among 
Palestinian citizens has resulted in high levels of psychological stress. Mental disorders are 
becoming more common, yet are given little attention. Palestinians have been subjected to 
Israeli checkpoints, physical violence, bombardment, massive demolitions, street closures, 
blockades, inadequate healthcare, clashes with Israeli occupation forces, imprisonment and 
discrimination, all of which could be considered risk factors of depressive disorders and have 
substantially contributed to the burden of mental health in the occupied Palestinian territories 
(oPt) (Giacaman et al., 2009, Marie et al., 2016). According to the GBD 2013, major depressive 
disorder (MDD) is the leading cause of YLDs and the third leading cause of DALYs in Palestine 
(Murray et al., 2012). Espié et al. found that 15.3%, 17.3% and 23.2% of citizens suffered from 
depression, anxiety and PTSD in the city of Nablus and Gaza Strip from 2005-2008, (Espié et 
al., 2009). Moreover, Madianos et al. found a prevalence of 24.3% and 10.6% for lifetime and 
one-month prevalence of major depression episode (MDE), respectively in a 2007 West Bank-
based study (Madianos et al., 2012).  
      Mental health services have been managed in the past by the Israeli government after the 
1967 war, and remain underdeveloped and neglected in Palestine. Although there is a need for 
effective secondary prevention and quality mental health care, there is a lack of resources, 
infrastructure and trained professionals. In addition, mental health services are underreported, 
undertreated, under researched and under supported in Palestine.  
     Currently there are only two psychiatric hospitals and approximately 30 psychiatrists serving 
the current 4.8 million people in Palestine (Jabr, 2013 , Awwad, 2016). Both the West Bank 
and Gaza Strip offer governmental and non-governmental services through 42 community 
mental health clinics (CMHCs), however these are not enough to provide care to the large 
proportion of the population that is in need (Jabr, 2013 ). According to the MOH, the CMHCs 
served 87.7 per 100,000 mental health patients in 2013. Among those who visited the clinics, 
24.2% were affected by neurotic disorders, 14.6%  schizophrenia, 10.7% epilepsy, 7.8% other 
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mental disorders and only 1.7% by substance abuse disorders (Marie et al., 2016). In 2015, the 
MOH reported 76, 018 attended the CMHCs, among those, 2735 were new cases (females more 
than males). Adding to the inadequate services to meet the mental health needs of the 
population, the MOH has not considered mental health in its financial budget. Currently only 
2% of the MOH budget has gone towards targeting mental health issues (Awwad, 2016).  
 
1.12 Rationale of thesis 
It is known from Western European and North-American contexts that mental health 
problems go largely unrecognized in cardiac patients. This problem is likely aggravated in 
Palestine, where CVD rates are high and the population faces severe psychological challenges 
in light of the difficult political situation. In addition, the prevalence of mental disorders in 
Palestine is increasing (Marie et al., 2016) and mental health services remain scarce both, 
because of limited resources, but more importantly as a result of the stigmatization of mental 
diseases in the Middle Eastern culture. The evidence base to promote mental health services is 
currently dearth in Palestine.   
     The process towards integrating mental health and cardiac care requires assessment of and 
customization for the specific platform; identification of tasks and human resources for case 
findings and delivery of interventions; and application of the principles of collaborative care, 
care management, and quality improvement. Action needs to be taken through addressing the 
social and political consequences of the conflict in Palestine and evaluating the well-being of 
the population (de Val D’Espaux et al., 2011). With that said, research and implementation 
depend on adequate and reliable screening instruments capable of assessing mental health, well-
being and its determinants in the unique sociocultural context of Palestine. No specific 
screening instruments have been established yet to study the mental health profile in the 
Palestinian adult population or in the subgroup of heart disease patients.  
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     The alarming increase in prevalence of mental disorders and the drastic rise in rates of CVDs 
in Palestine, calls for more studies to be conducted in these cultural settings where patients are 
in particular need for integrated mental health and routine cardiac care. There is a general 
knowledge gap in understanding the factors that mediate and modify the effect of mental 
disorders on the course of CVD, and in the case of this thesis, cardiac disease. Shared risk 
factors between the mental disorders of interest and cardiac disease such as socio-economic 
status, psychosocial factors and other comorbid conditions have been established, however 
whether the coexistence of these individual risk factors with depression increase risk of cardiac 
disease still remains unknown. It is of utmost importance to address these gaps in knowledge 
in order to prevent and treat these comorbid diseases.  
      Research into the effect of mental disorders on the health outcomes and quality of life in 
patients with cardiac disease and also into the effectiveness of screening for and treating mental 
health problems has not been conducted in Palestine. The studies in this thesis investigate the 
role of mental disorders among cardiac patients living in Palestine. The findings of this project 
will increase the awareness of mental health problems and their link to NCD control in various 
Palestinian organizations, health care workers and in the social networks of the participants.  
     This project ultimately sets the basis for intervention research and provides local evidence 
for the need of integrating mental health treatment into cardiac care and to characterize patient 
sub-groups that are likely to benefit most from mental health screening and intervention. The 
findings obtained among this Palestinian population have helped deepen our understanding of 
mental health issues in a unique sociocultural and marginalized setting such as refugee camps, 
the prevalence of which has become a global health issue of major concern. Refugees and 
migrants are population groups undergoing fast epidemiological transitions in the context of 
tremendous mental health pressure. The results from this thesis will provide guidance for 
integrated care provision to these highly susceptible populations.
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OBJECTIVES 
 
This PhD thesis aimed to contribute to a better understanding of the role of mental disorders 
among a well-characterized cohort of cardiac patients in conflict-affected Palestine. Specific 
objectives of this thesis were as follows (Figure 2.1):  
O1. Determine the prevalence and associated factors of depression and anxiety 
O2. Identify socio-demographic, clinical, psychosocial, and lifestyle factors associated 
with a high risk of depressive and anxiety symptoms 
O3. Assess if women are more likely to suffer from depression than men? Determine if 
and what socio-demographic, clinical psychosocial and lifestyle characteristics mediate 
the relationship between gender and depression  
O4. Investigate the longitudinal association of post-traumatic stress disorder (PTSD) 
with health-related quality of life (HRQL) 
O5. Assess the mediating roles of depression, anxiety and stress in the relationship 
between PTSD and HRQL to determine patient sub-groups that are likely to benefit 
most from mental health screening and intervention  
In order to answer objectives 1, 2 and 3 a cross sectional design was performed and to answer 
objectives 4 and 5 a longitudinal design was performed. The results of objectives 1 and 2 are 
presented in Chapter 4, Article I; the results of objective 3 are presented in Chapter 5, Article 
II; and the results of objectives 4 and 5 are presented in Chapter 6, Article III.  
 
28 
Figure 2.1 Conceptualization of thesis objectives  
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3 
 
 
METHODOLOGY 
 
This chapter describes the methodology of the three 
completed studies of this PhD thesis (Chapters 4-6), 
including (a) the study design, (b) study setting, (c) 
study population (d) data collection and 
instrumentation, and (e) ethical considerations. Study 
variables, procedures and analytic approaches specific 
to each study are described within each chapter and 
their respective supplementary material. As each thesis 
study was written as a standalone manuscript for 
publication, some of the methods detailed in this 
chapter will often be repeated in the subsequent 
chapters. 
3.1 Study setting  
 The study took place in four hospitals in the city of 
Nablus, Palestine, which is located in the north of the 
West Bank (figure 3.1) and 49 kilometers from Jerusalem. The city is home to a population of 
over 150,000 people. The four participating hospitals were Al-Watani Hospital 
(governmental), An-Najah National University Hospital (NGO), Arab-Specialized Hospital 
(private) and Al-Arabi Hospital (private).  These hospitals attend a population from both rural 
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and urban areas coming from different cities, villages, and camps from Jenin, Tubas, Tulkarem, 
Salfit, Ramallah, and also southern parts of the West Bank. The study is restricted to the city 
of Nablus for several reasons: budgetary and feasibility constraints given the complications in 
traveling between  different cities in Palestine; the high density of cardiology care in Nablus 
(there are only ten hospitals in the West Bank that offer cardiac services in which four of the 
ten are in Nablus and include either some or all cardiac services including a cardiac surgery 
department, a basic cardiology department and a coronary care unit (CCU); the chosen study 
sites cover a large proportion of the population residing in the North including those in the 
refugee camps. This sets the basis and offers the opportunity for a future population-based heart 
disease registry in the region of Nablus to evaluate and thereby improve quality of cardiac care.  
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3.2 Study design 
A baseline cross-sectional design and a prospective longitudinal design were undertaken to 
assess the role of mental diseases among cardiac patients (Figure 3.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Study population 
3.3.1 Inclusion criteria 
Female and male patients’ ages 30 to 80 years consecutively admitted to one of the 
participating hospitals with a new or pre-existing CVD including CAD, angina, MI, HF, AF or 
any other cardiac-related disease were invited to participate in the study. Patients were only 
recruited at cardiac clinics, cardiology departments or cardiac surgery departments at the 
respective hospitals.  
 
Figure 3.2 Study design for data collection 
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3.3.2 Exclusion criteria  
Patients with stroke, peripheral vascular disease, end-stage kidney disease (including dialysis 
patients), major co-morbidities affecting mental health (alcohol abuse, drug abuse), 
neurological disorders (dementia, Alzheimers, epilepsy, Parkinson’s), cognitive impairment or 
any severe psychiatric condition or any other condition that will affect the quality of responses. 
 
3.4 Data collection 
 3.4.1 Pilot study  
A pilot study was undertaken at An-Najah National University Hospital in the city of Nablus 
between July and August, 2016. Patients visiting the cardiology and orthopedic departments of 
the hospital were considered for the study. Patients in the cardiology department were recruited 
using convenient sampling if they were newly diagnosed or have had a pre-existing cardiac 
diagnosis for a minimum of four months. Patients were excluded if they suffered from a severe 
cardiac disease and were not able to respond to the questionnaire. Patients from the orthopedic 
department were recruited for the control group using convenient sampling. A total of 120 
patients agreed to participate in the pilot study and informed consent was 
obtained from all patients prior to the interviews. Interviews were conducted by previously 
trained field workers and lasted 90 minutes each. 
      The sole purpose of the pilot was to determine the feasibility of conducting the interviews 
within a hospital setting in Palestine, to determine patients perception/attitudes towards the 
questionnaires, time needed to complete the questionnaires, and limitations of the instruments 
and questions used in the questionnaires. The data from the pilot had not been analyzed, 
however, findings from the methodology of the pilot assisted and led to the study design of the 
current studies included in the thesis.  
3.4.2 Baseline study 
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Eligible patients were recruited for in-person interviews from March 2017 until November, 
2017 by the study team which included the PhD student and trained medical research assistants. 
Patients were identified using hospital registries and medical records. Interviews were 
conducted while patients were awaiting treatment (after CATH) or after their treatment, within 
one week of their admission to the hospital. Data was collected using a structured questionnaire 
consisting of two parts (see Appendix II). The first part included detailed socio-demographic 
and clinical information obtained from patients’ administrative and medical charts. The second 
part was administered during a private face-to-face interview and consisted of a sequence of 
screening instruments (see Appendix I) and lifestyle-related questions. Interview responses 
were entered directly into an electronic software (OpenDataKit) using tablets. The 
questionnaire, including the instruments, was translated from English to Arabic and back-
translated from Arabic to English by two bilingual experts. 
3.4.3 Longitudinal study  
All patients that were recruited for the baseline assessment and were included in the baseline 
analysis were invited to participate in a follow-up assessment between June and December, 
2018, approximately 12-months (on average) after initial enrollment. Patients were re-
contacted by telephone and asked to attend an in-person interview at a medical facility in 
Nablus, Palestine. Patients refusing in-person interviews were asked to provide relevant 
information during a phone interview. 
3.4.4 Study variables and Instruments  
All study variables including outcome variables are presented in detail in the upcoming thesis 
chapters 4, 5, and 6. Screening instruments used for both baseline and longitudinal studies are 
described in detail below: 
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Cardiac Depression (CDS). The Cardiac Depression Scale (CDS), by Hare et al., is a 26-item 
questionnaire used to measure depression in patients with CVD (Hare and Davis, 1996). It has 
been used and validated in cardiac patients with a range of diagnoses such as HF, post-MI, 
CAD, and arrhythmias. The CDS has accurate psychometric properties including internal and 
external reliability and validity. Items on the scale are measured on a seven-point Likert scale 
from 1 (strongly disagree) to 7 (strongly agree). CDS scores range from 26-182. The CDS can 
be used as a continuous measure, where higher scores indicate higher depressive symptoms or 
as an ordinal indicator of possible depression using cut-off points previously used in literature 
(Shi et al., 2010). 
Depression, anxiety, stress (DASS-42). Depression, anxiety and stress were additionally 
measured using the Depression Anxiety Stress Scale-42 (DASS-42) by Lovibond & Lovibond. 
The 42-item scale has been validated for clinical and non-clinical samples and has been proven 
to be a reliable screening tool for symptoms of depression, anxiety and stress. Prior studies 
have demonstrated high internal consistency and convergent and discriminant validity of the 
DASS. The questionnaire is divided into three scales (one for each state) each containing 14 
items. Items are scored on a four-point Likert scale ranging from 0 (did not apply to me at all) 
to 3 (applied to me very much) measuring the extent to which each state was experienced over 
the past week. Scores for each of the three scales are determined by summing up the scores and 
categorized into: depression 0-9 (normal), 10-20 (mild-moderate), >21 (severe-very severe); 
anxiety 0-7 (normal), 8-14 (mild-moderate), >15 (severe-very severe); stress 0-14 (normal); 
15-25 (mild-moderate), >26 (severe-very severe) (Lovibond SH, 1995). 
Health-related quality of life (HeartQoL Questionnaire). HRQL at follow-up was assessed 
using the HeartQoL Questionnaire, a 14-item IHD-specific scale, which measures overall 
quality of life. The global HeartQoL score indicates how the patient perceives being bothered 
by their heart disease (Oldridge et al., 2012). In this thesis, the total score was determined by 
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summing up the scores of all 14 items which were assessed on a four-point scale from 0 to 3 
(0=poor and 3=good quality of life). The overall score range was 0-42, with higher scores 
indicating better HRQL.  
Somatic symptoms (PHQ-15). The Patient Health Questionnaire-15 (PHQ-15) is a 15-item, 
somatic symptom scale derived from the full Patient-Health-Questionnaire to measure the 
severity of somatization in patients. Patients were asked to indicate the severity of 15 physical 
symptoms they may have experienced during the past four weeks on a three-point scale 0 (“not 
bothered at all”) to 2 (“bothered a lot”). The total PHQ-15 score was obtained by summing the 
scores of each item and classified as minimal (0-4); mild (5-9); moderate (10-14); and high 
(15-30) with higher scores indicating greater severity of somatic symptoms. Prorated scores 
were calculated if there were unanswered items on the measure (Kroenke et al., 2002). 
Quality of life (SF-12-PCS; SF-12-MCS). Quality of life at baseline was assessed using the 
12-item Short Form Health Survey (SF-12), an alternative to the SF-36 that measures overall 
health status. The SF-12 is comprised of two components, the Mental Component Summary 
(MCS) score and the Physical Component Summary (PCS) score. The SF-12 consists of 12 
items including mental health items (vitality, role-emotional, social function, and mental 
health) and physical health items (physical functioning, physical role, bodily pain). The 
possible scores of the 12 questions range from 0-100, in which lower scores reflect lower levels 
of health and higher scores reflect higher levels of health. The MCS and PCS scores were 
standardized based on data of a US general population using a mean score of 50 and a standard 
deviation (SD) of 10 (Ware et al., 1996). 
Post-traumatic stress disorder (PTSD-PCL-S). The Post-Traumatic Stress Disorder Checklist 
(PTSD-PCL-S) is a 17-item scale used to assess PTSD symptoms based on the DSM-IV 
criteria. Each item in the checklist is scored from 1 (not at all) to 5 (extremely), indicating the 
extent to which the patient has been bothered by the symptom in the past month. A total 
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symptom severity score is calculated. The range of the total score is divided into four categories 
of PTSD symptom severity:  “little” (17-29), “some” 28-29 “moderate-moderately high” (30-
44), and ”high” (45-85) (Blanchard et al., 1996). 
Social Support (ESSI). Social support was assessed using the seven-item ENRICHD 
(Enhancing Recovery in Coronary Heart) Social Support Instrument (ESSI) comprised from 
the Medical Outcomes Survey (MOS) and assesses for four components of social support 
including emotional, instrumental informational and appraisal. The ESSI has been used in 
previous studies on cardiac populations with post-MI and CAD. It has demonstrated high 
internal consistency, reliability, and good convergence. Items on the ESSI are summed up for 
a total score with item categories ranging from 1 (none of the time) to 5 (all of the time). 
Patients who score ≤18 on the scale are considered to have low social support and meet the 
ENRICHED eligibility criteria (The ENRICHD investigators, (2000b, 2001)).  
Self-esteem (SISE).The Single-Item Self-Esteem Scale (SISE) is a one-item scale developed 
as an alternative of the Rosenburg Self-Esteem scale, which is used to measure self-esteem. It 
is based on a seven-point Likert scale from 1 (not very true of me) to 7 (very true of me) (Lett 
et al., 2004). 
Resilience (RS-14). Resilience Scale-14 (RS-14) is a 14-item questionnaire that assesses 
resilience in a general population. The RS-14 is comprised of five characteristics of the 
resilience core, including purpose, perseverance, self-reliance, equanimity, and authenticity. 
Items of the RS-14 are scored on a seven-point Likert scale from 1 (strongly disagree) to 7 
(strongly agree). Total scores range from 14 to 98, and are categorized as very low (14-56); 
low (57-64); on the low end (65-73); moderate (74-81); moderately high (82-90) and high (91-
98) resilience levels (Wagnild and Guinn, 2009). 
 
3.5 Ethical considerations 
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The studies of this PhD thesis were carried out in accordance with the principles of ethics of 
the Declaration of Helsinki (DoH). The study protocols and questionnaires were submitted to 
the responsible ethics committees. Ethical approval was obtained from the Ethics Committee 
of Basel-Stadt and Basel-Land in Basel, Switzerland and from the Institutional Review Board 
(IRB) committee at An-Najah National University in Nablus, Palestine. Informed consent 
forms in Arabic, stating study objectives, purpose and significance of study were distributed to 
all participating patients prior to the beginning of the cross-sectional study and longitudinal 
study.  
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Abstract 
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Background. Mental health problems have an adverse effect on the course of cardiac disease. 
The integration of their diagnosis and treatment into cardiology care is generally poor. It is 
particularly challenging in cultural environments where mental health problems are 
stigmatized.  The objective of the current study was to investigate the proportion of cardiac 
patients with depression and anxiety as well as factors associated with the presence of these 
symptoms in a Palestinian population.  
Methods. This cross-sectional hospital-based study was conducted on patients consecutively 
admitted with a new or existing cardiac diagnosis to one of the four main hospitals in Nablus, 
Palestine over an eight-month period. Data was obtained from hospital medical charts and an 
in-person interview, using a structured questionnaire with a sequence of validated instruments. 
All subjects were screened for depression and anxiety using the Cardiac Depression Scale 
(CDS) and the Depression Anxiety Stress Scale (DASS-42). Multivariate ordered logistic 
regression analyses were performed to identify factors among four categories (socio-
demographic, clinical, psychosocial, lifestyle) independently associated with depression and 
anxiety. 
Results. In total, 1053 patients with a confirmed cardiac diagnosis were included in the study 
with a participation rate of 96%. Based on the CDS and DASS-42, 54% met the criteria for 
severe depression (CDS >100) and 19.2% for severe-to-very severe anxiety (DASS-anxiety 
>15), respectively. Symptoms of depression and anxiety were more prevalent among females 
and less educated patients. Factors independently associated with both depressive and anxiety 
symptoms were post-traumatic stress disorder symptoms, low levels of self-esteem, high 
somatic symptoms, low physical and mental health component scores, active smoking, physical 
inactivity, and longer disease duration. Patients with depressive and anxiety symptoms also 
reported poor social support and lower resilience. 
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Conclusion. There was a high level of depression and anxiety in this sample of cardiac patients. 
The results point to characteristics of patients in particular need for mental health screening 
and suggest possible targets for intervention such as strengthening of social support and of 
physical activity. The integration of mental health services into cardiac rehabilitation in 
Palestine and comparable cultural settings is warranted from the time of first diagnosis and 
onward.   
Keywords: Depression, anxiety, cardiovascular diseases, predictors, prevalence, cardiac 
rehabilitation  
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4.1 Background 
 
Cardiovascular diseases (CVDs) and depression are among the leading causes of the global 
disease burden (Murray et al., 2012). CVDs are the most common cause of death accounting 
for 17.9 million deaths globally, in 2015 (Roth et al., 2017). Depression affects over 300 million 
people around the world (WHO, 2012), and is expected to become the main cause of disability 
globally, in 2030 (Mensah and Collins, 2015). Similarly, in 2010, anxiety affected 
approximately 272 million people, worldwide (Baxter et al., 2014).  
     There is a high prevalence of mental disorders, particularly depression and anxiety, in CVD 
patients (Rutledge et al., 2009b). The bidirectional link between CVDs and these mental 
disorders has been extensively documented in literature (Lippi et al., 2009, Holt et al., 2013, 
Riba M, 2011). Approximately, 15-30% of patients with CVD suffer from depressive disorders 
(Lesperance and Frasure-Smith, 2000, Frasure-Smith and Lesperance, 2006a, Rudisch and 
Nemeroff, 2003, Thombs et al., 2008, Carney and Freedland, 2008). These rates of depression 
are two to three times higher than in the general population (Kessler et al., 2003). Moreover, 
depression and anxiety have been found to worsen prognosis and quality of life in patients with 
coronary artery disease (CAD), myocardial infarction (MI), heart failure (HF), unstable angina, 
and coronary artery bypass grafting (CABG) (Lett et al., 2004, Nicholson et al., 2006, Rutledge 
et al., 2006, Jiang et al., 2001, de Jonge et al., 2006, Blumenthal et al., 2003, de Jager et al., 
2018). CABG is defined as a surgical procedure that is performed to treat people who have 
severe coronary heart disease, which improves blood flow to the heart (Harris et al., 2013). 
They were also found to be the biggest driver of health care costs in coronary heart disease 
(CHD) patients (Palacios et al., 2018).  
     Mental health problems have a direct physiological effect on the course of cardiac disease 
and their adverse effect may be mediated by non-compliance to lifestyle interventions, 
treatment and medication (Chaddha et al., 2016, Lichtman et al., 2008). Furthermore, these 
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mental disorders add to the burden of managing CVD, from a perspective of treatment 
complexity and emotional distress. This problem is further aggravated by the high rate of 
additional co-morbidities such as diabetes, hypertension and obesity (Leon and Maddox, 2015). 
     The American Heart Association (AHA) has recommended routine depression screening in 
cardiac patients (Lichtman et al., 2008). However, health systems have not yet adequately 
responded and less than 15% of cardiac patients are being diagnosed and treated for depression 
(Huffman et al., 2006).  Integrating mental health into cardiac treatment is of particular 
relevance in low-middle-income countries (LMICs), where the burden of depression and 
anxiety is often high and aggravated by adverse life and political conditions. Similarly, mental 
health problems are stigmatized in many of these non-western cultures (Rathod et al., 2017). 
Little is known on the prevalence of depression and anxiety among cardiac patients in LMICs 
(Ormel et al., 2007). This also applies to Palestine, where mental disorders commonly are not 
recognized, diagnosed or treated, despite the increase in their prevalence (Marie et al., 2016).  
Unaddressed mental care needs may be an important barrier to the successful management of 
cardiac patients in Palestine, where CVD remains the leading cause of death (Mosleh et al., 
2018). 
     Mental health problems have not been studied in cardiac patients in the Palestinian 
population. Therefore, the aim of the current study was to determine the proportion of patients 
with depression and anxiety symptoms admitted with a cardiac diagnosis, to one of the four 
main hospitals in Nablus, Palestine. To guide physicians in effective mental health screening 
in the future, we also identified socio-demographic, clinical, psychosocial, and lifestyle factors 
associated with a high risk of depression and anxiety symptoms.   
 
 
 
4.2 Methods  
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4.2.1 Study design and population  
      This cross-sectional hospital-based  study was conducted on patients consecutively 
admitted to the cardiology and cardiac surgery departments of  An-Najah National University 
Hospital, Arab-Specialized Hospital, Watani Hospital and Nablus Specialized Hospital in the 
Northern West Bank city of Nablus, Palestine. Patients were eligible for the study if they were 
between 30 and 80 years of age and had an existing or newly confirmed cardiac diagnosis 
warranting hospitalization during the period between March and November 2017. In the 
present study, cardiac diagnoses considered included CAD, ST elevation or non-ST elevation 
MI, angina, HF, cardiac arrhythmia, valve disease or any other cardiac disease. Diagnoses were 
confirmed using hospital medical charts. Patients were excluded if they had a normal cardiac 
catheterization (CATH), an acute or past stroke, end-stage kidney disease (including dialysis 
patients), peripheral vascular disease, major co-morbidities affecting mental health (alcohol 
abuse, drug abuse), neurological disorders (dementia, Alzheimer’s disease, epilepsy, 
Parkinson’s disease), cognitive impairment, a severe clinically diagnosed psychiatric condition 
or any other condition affecting the quality of their responses.  
     Eligible patients were recruited for in-person interviews by trained medical research 
assistants. Patients were identified using hospital registries and medical records. Interviews 
were conducted while patients were awaiting treatment (after CATH) or after their treatment, 
within one week of their admission to the hospital. Eligible patients were informed about the 
study objectives and benefits and written informed consent was obtained from those who 
agreed to participate. The study was approved by the Ethics Committee of Nordwest-und 
Zentral Schweiz (EKNZ) in Basel, Switzerland, and by the Institutional Review Board (IRB) 
committee at An-Najah National University in Nablus, Palestine.  
 
4.2.2 Study assessments and measures  
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     Data was collected using a structured questionnaire consisting of two parts (Table 4.1). The 
first part included detailed socio-demographic and clinical information obtained from patients’ 
administrative and medical charts. 
 
Table 4.1. Predictor blocks used in bivariate and ordered logistic regression analyses 
Block Variable  
1 Socio-demographic factors Age, gender, marital status, residence, education level, 
occupation 
 
2 Clinical factors  Current diagnosis, previous cardiac diagnoses, years 
with cardiac disease, cardiac treatment (at admission), 
co-morbidities, medications, somatic symptoms 
(PHQ-15), family history of CVD, QoL (SF-12-PCS) 
 
3 Psychosocial factors PTSD (PTSD-PCL-S), social support (ESSI), 
resilience (RS-14), self-esteem (SISE), QoL (SF-12-
MCS) 
 
4 Lifestyle factors  Smoking status, currently on diet, fat consumption, 
vegetable and fruit consumption,  alcohol use, 
physical activity, BMI 
Note. CVD= cardiovascular disease; QoL= quality of life; PHQ-15= Patient Health Questionnaire-15; PCS= 
Physical Component Summary; PTSD=post-traumatic stress disorder; PTSD-PCL-S=Post-Traumatic Stress 
Disorder Checklist; ESSI= ENRICHD Social Support Instrument; RS-14= Resilience scale-14; MCS= Mental 
Component Summary; BMI= body mass index  
 
     The second part was administered during a private interview and consisted of a sequence of 
screening instruments. These validated tools have demonstrated to be suitable for clinical 
populations to assess for depression and anxiety symptoms, quality of life, posttraumatic stress 
disorder (PTSD), social support, resilience, self-esteem, somatic symptoms and lifestyle 
behaviors. The questionnaire, including the instruments, was translated from English to Arabic 
and back-translated from Arabic to English by two bilingual experts.  
 
 
 
 
 
Table 4.2. Study Instruments (see Chapter 3, p. 32 for further descriptions)   
Instrument  Description  
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Outcomes - assessment of depression, anxiety and stress  
Cardiac Depression (CDS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depression, anxiety, stress (DASS-42) 
 
 
 
 
 
 
The primary outcome of the study was measured using the 
Cardiac Depression Scale (CDS) by Hare et al., a disease-
specific, 26-item questionnaire used to measure depression in 
patients with CVDs. CDS scores range from 26-182, and items 
are scored on a seven-point Likert scale from 1 (strongly 
disagree) to 7 (strongly agree) (Hare and Davis, 1996). The CDS 
can be used as a continuous measure, where higher scores 
indicate higher depressive symptoms or as an ordinal indicator 
of possible depression using cut-off points previously used in 
literature. In this study, the presence of mild-to-moderate 
depression was defined as a CDS score of 90-100 and the 
presence of severe depression as a score ˃100. Scores below 90 
indicated no-to-minimal depression (Wise et al., 2006). 
 
Depression (DASS-depression), anxiety (DASS-anxiety) and 
stress (DASS-stress) were measured using the Depression 
Anxiety Stress Scale-42 (DASS-42) by Lovibond & Lovibond, 
a 42-item questionnaire consisting of three subscales, each 
containing 14 items scored on a four-point Likert scale ranging 
from 0 (did not apply to me at all) to 3 (applied to me very much), 
measuring the extent to which each item was experienced over 
the past week. The scores are classified as:  depression 0-9 
(normal), 10-20 (mild-moderate), >21 (severe-very severe); 
anxiety 0-7 (normal), 8-14 (mild-moderate), >15 (severe-very 
severe); stress 0-14 (normal); 15-25 (mild-moderate), >26 
(severe-very severe) (Lovibond SH, 1995). 
 
Predictors – correlates of depression and anxiety 
Somatic Symptoms (PHQ-15) 
 
 
 
 
Quality of life (SF-12-PCS; SF-12-MCS)  
 
 
 
 
 
Post-traumatic stress disorder (PTSD-PCL-
S) 
 
 
 
 
 
Social Support (ESSI) 
 
 
 
 
 
 
Self-esteem (SISE) 
 
 
 
Resilience (RS-14) 
The Patient Health Questionnaire (PHQ-15) is a 15-item somatic 
symptom scale derived from the full Patient-Health-
Questionnaire to measure the severity of somatization in patients 
(Kroenke et al., 2002). 
 
Quality of life was assessed using the 12-item Short-Form Health 
Survey (SF-12), which is a generic measure of overall health 
status. The SF-12 is comprised of two components, the Mental 
Component Summary (MCS) score and the Physical Component 
Summary (PCS) score (Ware et al., 1996). 
 
The Post-Traumatic Stress Disorder Checklist (PTSD-PCL-S) is 
a 17-item scale used to assess PTSD symptoms based on the 
Diagnostic and Statistical Manual of Mental Disorders (DSM 
IV) criteria. The PTSD-PCL-S is used to link symptom 
endorsements to a specific stressful or traumatic event or 
experience (Blanchard et al., 1996). 
 
The ENRICHD (Enhancing Recovery in Coronary Heart) Social 
Support Instrument (ESSI) is a seven-item scale comprised from 
the Medical Outcomes Survey (MOS). It assesses four 
components of social support including emotional, instrumental, 
informational and appraisal (2000b, 2001). 
 
The Single-Item Self-Esteem Scale (SISE) is a one-item scale 
developed as an alternative of the Rosenburg Self-Esteem scale 
(Robins et al., 2001). 
 
Resilience Scale (RS-14) is a 14-item questionnaire that assesses 
individual resilience in a general population (Wagnild and 
Guinn, 2009). 
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4.2.3 Statistical analyses  
 
     The primary endpoints in the present study were depression and anxiety. The four predictor 
blocks investigated for association with depression and anxiety were socio-demographic, 
clinical, psychosocial and lifestyle factors (Table 4.S1). Descriptive statistics for stress as an 
endpoint are presented in Table 4.S2, with no further description. Endpoints and predictors 
were described as means and standard deviations (SD) for quantitative variables and as absolute 
values and percentages for categorical variables. Differences in predictor variables according 
to presence or absence of depression and anxiety symptoms were described using chi-squared 
test and the Wilcoxon rank sum test, as appropriate. Fisher’s exact test was used for results 
presenting a frequency below five. Multivariate ordered logistic regression analyses were 
performed to examine the independent association between predictor variables and depression 
or anxiety symptoms. All variables were entered in each of the models at once. Results are 
presented in separate models for depression and anxiety and are expressed as odds ratio (OR) 
and 95% confidence intervals (95% CI). The cut-offs for the respective outcome variables were 
normal, mild/moderate, and severe/very severe according to standardized cut-offs. Correlations 
between the outcome variables and other instruments used in the study were assessed using 
Spearman’s rank correlation coefficient. Cronbach alpha was used to assess the internal 
consistency of the different scales. Statistical significance was defined as a two-sided p-value 
˂0.05. All data was analyzed using the STATA Data Analysis and Statistical Software, version 
14. 
4.3 Results  
     In total, 1092 patients were eligible and approached for an interview. Among the 1053 
(96%) patients which agreed to participate in the study, 1022 patients with complete outcome 
and predictor information were used in the analysis.  
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4.3.1 Characteristics of study population 
Characteristics of the participants are presented in Table 4.3. 
Socio-demographic factors. Among the 1022 patients, 73.4% were males. The mean age of 
patients was 58.9±10.1 years (range 30-80 years). The majority of participants were married 
(90.6%), 37% were unemployed, and 58.7% did not have a high school diploma. Most of the 
study population lived in cities (46.4%) or villages (46.3%), while 7.3% resided in refugee 
camps.  
Clinical factors. The primary diagnoses among the sample were MI (39.7%), CAD (32.7%), 
angina (15.9%) and other diagnoses (11.7%), including mitral or aortic valve stenosis, valve 
regurgitation, heart block and others. Among the category of other diagnoses, 29 (2.8%) 
patients had heart failure. Over 60% of participants had a previous cardiac diagnosis and had 
been diagnosed with a cardiac disease for one year or less. About half of participants underwent 
a CATH with a stent (52.2%), while others underwent a CATH with a CABG (23.5%), or some 
kind of other procedure (24.3%), which was not yet performed at the time of the interview. 
Forty one percent of participants reported having two or more co-morbidities (mainly diabetes 
and hypertension) and 72.2% were on three or more medications. In addition, more than half 
of the participants’ reported a family history of CVD. Approximately 37% of participating 
patients exhibited high somatic symptoms on the PHQ-15. The mean score of the participants 
on the SF-12- PCS score was 37.6 ±12.4.      
Psychosocial factors. Forty Percent of patients reported having PTSD symptoms on the PTSD-
PCL-S. Social support was generally high (64%) among participants, according to the ESSI. 
Almost half of the participants presented with moderate to moderately-high resilience. The 
mean score for self-esteem was 5.8±1.4, while the mean score for the SF-12-MCS was 
39.7±13.2.  
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Lifestyle factors. Almost half of the participants were current smokers while 35.6% had never 
smoked before. The vast majority of participants (83.4%) reported not being on a diet, 47% 
low fat consumption, and 55.5% high vegetable and fruit consumption. The reported alcohol 
consumption was very low with 95% of participants not consuming any alcohol. Almost half 
of the patients reported no-to-minimal daily physical activity. Eighty percent of patients were 
either overweight or obese. 
 
Table 4.3. Socio-demographic, clinical, psychosocial and lifestyle characteristics of study 
population, (n=1022) 
Variable  n (%) Variable  n (%) 
Socio-demographic factors 
Age, mean (SD) 
Gender  
     Female  
     Male  
Marital status 
     Married  
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree  
     No HS diploma  
     HS diploma  
     College degree  
Occupation  
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
 
Clinical factors  
Cardiac diagnosis  
     CAD 
     MI 
     Angina  
     Other  
Previous cardiac diagnosis  
     Yes 
     No  
Years with cardiac disease  
     ≤1 year  
     2-9 years  
     ≥10 years  
Cardiac treatment  (at admission) 
     CATH/stent  
     CATH/CABG  
     CATH/other & unknown  
 
58.9±10.1 
 
272 (26.6) 
750 (73.4) 
 
926 (90.6) 
   96 (9.4) 
 
474 (46.4) 
473 (46.3) 
    75 (7.3) 
 
600 (58.7) 
167 (16.3) 
255 (25.0) 
 
209 (20.5) 
307 (30.0) 
378 (37.0) 
81 (7.9) 
    47 (4.6) 
 
 
 
334 (32.7) 
406 (39.7) 
162 (15.9) 
120 (11.7) 
 
690 (67.5) 
332 (32.5) 
 
628 (61.5) 
255 (24.9) 
139 (13.6) 
 
534 (52.2) 
240 (23.5) 
248 (24.3) 
Psychosocial factors  
PTSD (PTSD-PCL-S) 
       Minimal  
       Some  
       Moderate  
       High  
Social support (ESSI) 
       Low   
       High  
Resilience (RS) 
       Very low  
       Low  
       Low-end  
       Moderate  
       Moderately-high 
       High  
Self-esteem (SISE) score,  
mean (SD) 
QoL,(SF-12-MCS score),  
mean (SD)    
 
 
 
Lifestyle factors  
  Smoking status  
       Never  
       Former  
       Current 
  Currently on diet  
       Yes 
       No 
  Fat consumption 
       Low 
       Medium  
       High  
  Vegetable & fruit consumption      
       Low 
       Medium  
       High  
Alcohol use, (n=1019) 
 
 
611 (59.7) 
    95 (9.3) 
253 (24.8) 
    63 (6.2) 
 
364 (35.6) 
658 (64.4) 
 
    92 (9.0) 
103 (10.1) 
204 (20.0) 
257 (25.1) 
274 (26.8) 
    92 (9.0) 
5.8±1.4 
 
39.7±13.2 
 
 
 
 
 
 
364 (35.6)           
170 (16.6) 
488 (47.8) 
  
 170 (16.6) 
 852 (83.4) 
 
 480 (47.0) 
 323 (31.6) 
 219 (21.4) 
 
 102 (10.0) 
 353 (34.5) 
 567 (55.5) 
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Note. HS= high school; MI= myocardial infarction; CAD= coronary artery disease; CATH= catheterization; 
CABG= coronary artery bypass graft; CVD= cardiovascular disease; PHQ-15= Patient Health Questionnaire-15; 
PCS= Physical Component Summary; QoL= quality of life; SD= standard deviation; PTSD=post-traumatic stress 
disorder; PTSD-PCL-S=Post-Traumatic Stress Disorder Checklist; ESSI= ENRICHD Social Support Instrument; 
RS-14= Resilience scale-14; MCS= Mental Component Summary; BMI= body mass index  
 
4.3.2 Proportion of patients with depressive and anxiety symptoms at different severity levels 
     Table 4.4 shows the proportion of patients with depression (CDS), depression (DASS-
depression), anxiety (DASS-anxiety) and stress (DASS-stress) symptoms at different severity 
levels. Cutoffs for the levels of CDS and DASS subscales are also presented in Table 4.4. Based 
on our findings, the mean ± SD depression score on the CDS was 101.3±15.6 and the overall 
proportion of patients with depression was 78.7%. According to the recommended cutoffs for 
the CDS, 21.3%, 25.2% and 53.5% of the sample had no, mild-to-moderate and severe-to-very 
severe depression symptoms, respectively. The means ± SDs on the DASS-42 were 9.4±8.6, 
9.4± 6.8 and 15.2± 9 for depression, anxiety, and stress, respectively. It was found that the 
overall proportion was 52.9%, 53.1% and 37.4% for the presence of depressive, anxiety and 
stress symptoms according to the DASS-42.  Based on recommended cutoffs, 47.1%, 33.4% 
and 19.5% of patients reported normal, mild-to-moderate and severe-to-very severe depressive 
symptoms (DASS-depression). In addition, 46.9% patients did not report any anxiety, while 
33.9% reported mild-to-moderate anxiety and 19.2% reported severe-to-very severe anxiety 
Co-morbidities  
     None  
     One 
     Two or more  
Medications  
     None 
     1-2  
     3-4  
Somatic symptoms (PHQ-15) 
     Minimal      
     Low  
     Medium      
     High  
Family history  
     Yes  
     No  
QoL, (SF-12-PCS score), mean 
(SD) 
 
299 (29.3) 
303 (29.6) 
420 (41.1) 
 
132 (12.9) 
152 (14.9) 
738 (72.2) 
 
91 (8.9) 
241 (23.6) 
314 (30.7) 
376 (36.8) 
 
614 (60.1) 
408 (39.9) 
37.6±12.4 
       Yes 
       No  
Physical activity  
       None 
       Not daily 
       Daily 
 
 
    49 (4.8) 
 973 (95.2) 
 
 337 (33.0) 
 189 (18.5) 
 496 (48.5) 
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symptoms. According to the stress scale, 62.6% reported having no stress, 30% reported having 
mild-moderate stress symptoms and 7.4% severe-very severe stress symptoms. Patients that 
had mild-moderate and severe-very severe symptoms of depression or anxiety according to the 
DASS-42 were more likely to have severe depressive symptoms on the CDS. Nevertheless, 8 
(4.0%) and 9 (4.6%) patients without any signs of depressive symptoms on the CDS, showed 
symptoms of depression and anxiety, respectively, on the DASS-42. 
 
Table 4.4. Proportion of patients with CDS-depression, DASS-depression, DASS-anxiety, 
DASS-stress at different severity levels, (n=1022) 
 Depression, anxiety, stress according to 
CDS levels 
 
Normal 
n (%) 
Mild-             
Moderate 
n (%) 
Severe-very     
severe 
n (%) 
Percentage above 
normal level 
CDS CDS<90             
218 (21.3) 
 
CDS 90-100 
257 (25.2) 
CDS>100            
547 (53.5) 
78.7 
DASS-depression (D≥10) 
Normal (0-9) 
Mild/moderate (10-20) 
Severe/very severe (21-42) 
 
481 (47.1) 
166 (34.5) 
44 (12.9) 
8 (4.0) 
 
341 (33.4) 
164 (35.1) 
82 (24.1) 
11 (5.5) 
200 (19.5) 
151 (31.4) 
215 (63.1) 
181 (90.5) 
52.9 
DASS-anxiety, (A≥7) 
Normal (0-6) 
Mild/moderate (7-14) 
Severe/very severe (15-42) 
479 (46.9) 
152 (31.7) 
57 (16.4) 
9 (4.6) 
 
347 (33.9) 
164 (34.2) 
77 (22.2) 
16 (8.2) 
196 (19.2) 
163 (34.0) 
213 (61.4) 
171 (87.2) 
53.1 
DASS-stress, (S≥15)                                   
Normal (0-14) 
Mild/moderate (15-25) 
Severe/very severe (26-42) 
640 (62.6) 
178 (27.8) 
36 (11.7) 
4 (5.3) 
307 (30.0) 
206 (32.2) 
44 (14.3) 
7 (9.3) 
75 (7.4) 
256 (40.0) 
227 (73.9) 
64 (85.3) 
37.4 
Note. CDS= Cardiac Depression Scale; DASS= Depression, Anxiety, Stress Scale 
 
4.3.3 Unadjusted correlations between continuous scores of the scales used in study       
Spearman correlation coefficients were calculated between the CDS and other instruments used 
in the study (figure 4.1). The correlation of the CDS with the DASS-depression was =0.57 
(p=<0.001), with DASS-stress =0.51 (p<0.001), and with DASS-anxiety =0.50 (p<0.001). The 
correlations between the DASS subscales were as follows:  DASS-depression and DASS-
anxiety (0.65, p<0.001); DASS-depression and DASS-stress (0.63, p<0.001); DASS-anxiety 
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and DASS-stress (0.61, p<0.001). CDS was positively correlated with the PHQ-15 (0.44, 
p<.001) and the PTSD-PCL-S (0.37, p<.001) and the DASS-depression was also positively 
correlated with the PTSD-PCL-S (0.57, p<.001).  
     The above cluster of positively associated factors were weakly correlated to the physical 
and mental quality of life components of the SF-12, social support, resilience, and self-esteem, 
which were strongly correlated among each other.  Specifically, weak correlations were 
observed between CDS and the SF-12-MCS (-0.39, p<0.001), SF-12-PCS (-0.29, p<0.001), 
ESSI (-0.12 p<0.001), RS-14 (-0.24, p<0.001) and with the self-esteem scale (-0.23, p<0.001).  
 
4.3.4 Association between socio-demographic, clinical, psychosocial, lifestyle factors and 
depressive and anxiety symptoms  
The bivariate distribution of socio-demographic, clinical, psychological, and lifestyle 
characteristics according to the presence or absence of depression symptoms (CDS), anxiety 
symptoms (DASS-anxiety) and stress symptoms (DASS-stress) is presented in Table 4.S1 
(depression (CDS) and anxiety)]  and Table 4.S2 (stress)].  Briefly, with regard to socio-
demographic factors, bivariate analysis revealed depressive and anxiety symptoms were more 
frequent among females than males (depression: 84.9% vs. 76.4%, p=0.003; anxiety: 72.4% 
vs. 55.6%, p=<0.001) and among  those with lower educational level (depression: 81.0% [no 
high school diploma] vs. 78.0% [high school diploma] and 71.1% [college degree], p=0.02; 
anxiety: 63.2% [no high school diploma] vs. 59.8% (high school diploma) and 52.8% (college 
degree), p<0.05). Both, depressive and anxiety symptoms were most prevalent among those 
unemployed and housewives (depression: p<0.001; anxiety: p<0.001). 
     Multivariable ordered logistic regression was performed to determine the independent 
association of factors in the four predictor blocks with a) depressive symptoms, categorized as 
no depressive symptoms, moderate depressive symptoms, and severe depressive symptoms 
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according to the CDS and b) anxiety symptoms, categorized as minimal anxiety symptoms, 
mild-moderate anxiety symptoms, and severe-severe anxiety symptoms according to the 
DASS-anxiety subscale. The results for the four blocks of variables are presented in table 4.5.  
     Overall, most of the psychosocial factors were consistently associated with both, depression 
and anxiety. Participants with depression or anxiety were more likely to exhibit at least some 
symptoms of PTSD. Odds ratios tended to be higher for anxiety than for depression (moderate 
symptoms vs. minimal symptoms: ORdepresssion 1.87 (95% CI 1.29-2.71) vs. ORanxiety 3.01 (95% 
CI 2.12-4.27). Patients with depression or anxiety had a lower score for the mental component 
of quality of life (SF-12-MCS) [ORdepression 0.96 (95% CI 0.95-0.97); ORanxiety 0.98 (95% CI 
0.97-0.99)]. High resilience and high social support were inversely associated with depression 
and anxiety [high vs. low social support: ORdepression 0.71 (95% CI 0.52-0.97); ORanxiety 0.74 
(95% CI 0.54-1.00)]. The inverse association with resilience tended to be stronger in the 
presence of anxiety [high vs. very low resilience: ORdepression 0.42 (95% CI 0.18-0.94); ORanxiety 
0.22 (95% CI 0.11-0.48)].  
     In addition to psychosocial factors, the physical component of quality of life (SF-12-PCS) 
and somatic symptoms (PHQ-15) also showed consistent associations with both depression and 
anxiety [high vs. minimal somatic symptoms: ORdepression 3.00 (95% CI 1.73-5.18); ORanxiety 
7.64 (95% CI 3.96-14.78)]; [SF-12-PCS: ORdepression 0.98 (95% CI 0.97-1.00); ORanxiety 0.97 
(95% CI 0.96-0.99)].  Current smoking was associated with depression with the strongest odds 
ratio observed for depression and former smoking: OR 1.87 (95% CI 1.17-2.97). Finally, 
patients with depression and anxiety were more likely to be physically inactive compared to 
patients without the respective psychological problems. 
      A few factors exhibited associations with only one of the two mental health outcomes. For 
example, patients residing in villages or camps were less likely to show symptoms of anxiety 
compared to patients living in the city [(ORvillage 0.74 (0.54-1.00); ORcamp 0.56 (0.31-1.01)]. 
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Unemployment was positively associated with depression, but not anxiety.  The presence of 
previous cardiac diagnoses was positively associated with anxiety, but inversely associated 
with depression [(ORdepression 0.67 (95% 0.47-0.96); ORanxiety 1.52 (95% 1.05-2.21)]. Symptoms 
of depression were more frequent among patients with a cardiac diagnosis for more than ten 
years compared to patients with a diagnosis for a year or less [years since first diagnosis ≥10 
vs. ≤ 1 year OR 1.71 (95% 1.06-2.75)]. Patients who were diagnosed with angina were more 
likely to have anxiety symptoms than those diagnosed with an MI. Underweight and obese 
participants were more likely to exhibit symptoms of anxiety than those of normal weight and 
overweight. 
Figure 4.1 Spearmen correlations between CDS, DASS-depression, DASS-anxiety,  
DASS-stress and other instruments used in the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CDS= Cardiac Depression Scale; PHQ= Patient Health Questionnaire-15; PTSD= Post-Traumatic Stress 
Disorder; MCS= Mental Component Summary; PCS= Physical Component Summary; RS= Resilience Scale-14; 
SE= Self-esteem; ESSI= ENRICHD Social Support Instrument.  
Blue colors represent positive correlations and red colors represent negative correlations. Correlations measured 
are expressed as rho spearman. 
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Table 4.5 Factors associated with DEPRESSION and ANXIETY in multivariate ordered 
logistic regression 
 Depression (CDS) Anxiety (DASS-anxiety) 
Variable OR        95% CI P value     OR    95% CI P value 
Socio-demographic factors  
Age, mean (SD) 
Gender  
     Female  
     Male  
Marital status 
     Married 
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree  
     No HS diploma  
     HS diploma  
     College degree  
Occupation  
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
 
Clinical Factors  
Cardiac diagnosis  
     CAD 
     MI 
     Angina  
     Other  
Previous cardiac diagnosis  
     Yes 
     No  
Years with cardiac disease  
     ≤1 year  
     2-9 years  
     ≥10 years  
Cardiac treatment  (at 
admission) 
     CATH/stent  
     CATH/CABG  
     CATH/other & unknown  
Co-morbidities  
     None 
     1 
     2+ 
Medications  
     None 
     1-2  
     3-4  
Somatic symptoms (PHQ-15) 
     Minimal      
     Low  
     Medium      
     High  
Family history  
0.99 
 
(reference) 
0.83 
 
(reference) 
0.38 
 
(reference) 
1.22 
1.35 
 
(reference) 
1.15 
1.19 
 
(reference) 
0.85 
1.12 
0.71 
0.33 
 
 
 
0.89 
(reference) 
1.26 
0.82 
 
0.67 
(reference) 
 
(reference) 
1.46 
1.71 
 
 
(reference) 
1.42 
1.34 
 
(reference) 
0.93 
1.39 
 
(reference) 
1.33 
1.19 
 
 
(reference) 
1.18 
1.86 
3.00 
(0.98-1.00) 
 
 
(0.51-1.36) 
 
 
(0.22-0.65) 
 
 
(0.91-1.64) 
(0.76-2.40) 
 
 
(0.82-1.62) 
(0.76-1.87) 
 
 
(0.55-1.31) 
(0.67-1.88) 
(0.38-1.33) 
(0.14-0.80) 
 
 
 
(0.63-1.25) 
 
(0.83-1.92) 
(0.49-1.37) 
 
(0.47-0.96) 
 
 
 
(1.00-2.13) 
(1.06-2.75) 
 
 
 
(0.98-2.04) 
(0.95-1.89) 
 
 
(0.64-1.34) 
(0.94-2.04) 
 
 
(0.78-2.29) 
(0.74-1.92) 
 
 
 
(0.72-1.94) 
(1.12-3.08) 
(1.73-5.18) 
0.393 
 
 
0.469 
 
 
0.001 
 
 
0.191 
0.308 
 
 
0.421 
0.449 
 
 
0.472 
0.662 
0.289 
0.014 
 
 
 
0.508 
 
0.271 
0.440 
 
0.028 
 
 
 
0.048 
0.028 
 
 
 
0.065 
0.097 
 
 
0.695 
0.096 
 
 
0.293 
0.470 
 
 
 
0.506 
0.015 
<0.001 
0.96 
 
(reference) 
0.68 
 
(reference) 
1.28 
 
(reference) 
0.74 
0.56 
 
(reference) 
0.93 
1.09 
 
(reference) 
1.15 
0.89 
1.44 
0.65 
 
 
 
0.75 
(reference) 
0.54 
1.23 
 
1.52 
(reference) 
 
(reference) 
1.10 
0.95 
 
 
(reference) 
0.89 
1.44 
 
(reference) 
0.96 
1.36 
 
(reference) 
1.20 
1.31 
 
 
(reference) 
1.41 
3.35 
7.64 
(0.95-0.99) 
 
 
(0.43-1.10) 
 
 
(0.76-2.13) 
 
 
(0.54-1.00) 
(0.31-1.01) 
 
 
(0.65-1.31) 
(0.68-1.76) 
 
 
(0.73-1.81) 
(0.54-1.48) 
(0.75-2.73) 
(0.27-1.56) 
 
 
 
(0.53-1.07) 
 
(0.35-0.86) 
(0.76-1.99) 
 
(1.05-2.21) 
 
 
 
(0.76-1.59) 
(0.60-1.50) 
 
 
 
(0.62-1.29) 
(1.02-2.04) 
 
 
(0.65-1.43) 
(0.92-2.01) 
 
 
(0.68-2.10) 
(0.79-2.18) 
 
 
 
(0.74-2.72) 
(1.76-6.35) 
(3.96-14.78) 
 
<0.001 
 
 
0.117 
 
 
0.350 
 
 
0.054 
0.054 
 
 
0.666 
0.715 
 
 
0.544 
0.660 
0.269 
0.335 
 
 
 
0.111 
 
0.009 
0.407 
 
0.026 
 
 
 
0.663 
0.832 
 
 
 
0.558 
0.036 
 
 
0.860 
0.127 
 
 
0.521 
0.299 
 
 
 
   0.296 
 <0.001 
 <0.001 
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     Yes  
     No  
QoL, (SF-12-PCS score) 
 
Psychosocial factors 
PTSD (PTSD-PCL-S) 
     Minimal  
     Some  
     Moderate  
     High  
Social support (ESSI) 
     Low   
     High  
Resilience (RS-14) 
     Very low  
     Low  
     Low-end  
     Moderate  
     Moderately-high 
     High  
  Self-esteem (SE) score 
  QoL,(SF-12-MCS score) 
 
Lifestyle factors  
Smoking status  
     Never  
     Former  
     Current 
  Currently on diet  
     Yes 
     No 
  Fat consumption 
     Low 
     Medium  
     High  
  Vegetable & fruit 
consumption  
     Low 
     Medium  
     High  
  Alcohol use  
     Yes 
     No  
  Physical activity  
     None 
     Not daily 
     Daily 
BMI  
     Underweight 
     Normal weight 
     Overweight 
     Obese 
 
1.03 
(reference) 
0.98 
 
 
 
(reference) 
1.32 
1.87 
1.28 
 
(reference) 
0.71 
 
(reference) 
1.05 
0.78 
0.60 
0.48 
0.42 
0.97 
0.96 
 
 
 
(reference) 
1.87 
1.61 
 
0.59 
(reference) 
 
(reference) 
0.73 
0.79 
 
 
(reference) 
0.83 
0.73 
 
1.31 
(reference) 
 
(reference) 
0.64 
0.43 
 
0.63 
(reference) 
0.81 
0.95 
 
 
(0.77-1.38) 
 
(0.97-1.00) 
 
 
 
 
(0.83-2.10) 
(1.29-2.71) 
(0.00) 
 
 
(0.52-0.97) 
 
 
(0.49-2.25) 
(0.39-1.56) 
(0.30-1.21) 
(0.23-0.98) 
(0.18-0.94) 
(0.85-1.10) 
(0.95-0.97) 
 
 
 
 
(1.17-2.97) 
(1.11-2.33) 
 
(0.40-0.86) 
 
 
 
(0.53-1.00) 
(0.55-1.14) 
 
 
 
(0.50-1.37) 
(0.45-1.19) 
 
(0.66-2.61) 
 
 
 
(0.42-0.98) 
(0.30-0.60) 
 
(0.05-7.7) 
 
(0.55-1.18) 
(0.63-1.43) 
 
0.824 
 
0.015 
 
 
 
 
0.247 
0.001 
0.974 
 
 
0.032 
 
 
0.896 
0.479 
0.154 
0.044 
0.035 
0.640 
<0.001 
 
 
 
 
0.008 
0.013 
 
0.007 
 
 
 
0.054 
0.206 
 
 
 
0.466 
0.207 
 
0.439 
 
 
 
0.040 
<0.001 
 
0.720 
 
0.272 
0.824 
 
0.76 
(reference) 
0.97 
 
 
 
(reference) 
2.34 
3.01 
7.37 
 
(reference) 
0.74 
 
(reference) 
0.76 
0.43 
0.37 
0.19 
0.22 
0.85 
0.98 
 
 
 
(reference) 
0.71 
1.37 
 
1.45 
(reference) 
 
(reference) 
1.09 
1.28 
 
 
(reference) 
0.52 
0.80 
 
1.19 
(reference) 
 
(reference) 
0.57 
0.98 
 
2.09 
(reference) 
0.61 
0.87 
 
(0.57-1.03) 
 
(0.96-0.99) 
 
 
 
 
(1.47-3.71) 
(2.12-4.27) 
(3.89-14.0) 
 
 
(0.54-1.00) 
 
 
(0.41-1.41) 
(0.25-0.77) 
(0.20-0.66) 
(0.10-0.36) 
(0.11-0.48) 
(0.76-0.96) 
(0.97-0.99) 
 
 
 
 
(0.44-1.14) 
(0.93-2.02) 
 
(0.98-2.13) 
 
 
 
(0.79-1.51) 
(0.88-1.86) 
 
 
 
(0.31-0.86) 
(0.49-1.30) 
 
(0.63-2.24) 
 
 
 
(0.37-0.87) 
(0.70-1.38) 
 
(0.22-19.9) 
 
(0.42-0.89) 
(0.59-1.29) 
 
 
  0.075 
 
<0.001 
 
 
 
 
<0.001 
<0.001 
<0.001 
 
 
 0.049 
 
 
0.381 
0.004 
0.001 
 <0.001 
 <0.001 
 0.007 
 <0.001 
 
 
 
 
0.154 
0.106 
 
0.060 
 
 
 
0.583 
0.187 
 
 
 
0.011 
0.375 
 
0.591 
 
 
 
0.009 
0.908 
 
0.522 
 
0.010 
0.495 
Note. Multivariate ordered logistic regression reported for socio-demographic, clinical, psychosocial and 
lifestyle factors associated with depression, CDS (not depressed; mild-moderate depression; severely-very severe 
depression) and DASS-anxiety (no anxiety, mild-moderate anxiety; severe-very severe anxiety). Analyses were 
performed in two separate models for depression and anxiety, mutually adjusting for all factors in the four 
predictor blocks in both models. Analyses are also adjusted for the hospital to which patients were admitted. OR= 
odds ratio; CI= confidence Interval; SD=standard deviation; HS= high school; MI= myocardial infarction; CAD= 
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coronary artery disease; CATH= catheterization; CABG= coronary artery bypass graft; PHQ-15= Patient Health 
Questionnaire-15; PCS=Physical Component Summary; PTSD=Post-Traumatic Stress Disorder; PTSD-PCL-
S=Post-Traumatic Stress Disorder Checklist; ESSI= ENRICHD Social Support Instrument; RS-14= Resilience 
Scale-14; MCS=Mental Component Summary; BMI= body mass index; P values in bold are significant at p <0.05.   
 
4.3.5 Reliability assessment (Cronbach’s alpha) of the study instruments 
  
     Cronbach α for the primary outcome variable, CDS was 0.86 and 0.92 (DASS-depression), 
0.82 (DASS-anxiety), and 0.89 (DASS-stress) for the DASS subscales, respectively, indicating 
high consistency for the relevant psychometric scales. This indicates all scales exhibit 
acceptable internal consistency with little likelihood of item redundancy. Inter-item 
correlations between the 26 items of the CDS and the total CDS scores ranged from 0.08 to 
0.58, and all correlations were statistically significant at the 0.01 level. Cronbach α for the other 
scales used in the study was: 0.78 for PHQ-15, 0.86 for PTSD-PCL-S, 0.82 for ESSI and 0.88 
for RS-14.       
 
4.4 Discussion 
     In the present study, the observed rates of depressive and anxiety symptoms were high. Only 
21% (CDS) and 46% (DASS-anxiety) of patients did not exhibit any symptoms of depression 
and anxiety, respectively.  Our findings point to the need for integrating mental health care into 
cardiac treatment. It is noteworthy that several factors found to be associated with depression 
and anxiety may serve as screening and possibly as intervention targets.  
     Rates of mental health problems reported in earlier studies for patients with different cardiac 
diagnoses and in different cultural and health system settings ranged from 14-73% (Hanssen et 
al., 2009, Meneghetti et al., 2017, Liang et al., 2014, Akhtar et al., 2004, Bayani et al., 2011, 
Goudarzian et al., 2016) for depressive symptoms and 15 to 48% (Hanssen et al., 2009, 
Meneghetti et al., 2017, Liang et al., 2014, Akhtar et al., 2004, Bayani et al., 2011) for anxiety 
symptoms.  These varying rates are explained in part by differences in sample sizes, the 
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instruments and cutoffs used for classifying depression and anxiety and the type of cardiac 
disease targeted in studies.    
     Lower rates of depression than in the current study were observed in other settings including 
Norway (14%) (Hanssen et al., 2009), USA (15%) (Moraska et al., 2013), Brazil (26.4%) 
(Meneghetti et al., 2017) and Pakistan (14%) (Akhtar et al., 2004). Similar among these studies, 
was the common psychiatric instruments used to assess for depression, all of which were not 
specific for cardiac populations. In contrast, a different study assessing depression using the 
CDS found a rate of 73.2% of severe depression in Iranian patients with acute coronary 
syndrome (ACS), a rate even higher than in this study (Goudarzian et al., 2016). 
    Similar anxiety rates to the current study were observed in Iran (28.5%) (Bayani et al., 2011)  
and Pakistan (18%) (Akhtar et al., 2004). Interestingly, in another study conducted in Brazil, 
Meneghetti et al. found a very high prevalence of 48.4% for anxiety symptoms among ACS 
patients using the Hospital Anxiety and Depression Scale (HADS) (Meneghetti et al., 2017). 
A study in the USA also reported, 37% of patients with MI due to spontaneous coronary artery 
dissection screened for anxiety using the Generalized Anxiety Disorder 7-Item Scale (GAD-7) 
(Liang et al., 2014).  
     Mental health problems are generally high in the Palestinian population (Marie et al., 2016). 
In the absence of a healthy control group the results of this study do not allow to conclude that 
depression and anxiety are more common in cardiac patients. However, cardiac patients are in 
particular need of treatment for depression and anxiety given that existing evidence points to 
their adverse effect on the course of heart disease. Furthermore, cardiac rehabilitation may be 
an efficient starting point to address mental health issues beyond the patient and to the extended 
family and social network. Given the shortage of mental health services available and the local 
economic instability in Palestine, the provision of additional services needs to be implemented 
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in a cost-effective way. The identification of subgroups of cardiac patients at higher risk of 
depression and anxiety can guide screening and interventions. 
     In perspective of mental health screening among cardiac patients, focus should be given to 
females and less educated patients. The higher rates of depression and anxiety seen in these 
sub-groups were previously described in literature (Bayani et al., 2011, Dogar et al., Alexandri 
et al., 2017, Meneghetti et al., 2017). Women seem to be more vulnerable to the trauma caused 
by cardiac events, which leads to a deterioration in depression and anxiety symptoms (Bayani 
et al., 2011).  As observed in some (Meneghetti et al., 2017, Shokrgozar et al., 2015, Su et al., 
2018),, but not all studies (Bayani et al., 2011, Al-Abbudi et al., 2018, Goudarzian et al., 2016), 
the association between gender and social status may not be direct as suggested by the 
disappearance of gender and social status differences in the fully adjusted models (Meneghetti 
et al., 2017, Shokrgozar et al., 2015, Bayani et al., 2011, Goudarzian et al., 2016). 
     The presence of the following additional characteristics in cardiac patients should be a red 
flag for cardiologists to consider mental health care in cardiac practice: symptoms of PTSD, 
low levels of self-esteem, somatic symptoms, low quality of life components, active smoking, 
physical inactivity, and longer disease duration. In contrast, a high level of resilience seems to 
reduce symptoms of psychological problems, as previously observed in patients with heart 
failure (Toukhsati et al., 2017, Chang et al., 2017). Unlike findings reported previously, 
comorbidities were not consistently more common in the presence of mental health disorders 
(Eng et al., 2011). Little is known about the association of PSTD symptoms with depression 
and anxiety in cardiac patients. A study conducted on 813 patients who received angiograms 
at a large U.S. Veterans Administration Medical Center found depression to be positively 
associated with PTSD, smoking and alcohol consumption (Shankman et al., 2012). Low MCS 
and PCS scores on the SF-12, smoking, and chest pain were recently identified as the strongest 
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predictors of longitudinally sustained high levels of depression and anxiety in CHD patients 
(Palacios et al., 2018).  
     Factors serving as targets for intervention include smoking, physical activity and social 
support. Smoking cessation interventions are crucial for cardiac rehabilitation, however in the 
presence of depression, results are less successful and interventions may need to be adapted 
(Doyle et al., 2014). Sedentary behavior, a risk factor for depression in the general population 
(Hamer and Stamatakis, 2014), was previously associated with depression according to the 
Beck Depression Inventory-II in patients hospitalized for ACS (Zhu et al., 2018). In a small 
non-randomized intervention study with heart failure patients, aerobic interval training 
decreased symptoms of depression over a period of 12-weeks (Isaksen et al., 2016).  In studies 
on breast cancer (Segar et al., 1998), promotion of physical activity may have the additional 
benefit of improving self-esteem, a factor associated with depression and anxiety in this study 
and a predictor of mortality in the general population (Stamatakis et al., 2004). In addition, 
according to previous studies (Su et al., 2018, Compare et al., 2013, Bucholz et al., 2014, Notara 
et al., 2015, Zarbo et al., 2013), the inverse association between high social support and low 
levels of anxiety and depression points to another important target for prevention as it is 
supported by firm evidence from previous studies. Poor social support among patients with 
ACS was observed in secondary analyses of a randomized trial to reduce the effectiveness of 
treatment with antidepressants (Kim et al., 2018). The quality of social support plays an 
important role, as overprotective behaviors of partners can have an adverse effect (Zarbo et al., 
2013). Interestingly, in the current study marital status and social support were associated with 
presence of depressive symptoms independently and in opposite directions. 
     The current study has several strengths. First, it utilized a broad set of validated instruments 
to identify depression and anxiety symptoms as well as associated factors. The overall validity 
of the CDS in this study was almost similar to levels originally reported by Hare and Davis 
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(Hare and Davis, 1996). The validity of the DASS-42 was satisfactory, in line with other 
findings of other studies, including those originally reported by Lovibond and Lovibond 
(Lovibond and Lovibond, 1995).  Furthermore, the CDS is the only psychometric scale suitable 
for the comparative depression assessment in heart disease patients, subjected to different 
interventions (Shi et al., 2010, Hare and Davis, 1996) .  This is evident in the present study, as 
depression rates were lower when assessed by the DASS-42. The CDS, also has excellent 
properties for the diagnosis of MDD, a score of ≥95 having a 97% sensitivity at 85% specificity 
(AUC 0.96) (Shi et al., 2010). Second, the large sample size provided sufficient statistical 
power for testing independent associations. Third, the study subjects are well characterized, 
which allowed for addressing confounding. Fourth, the high participation rate decreased the 
likelihood of selection and participation bias. Finally, the findings of the study despite being 
hospital-based are likely generalizable to the entire cardiac patient population in the city of 
Nablus and surrounding cities of Palestine, considering the study sites provide cardiac care to 
a large percentage of cardiac patients in the area.  
     Nonetheless, the cross-sectional nature of the study does not enable us to make causal 
inferences. A long-term follow-up is foreseen to investigate the predictive effect of the study 
characteristics and predictors with regard to the course of depression, anxiety and heart disease. 
While the reliability of the previously validated instruments was confirmed in our study, the 
instruments have not been validated specifically for the context of cardiac patients in Palestine. 
Furthermore, some of the risk factors could only be captured broadly to avoid lengthy 
interviews. This likely caused some misclassification, as in the case of physical activity. Recall 
bias may have added to the misclassification of risks, given the retrospective nature of the 
interview. Also, the study was not sufficiently powered to investigate differences in the 
frequency of depression and anxiety as well as associated factors between relevant subgroups 
of clinical diagnoses, for example MI and HF. Finally, some patients were recruited at the time 
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of admission and for the most part before receiving their intervention or diagnosis, and thus 
were under much pressure and stress. The level of depression and anxiety could have been 
overestimated and may decrease in part over the course of disease. The most appropriate time 
point to assess depression and anxiety from a prognostic perspective is unknown. 
 
4.5 Conclusions 
     The alarmingly high rate of depression and anxiety symptoms observed in cardiac patients 
in Palestine points to the need for integrating mental health care into cardiac rehabilitation.  
The prognostic value of depression and anxiety with regard to the course of heart disease, 
adherence to treatment and quality of life needs to be investigated. Treatment of psychological 
problems from the disease onset and onwards is crucial considering longer disease duration 
puts individuals at higher risk of being depressed. The expertise of social scientists and medical 
anthropologists is needed for identifying efficient means to overcome barriers related to the 
stigmatization of psychological disorders. 
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4.6 Supplementary Material  
Table 4.S1. Socio-demographic, clinical, psychosocial, lifestyle factors by DEPRESSION and 
ANXIETY status, (n=1022) 
Variable     Depression (CDS) Anxiety (DASS-anxiety) 
 NO 
n=218 
(%)† 
YES 
n=804 
(%)†† 
P value 
NO 
n=408 
(%)††† 
YES 
n=614 
(%)†††† 
P value 
Socio-demographic factors 
Age, mean (SD) 
Gender  
     Female  
     Male  
Marital status 
     Married  
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree  
     No HS diploma  
     HS diploma  
     College degree  
Occupation  
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
58.9±10.6* 
 
15.1 
23.6 
 
20.6 
28.1 
 
23.0 
20.9 
13.3 
 
19.0 
22.1 
28.9 
 
22.5 
25.1 
15.9 
32.1 
17.0 
59±10.0* 
 
84.9 
76.4 
 
79.4 
71.9 
 
77.0 
79.1 
86.7 
 
81.0 
77.9 
71.1 
 
77.5 
74.9 
84.1 
67.9 
83.0 
0.560 
0.003 
 
 
0.088 
 
 
0.158 
 
 
 
 0.024 
 
 
 
 0.004 
 
59.2±9.8* 
 
27.6 
44.4 
 
40.7 
32.3 
 
40.1 
40.2 
37.3 
 
36.8 
42.5 
47.2 
 
45.0 
47.6 
31.0 
49.4 
23.4 
58.8±10.3* 
 
72.4 
55.6 
 
59.3 
67.7 
 
59.9 
59.8 
62.7 
 
63.2 
57.4 
52.8 
 
55.0 
52.4 
69.0 
50.6 
76.6 
 0.66 
<0.001 
 
 
 0.109 
 
 
 0.893 
 
 
 
 0.036 
 
 
 
<0.001 
 
Clinical factors 
Cardiac diagnosis  
     CAD 
     MI 
     Angina  
     Other  
Previous cardiac diagnosis  
     Yes 
     No  
Years with cardiac disease  
     ≤1 year  
     2-9 years  
     ≥10 years  
Cardiac treatment  (at admission) 
     CATH/stent  
     CATH/CABG  
     CATH/other & unknown  
Co-morbidities  
     None 
     One 
     Two or more  
Medications  
     None 
     1-2  
     3-4  
Somatic symptoms (PHQ-15) 
     Minimal      
     Low  
 
24.9 
21.7 
17.3 
15.8 
 
19.0 
26.2 
 
24.0 
18.0 
15.1 
 
24.3 
17.9 
18.1 
 
28.4 
21.8 
16.0 
 
28.8 
19.7 
20.3 
 
40.7 
36.9 
 
75.1 
78.3 
82.7 
84.2 
 
81.0 
73.8 
 
76.0 
82.0 
84.9 
 
75.7 
82.1 
81.9 
 
71.6 
78.2 
84.0 
 
71.2 
80.3 
79.7 
 
59.3 
63.1 
  0.101 
 
 
 
 
  0.008 
 
 
  0.022 
 
 
 
  0.048 
 
 
 
<0.001 
 
 
 
  0.080 
 
 
 
<0.001 
 
 
 
39.5 
37.9 
54.3 
28.3 
 
33.5 
53.3 
 
43.3 
34.1 
35.2 
 
44.2 
38.2 
31.4 
 
48.2 
40.9 
33.3 
 
50.0 
34.9 
39.2 
 
72.5 
61.4 
 
60.5 
62.1 
45.7 
71.7 
 
66.5 
46.7 
 
56.7 
65.9 
64.8 
 
55.8 
60.8 
68.6 
 
51.8 
59.1 
66.7 
 
50.0 
65.1 
60.8 
 
27.5 
38.6 
<0.001 
 
 
 
 
<0.001 
 
 
  0.020 
 
 
 
  0.003 
 
 
 
<0.001 
 
 
 
  0.025 
 
 
 
<0.001 
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     Medium      
     High  
Family history  
     Yes  
     No  
QoL, (SF-12-PCS score), mean 
(SD) 
18.1 
9.3 
 
20.8 
21.7 
42.7±12.7* 
81.9 
90.7 
 
79.2 
78.3 
36.3±11.9* 
 
 
  0.752 
 
 
<0.001 
39.2 
18.9 
 
42.9 
37.9 
43.1±11.8* 
60.8 
81.1 
 
57.1 
62.1 
34.0±11.3* 
 
 
  0.114 
 
 
<0.001 
 
Psychosocial factors 
PTSD (PTSD-PCL-S) 
       Minimal  
       Some  
       Moderate  
       High  
Social support (ESSI) 
       Low   
       High  
Resilience (RS-14) 
       Very low  
       Low  
       Low-end  
       Moderate  
       Moderately-high 
       High  
Self-esteem (SISE) score,     
mean (SD) 
QoL, (SF-12-MCS score), mean 
(SD)    
 
29.0 
14.7 
10.7 
0.0 
 
19.2 
22.5 
 
9.8 
9.7 
19.6 
22.2 
26.6 
31.5 
6.2±1.0* 
 
46.3±12.5* 
 
71.0 
85.3 
89.3 
100.0 
 
80.8 
77.5 
 
90.2 
90.3 
80.4 
77.8 
73.4 
68.5 
5.7±1.5* 
 
37.9±12.9* 
<0.001 
 
 
 
 
<0.001 
 
 
<0.001 
 
 
 
 
 
 
<0.001 
 
<0.001 
 
53.5 
25.3 
20.2 
9.5 
 
34.3 
43.0 
 
7.6 
14.6 
31.4 
42.4 
58.8 
56.5 
6.3±0.9* 
 
44.4±12.8* 
 
46.5 
74.7 
79.8 
90.5 
 
65.7 
57.0 
 
92.4 
85.4 
68.6 
57.6 
41.2 
43.5 
5.4±1.5* 
 
36.7±12.6* 
<0.001 
 
 
 
 
  0.007 
 
 
<0.001 
 
 
 
 
 
 
<0.001 
 
<0.001 
 
Lifestyle factors 
Smoking status  
       Never  
       Former  
       Current 
  Currently on diet  
       Yes 
       No 
  Fat consumption 
       Low 
       Medium  
       High  
  Vegetable & fruit consumption  
       Low 
       Medium  
       High  
  Alcohol use  
       Yes 
       No  
  Physical activity  
       None 
       Not daily 
       Daily 
BMI  
     Underweight 
     Normal weight 
     Overweight 
     Obese 
 
22.3 
19.4 
20.9 
 
27.1 
20.2 
 
22.1 
21.7 
19.2 
 
17.7 
19.8 
22.9 
 
22.5 
21.2 
 
12.5 
19.1 
28.2 
 
25.0 
21.1 
25.1 
17.4 
 
77.7 
80.6 
79.1 
 
72.9 
79.8 
 
77.9 
78.3 
80.8 
 
82.3 
80.2 
77.1 
 
77.5 
78.8 
 
87.5 
81.9 
71.8 
 
75.0 
78.9 
74.9 
82.6 
  0.701 
 
 
 
  0.046 
 
 
  0.674 
 
 
 
  0.340 
 
 
 
  0.840 
 
 
<0.001 
 
 
 
<0.063 
 
42.6 
49.4 
31.9 
 
33.5 
41.1 
 
42.9 
37.2 
37.4 
 
41.2 
45.0 
36.5 
 
34.7 
40.3 
 
31.0 
48.7 
42.5 
 
0.0 
36.2 
47.1 
34.4 
 
57.4 
50.6 
68.1 
 
66.5 
58.9 
 
57.1 
62.8 
62.6 
 
58.8 
55.0 
63.5 
 
65.3 
59.7 
 
69.0 
51.3 
57.5 
 
100.0 
63.8 
52.9 
65.6 
<0.001 
 
 
 
  0.062 
 
 
  0.184 
 
 
 
  0.035 
 
 
 
  0.434 
 
 
<0.001 
 
 
 
<0.001 
Note. Bivariate analysis was performed using chi-squared test to assess the association of depression with factors 
of the four predictor blocks. Analysis was adjusted for hospital site. HS= high school; MI= myocardial infarction; 
CAD= coronary artery disease; CATH= catheterization; CABG= coronary artery bypass graft; CVD= 
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cardiovascular disease; PHQ-15= Patient Health Questionnaire-15; PCS= Physical Component Summary; QoL= 
quality of life; SD= standard deviation; PTSD= post-traumatic stress disorder; PTSD-PCL-S=Post-Traumatic 
Stress Disorder Checklist; ESSI= ENRICHD Social Support Instrument; RS-14= Resilience 
Scale-14; MCS= Mental Component Summary; BMI= body mass index *= Wilcoxon rank sum test; † Scores 26-
89 (no depressive symptoms); †† Scores ≥90 (depressive symptoms); ††† Scores of 0-6 (no anxiety); †††† Scores 
≥7 (mild, moderate, severe, very severe anxiety); P values in bold are significant at p <0.05.         
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Table 4.S2. Socio-demographic, clinical, psychosocial, lifestyle factors by STRESS status,  
(n=1022) 
Variable  Stress (DASS-stress) 
 No 
n= 370 
(%)† 
Yes 
n=652                              
(%)†† 
P value 
Socio-demographic factors  
Age, mean (SD) 
Gender  
     Female  
     Male  
Marital status 
     Married  
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree  
     No HS diploma  
     HS diploma  
     College degree  
Occupation  
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
60.3±10.1* 
 
36.0 
36.3 
 
36.3 
35.4 
 
40.3 
33.4 
28.0 
 
35.2 
34.6 
42.8 
 
33.0 
41.0 
36.2 
29.6 
29.8 
58.3±10.1* 
 
64.0 
63.7 
 
63.7 
64.6 
 
59.7 
66.6 
72.0 
 
64.8 
65.4 
57.2 
 
67.0 
59.0 
63.8 
70.4 
70.2 
0.002 
0.944 
 
 
0.866 
 
 
0.027 
 
 
 
0.171 
 
 
 
0.172 
 
Clinical factors 
Cardiac diagnosis  
     CAD 
     MI 
     Angina  
     Other  
Previous cardiac diagnosis  
     Yes 
     No  
Years with cardiac disease  
     ≤1 year  
     2-9 years  
     ≥10 years  
Cardiac treatment  (at admission) 
     CATH/stent  
     CATH/CABG  
     CATH/other & unknown  
Co-morbidities  
     None  
     One  
     Two or more  
Medications  
     None 
     1-2  
     3-4  
Somatic symptoms (PHQ-15) 
     Minimal      
     Low  
     Medium      
     High  
 
28.1 
38.4 
51.2 
30.8 
 
34.2 
40.4 
 
39.7 
32.6 
27.3 
 
37.1 
35.0 
35.5 
 
42.5 
34.0 
33.3 
 
33.3 
30.9 
37.8 
 
56.0 
50.2 
34.7 
23.7 
 
71.9 
61.6 
48.8 
69.2 
 
65.8 
59.6 
 
60.3 
67.4 
72.7 
 
62.9 
65.0 
64.5 
 
57.5 
66.0 
66.7 
 
66.7 
69.1 
62.2 
 
44.0 
49.8 
65.3 
76.3 
<0.001 
 
 
 
 
0.055 
 
 
0.009 
 
 
 
0.826 
 
 
 
0.027 
 
 
 
0.209 
 
 
 
<0.001 
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Family history  
     Yes  
     No  
QoL, (SF-12-PCS score), mean (SD) 
 
38.0 
35.0 
40.0±12.3* 
 
62.0 
65.0 
36.3±12.2* 
0.333 
 
 
<0.001 
 
Psychosocial factors 
PTSD (PTSD-PCL-S) 
       Minimal  
       Some  
       Moderate  
       High  
  Social support (ESSI) 
       Low   
       High  
  Resilience (RS-14) 
       Very low  
       Low  
       Low-end  
       Moderate  
       Moderately-high 
     High  
  Self-esteem (SISE) score, mean   (SD) 
  QoL, (SF-12-MCS   score), mean (SD)   
 
52.9 
17.9 
10.3 
6.3 
 
36.0 
36.3 
 
14.1 
23.3 
38.2 
43.2 
41.2 
33.7 
6.0±1.2* 
44.6±12.4* 
 
47.1 
82.1 
89.7 
93.7 
 
64.0 
63.7 
 
85.9 
76.7 
61.8 
56.8 
58.8 
66.3 
5.7±1.5* 
37.0±12.9* 
<0.001 
 
 
 
0.915 
 
 
 
<0.001 
 
 
 
 
 
 
<0.001 
<0.001 
 
Lifestyle factors 
Smoking status  
       Never  
       Former  
       Current 
  Currently on diet  
       Yes 
       No 
  Fat consumption 
       Low 
       Medium  
       High  
  Vegetable & fruit consumption  
       Low 
       Medium  
       High  
  Alcohol use  
       Yes 
       No  
  Physical activity  
       None 
       Not daily 
       Daily 
BMI  
     Underweight 
     Normal weight 
     Overweight 
     Obese 
 
37.6 
35.3 
35.4 
 
38.2 
35.8 
 
35.4 
38.7 
34.2 
 
32.3 
37.1 
36.3 
 
16.3 
37.3 
 
28.8 
39.7 
39.9 
 
0.0 
32.7 
40.5 
33.7 
 
62.4 
64.7 
64.6 
 
61.8 
64.2 
 
64.6 
61.3 
65.8 
 
67.7 
62.9 
63.7 
 
83.7 
62.7 
 
71.2 
60.3 
60.1 
 
100.0 
67.3 
59.5 
66.3 
0.777 
 
 
 
0.546 
 
 
0.506 
 
 
 
0.676 
 
 
 
0.003 
 
 
0.002 
 
 
 
0.049 
Note. Bivariate analysis was performed using chi-squared test to assess the association of depression with factors 
of the four predictor blocks. Analysis was adjusted for hospital site. HS= high school; MI= myocardial infarction; 
CAD= coronary artery disease; CATH= catheterization; CABG= coronary artery bypass graft; CVD= 
cardiovascular disease; PHQ-15= Patient Health Questionnaire; PCS= Physical Component Summary; QoL= 
quality of life; SD= standard deviation;  PTSD=post-traumatic stress disorder; PTSD-PCL-S=Post-Traumatic 
Stress Disorder Checklist; ESSI= ENRICHD Social Support Instrument; RS-14= Resilience Scale-14; 
MCS=Mental Component Summary; BMI= body mass index *=Wilcoxon rank sum test;  † Scores 0-14 (no 
stress); †† Scores 15-42 (mild, moderate, severe, very severe stress); P values in bold are significant at p <0.05.                                                              
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Abstract  
Background. Among patients suffering from coronary heart disease (CHD) and comorbid 
depression, women experience a higher burden compared to men. Little is known on the 
characteristics that differentiate men and women with both diseases and whether these factors 
mediate gender effects on depression. This study assessed whether women are more likely to 
suffer from depression and which characteristics mediate gender effects on depression among 
a cardiac population in Palestine, specifically addressing the role of PTSD. 
Methods. Using a cross-sectional design, patients consecutively admitted with a CHD to one 
of the four main hospitals in Nablus, Palestine, were interviewed using a structured 
questionnaire with validated instruments. Data was also obtained from hospital medical 
records. Patients were assessed for depression using the Cardiac Depression Scale (CDS). 
Bivariate analysis was conducted to compare characteristics of women and men with and 
without depressive symptoms. Mediators (direct and indirect effects) of the association 
between gender and depression were evaluated using a structural equation model (SEM).  
Results. Women were more likely to suffer from severe depression than men (28.7% vs. 
18.8%). Female gender was positively associated with higher PTSD symptoms, comorbidities, 
somatic symptoms and income, and with lower resilience, self-esteem, quality of life, 
education, prevalence of smoking and physical activity. Structural equation modeling revealed 
negative indirect effects of gender on depression (CDS score) through resilience, self-esteem 
and physical activity, whereas positive indirect effects of gender on depression were observed 
through PTSD, comorbidities, somatic symptoms and smoking.  There was no direct effect of 
gender on depression. 
Conclusion. This study found a higher prevalence of severe depression in female patients with 
cardiac disease compared to male cardiac patients. Our findings provide novel information on 
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mediating factors of the association between gender and depression among cardiac patients, in 
particular PTSD. The results emphasize the need for further research on potential mediating 
factors that could account for gender differences in depression and the need to provide support 
programs for female patients with comorbid CHD and depression to improve their psycho-
social well-being.  
Keywords: Gender, depression, cardiovascular disease, mediators, post-traumatic stress 
disorder  
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5.1 Introduction  
     Depression is an increasingly recognized risk factor for cardiovascular disease (CVD), 
particularly coronary heart disease (CHD) (Barth et al., 2004, Frasure-Smith and Lesperance, 
2006b). The prevalence of depression among cardiac patients ranges from 15% to 30%, which 
is considerably higher than in the general population (Lesperance and Frasure-Smith, 2000). 
Depression in cardiac patients is associated with poor outcomes (Nicholson et al., 2006), long-
term prognosis (Lett et al., 2004), overall quality of life (Barrett-Connor, 2013), mortality 
(Barth et al., 2004), and a dose-response relationship has been reported between depressive 
symptom level and subsequent mortality (Lesperance et al., 2002). 
     Depression is up to two times higher in women than in men (Piccinelli and Wilkinson, 2000, 
Nolen-Hoeksema et al., 1999). Many factors could  explain these differences including 
biological, genetic, psychological and social differences between women and men (Kornstein, 
1997). Gender and sex are often used interchangeably suggesting biological and psychosocial 
attributes vary with one another (Möller-Leimkühler, 2007). While sex denotes genetic and 
biological characteristics, gender refers to the array of socially constructed roles and 
relationships, personality traits, attitudes, behaviors and values that society ascribes to the sexes 
on a differential basis (Krieger, 2003). However, the use of the term sex as a ‘stand-alone 
indicator of biology’ is rejected as gendered experiences materialize in the body and measures 
of sex can include effects of gender (Springer et al., 2012). In the case of depression and in the 
presence of sex differences, biology alone cannot provide an accurate explanation. Higher 
depression rates are found in women than men due to stressors related to social roles whereas 
lower rates of depression are found among men because male-attributed symptoms of 
depression such as anger, aggression, irritation, and abusive behavior are commonly not 
recognized as depressive symptoms (Moller-Leimkuhler et al., 2004). Evidence suggests that 
women underprivileged in different aspects of life suffer from greater stressors and poorer 
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health than men, including mental disorders and chronic diseases (Rahman et al., 1994). 
Women also report poorer health than men due to lack of access to healthcare and due to the 
stressors caused by their gender and marital roles (McDonough and Walters, 2001, Matthews 
et al., 1999). 
     The role of gender for CHD has been addressed extensively in literature since the 1980’s 
(Mosca et al., 2011, Barrett-Connor, 2013). Studies have reported that being female is 
associated with higher mortality and morbidity after cardiac events compared to being male 
(Khan et al., 1990, Penckofer and Holm, 1990) and that women are likely to develop more 
depressive symptoms associated with CHD than men (Naqvi et al., 2005). A meta-analysis 
found an overall prevalence of comorbid major depression of 18.7% in women compared to 
12.0% in men. In particular, women are more vulnerable after coronary artery bypass graft 
(CABG) compared to men, suffer from more comorbid illness (Mickleborough et al., 1995), 
are more likely to experience anxiety and more likely to be socially isolated 
(Shanmugasegaram, 2012). Among myocardial infarction (MI) patients, women report less 
social support and more role disruption during recovery (Kristofferzon et al., 2003) and are two 
times more prone to depression post-MI than men (Mallik et al., 2006). Therefore, female 
cardiac patients have a higher risk of suffering from adverse effects of depression on the 
prognosis of their disease (Nolen-Hoeksema et al., 1999, Barth et al., 2004, Frasure-Smith et 
al., 1999). In addition, women have greater symptom frequency, experience greater risk of re-
infarction, have lower survival rates after CABG and higher rates of subsequent heart failure 
(HF) compared to men (Regitz-Zagrosek et al., 2016, Vaccarino et al., 2002, Gruberg and 
Beyar, 2003). In several studies, the worse cardiac outcomes in women persist after adjustment 
for age, medical history, clinical severity, hospital treatment, and cardiac procedures 
(Vaccarino et al., 2002, Vaccarino and Mallik, 2004, Wenger, 2003, Czajkowski et al., 1997). 
Despite the burden observed in women due to comorbid CHD and depression, they continue to 
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be understudied in research and data are often not presented by gender. The high burden of 
CVD and the rise of depression rates among women in the general population as well as in 
CHD populations call for assessment of the gender gap in depression. There is scarce literature 
on characteristics that distinguish men and women with comorbid CHD and depression. 
Furthermore, whether these factors mediate gender effects on depression in cardiac patients 
remains unclear. This ultimately makes it difficult to identify women at higher risk of adverse 
outcomes associated with both CHD and depression. In this paper, the terms sex and gender as 
well as women and men are used: ‘gender’ as an overarching notion; ‘sex’ when referring to 
associations reported in the literature for being female and male respectively; and the terms 
‘women’ and ‘men’ to denote population subgroups.     
     Post-traumatic stress disorder (PTSD) is also a common co-morbid condition in cardiac 
patients (Tulloch et al., 2014) and rates are higher among female cardiac patients. PTSD has 
been associated with recurrent MI, hospitalizations and mortality (Ladwig et al., 2008, 
Edmondson et al., 2012b). Similarly, PTSD exhibits gender-specific patterns and is known to 
be comorbid with depression (O'Donnell et al., 2004).  
     Previous literature has focused on gender differences in depression among heart disease 
patients mainly in high income countries (Mosca et al., 2011, Regitz-Zagrosek et al., 2016). In 
Middle Eastern countries, CVD accounts for 34% of all deaths and PTSD is high among 
individuals living in regions of conflict (Marie et al., 2016). The Occupied Palestinian 
Territories (oPt) in particular, report high rates of depression in response to the stressful living 
conditions. The different societal roles of women and the evidence based CVD-gender 
differences call for more research into the understanding of gender-related factors with regard 
to depression and mediating factors among cardiac patients. In this study, we sought to assess 
whether Palestinian women are more likely to suffer from depression than Palestinian men 
among a sample of 1022 consecutively admitted cardiac patients at one of the four major 
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hospitals in the West Bank city of Nablus, Palestine, and to investigate whether socio-
demographic, clinical, psychosocial and lifestyle characteristics mediate gender effects on 
depression, especially addressing the role of PTSD.  
5.2 Methods 
5.2.1 Study design and population 
     This cross-sectional hospital-based study was conducted on consecutive patients aged 30-
80 years admitted to the cardiology and cardiac surgery departments at one of the four main 
hospitals in Nablus, Palestine, during their stay in the hospital (1-7 days) between March 2017 
and November 2017. They were included in the study if they were diagnosed with CHD, ST 
elevation or non-ST elevation MI, angina, HF, cardiac arrhythmia, valve disease or any other 
cardiac disease. Patients with a normal cardiac catheterization (CATH), an acute or past stroke, 
end-stage kidney disease (including dialysis patients), peripheral vascular disease, 
psychological disorders, cognitive deficit, neurological disorders (dementia, Alzheimer’s 
disease, epilepsy, Parkinson’s disease), use of antidepressant or any other condition affecting 
the quality of their responses were excluded from the study. A total of 1092 patients were 
approached and met initial eligibility requirements, and 1053 agreed to participate in the study. 
The analytic sample included 1022 subjects. The study was approved by the Ethics Committee 
of Nordwest-und Zentral Schweiz (EKNZ) in Basel, Switzerland, and by the Institutional 
Review Board (IRB) committee at An-Najah National University in Nablus, Palestine. 
5.2.2 Data Collection  
     Eligible patients were approached for private in-person interviews using hospital registries 
and written informed consent was obtained from those who agreed to participate. Prior to 
completion of the interview, socio-demographic and clinical characteristics including: age, 
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gender, marital status, residence, education level, occupation, income; current diagnosis, 
previous cardiac diagnoses, years with cardiac disease, cardiac treatment (at admission), co-
morbidities, medications and family history of CVD were retrieved from patients’ medical 
records and were ascertained via patient interview. In-person interviews consisted of a 
sequence of validated instruments assessing physical and psychosocial factors and questions 
assessing lifestyle factors.  
5.2.3 Study Measurements  
     Depressive symptoms were assessed by the Cardiac Depression Scale (CDS), a disease-
specific, 26-item questionnaire used to accurately measure depression in patients with CVD. 
The CDS is scored based on a Likert scale ranging from strongly disagree (1) to strongly agree 
(7). Total scores are calculated as the sum of the scores of each item and range from 26 to 182 
(Shi et al., 2010). The CDS can be used as a continuous measure, where higher scores indicate 
more severe depressive symptoms, or as an ordinal indicator of possible depression using 
previously established cut-off points which include: <90 for no depression; 90-100 for mild to 
moderate depression; and ˃100 for severe depression. These cut offs were used in the current 
study to categorize depressive symptoms. The CDS has a sensitivity of 88% and a specificity 
of 84% for severe depression when a cutoff of >100 is used, and 84% sensitivity and 78% 
specificity for cutoff scores of 90-100 (Wise et al., 2006). Further instruments used include the 
Post-Traumatic Stress Disorder Checklist (PTSD-PCL-S) (Blanchard et al., 1996); Enhancing 
Recovery in Coronary Heart Social Support Instrument (ESSI) (2000b, 2001); Resilience 
Scale-14 (RS-14) (Wagnild GM, 2009); Single-Item Self-Esteem Scale (SISE) (Robins et al., 
2001); Short-form 12 Health Survey (SF-12-PCS; SF-12-MCS) (Ware et al., 1996) and the 
Patient Health Questionnaire-15 (PHQ-15) (Kroenke et al., 2002). The instruments have been 
described in detail elsewhere (Allabadi et al., 2019). 
5.2.4 Statistical Analyses 
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Depressive symptoms were examined both as a continuous variable (CDS score) and as a 
dichotomous variable (presence of moderate-severe depressive symptoms using the standard 
cutoff of CDS ≥90). Characteristics of women and men with and without depressive symptoms 
were compared using Chi-squared or Fisher exact tests for categorical variables, and 
independent t-tests for continuous variables, as appropriate.  
     A structural equation model (SEM) was built to assess direct and indirect (i.e. mediated) 
effects of gender on depression. Mediators are variables which transfer part of the effect of an 
independent variable (IV) on a dependent variable (DV). In our analysis, the IV was gender 
(used as a binary variable, with “being female” coded as 1), the DV was depression (CDS score, 
used as a continuous variable), and the potential mediator variables were socio-demographic, 
clinical, psychosocial and lifestyle factors (Cole and Hernan, 2002). First, mediator groups (i.e. 
socio-demographic, clinical, psychosocial and lifestyle factors) were assessed in separate 
models. In a second step, the final model was built (reference model, n=1022), including 
education, income, comorbidities, somatic symptoms, quality of life, PTSD, resilience, self-
esteem, smoking, physical activity. These potential mediators were chosen based on 1) their 
statistical significance in the preceding analyses, using a cut-off level of  p<0.10 2) the 
magnitude of their association 3) whether the associations were significant between gender and 
the potential mediator, as well as between the potential mediator and depression (CDS score). 
The SEM was estimated using the maximum likelihood method and included continuous, 
binary and ordinal variables which were all treated as continuous. Inclusion of a larger number 
of potential mediators reduces bias in estimating the true direct effect of gender on depression 
(CDS score). Potential confounding factors assessed were age, marital status, occupation, 
social support, and lifestyle factors (i.e. BMI, alcohol consumption). A further SEM-analysis 
was then conducted stratifying by age, running separate models for two age groups (those aged 
below and above the median age of 59 years; see figure 6.S1). Moderation by age was assessed 
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by testing the differences between corresponding age-specific effects using Chi-squared tests. 
In further analyses, two additional SEM’s were computed to assess whether resilience and 
smoking could be potential mediators and/or moderators of the effect of PTSD on depression, 
adding the respective factor as mediator between PTSD and depression and testing its 
interaction with PTSD to assess potential moderation. This additional analysis was based on 
general conceptualization and literature on psychological comorbidity of PTSD and depression 
(O'Donnell et al., 2004, Dao et al., 2010). Analysis was conducted using the STATA Statistical 
Software Release 15 (StataCorp., College Station, U.S.A.).  
 
5.3 Results 
5.3.1 Patient characteristics 
This sample consisted of 750 (73.4%) men and 272 (26.6%) women. Among the cardiac 
patients with depressive symptoms, 231 (28.7%) were women. In contrast, among patients 
without depressive symptoms, 41 (18.8%) were women. Socio-demographic, clinical, 
psychosocial and lifestyle factors of depressed and non-depressed men and women are 
presented in Table 5.1. In terms of socio-demographic factors, among those with depressive 
symptoms, women were on average older than men, more likely to be unmarried (i.e. single, 
widowed), less educated, unemployed and have no income compared to men.             
     Differences among women and men with depressive symptoms in terms of clinical factors 
were also found. Women with depressive symptoms were more likely to have a severe cardiac 
disease (i.e. heart failure, mitral or aortic valve stenosis) compared to men with depressive 
symptoms who had mostly CHD or a MI diagnosis, more likely to report a previous cardiac 
diagnosis, undergo a CATH/complex procedure (i.e. valve replacement), have two or more 
comorbid conditions (i.e. diabetes, hypertension, the combination of both), take three to four 
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medications, have higher somatic symptoms and to score lower on the SF-12-PCS for quality 
of life.   
Table 5.1. Bivariate comparison of study characteristics in men and women with CVD, by 
presence and absence of depressive symptoms, n=1022 
 
 Sample with depressive 
Symptoms (CDS ≥90) 
(n=804) 
Sample without depressive 
symptoms (CDS<90) 
(n=218) 
Variable  Male 
(n=573) 
n (%) 
Female 
(n=231) 
n (%) 
P value Male 
(n=177) 
n (%) 
Female 
(n=41) 
n (%) 
P value 
Socio-demographic factors 
Age, mean (SD) † 
Marital status 
     Married 
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree  
     No HS diploma  
     HS diploma  
     College degree  
Occupation  
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
Income  
     Yes 
     No 
 
57.9±9.6 
 
564 (98.4) 
9 (1.6) 
 
261 (45.5) 
270 (47.1) 
42 (7.3) 
 
298 (52.0) 
173 (30.2) 
102 (17.8) 
 
153 (26.7) 
226 (39.4) 
143 (25.0) 
51 (8.9) 
0 (0.0) 
 
442 (77.1) 
131 (22.9) 
 
61.6±10.5 
 
171 (74.0) 
60 (26.0) 
 
104 (45.0) 
104 (45.0) 
23 (10.0) 
 
188 (81.4) 
32 (13.8) 
11 (4.8) 
 
9 (3.9) 
4 (1.7) 
175 (75.8) 
4 (1.7) 
39 (16.9) 
 
77 (33.3) 
154 (66.7) 
 
<0.001 
<0.001 
 
 
0.456 
 
 
 
<0.001 
 
 
 
<0.001 
 
 
 
 
 
<0.001 
 
57.8±10.2 
 
166 (93.8) 
11 (6.2) 
 
89 (50.3) 
79 (44.6) 
9 (5.1) 
 
84 (47.4) 
49 (27.7) 
44 (24.9) 
 
47 (26.6) 
76 (42.9) 
31 (17.5) 
23 (13.0) 
0 (0.0) 
 
146 (82.5) 
31 (17.5) 
 
63.7±10.7 
 
25 (60.7) 
16 (39.0) 
 
20 (48.8) 
20 (48.8) 
1 (2.4) 
 
30 (73.2) 
9 (21.9) 
2 (4.9) 
 
0 (0.0) 
1 (2.4) 
29 (70.8) 
3 (7.3) 
8 (19.5) 
 
12 (29.3) 
29 (70.7) 
 
0.001 
<0.001 
 
 
0.723 
 
 
 
0.004 
 
 
 
<0.001 
 
 
 
 
 
<0.001 
 
Clinical Factors  
Cardiac diagnosis  
     CHD 
     MI 
     Angina  
     Other  
Previous cardiac diagnosis  
     Yes 
     No  
Years with cardiac disease  
     ≤1 year  
     2-9 years  
     ≥10 years  
Cardiac treatment  (at admission) 
     CATH/stent  
     CATH/CABG  
     CATH/other & unknown  
Co-morbidities  
     None 
     1 
     2+ 
Medications  
 
 
 
188 (32.8) 
242 (42.2) 
96 (16.8) 
47 (8.2) 
 
386 (67.4) 
187 (32.6) 
 
347 (60.6) 
148 (25.8) 
78 (13.6) 
 
306 (53.4) 
139 (24.3) 
128 (22.3) 
 
182 (31.8) 
169 (29.5) 
222 (38.7) 
 
 
 
 
63 (27.3) 
76 (32.9) 
38 (16.4) 
54 (23.4) 
 
173 (74.9) 
58 (25.1) 
 
130 (56.3) 
61 (26.4) 
40 (17.3) 
 
98 (42.4) 
58 (25.1) 
75 (32.5) 
 
32 (13.9) 
68 (29.4) 
131 (56.7) 
 
 
 
<0.001 
 
 
 
 
0.036 
 
 
0.356 
 
 
 
0.005 
 
 
 
<0.001 
 
 
 
0.003 
 
 
 
    70 (39.6) 
    73 (41.2) 
 24 (13.6) 
   10 (5.6) 
 
106 (59.9) 
71 (40.1) 
 
124 (70.1) 
37 (20.9) 
16 (9.0) 
 
107 (60.5) 
34 (19.2) 
36 (20.3) 
 
73 (41.2) 
57 (32.2) 
47 (26.6) 
 
 
 
 
13 (31.7) 
15 (36.6) 
4 (9.8) 
9 (21.9) 
 
25 (61.0) 
16 (39.0) 
 
27 (65.8) 
9 (22.0) 
5 (12.2) 
 
23 (56.0) 
9 (22.0) 
9 (22.0) 
 
12 (29.3) 
9 (22.0) 
20 (48.7) 
 
 
 
0.010 
 
 
 
 
0.898 
 
 
0.800 
 
 
 
0.872 
 
 
 
0.021 
 
 
 
0.471 
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     None 
     1-2  
     3-4  
Somatic symptoms (PHQ-15) 
     Minimal      
     Low  
     Medium      
     High  
Family history  
     Yes  
     No  
QoL, (SF-12-PCS score), 
mean (SD) † 
81 (14.1) 
85 (14.9) 
407 (71.0) 
 
48 (8.4) 
118 (20.6) 
193 (33.7) 
214 (37.3) 
 
236 (41.2) 
337 (58.8) 
38.2±12.1 
13 (5.6) 
37 (16.0) 
181 (78.4) 
 
6 (2.6) 
34 (14.7) 
64 (27.7) 
127 (55.0) 
 
87 (37.7) 
144 (62.3) 
31.4±10.1 
 
 
 
<0.001 
 
 
 
 
0.356 
 
 
<0.001 
32 (18.1) 
22 (12.4) 
123 (69.5) 
 
35 (19.8) 
74 (41.8) 
43 (24.3) 
25 (14.1) 
 
63 (35.6) 
114 (64.4) 
44.6± 12.1 
6 (14.6) 
8 (19.5) 
27 (65.8) 
 
2 (4.9) 
15 (36.6) 
14 (34.1) 
10 (24.4) 
 
22 (53.7) 
19 (46.3) 
34.4±1.9 
 
 
 
0.046 
 
 
 
 
0.033 
 
 
<0.001 
 
Psychosocial factors 
PTSD (PTSD-PCL-S) 
     Minimal  
     Some  
     Moderate  
     High  
Social support (ESSI) 
     Low   
     High  
Resilience (RS-14) 
     Very low  
     Low  
     Low-end  
     Moderate  
     Moderately-high 
     High  
  Self-esteem (SISE),  
  mean (SD) † 
  QoL,(SF-12-MCS score), 
  mean (SD) † 
 
 
 
329 (57.4) 
66 (11.5) 
141 (24.6) 
37 (6.5) 
 
186 (32.5) 
387 (67.5) 
 
45 (7.9) 
55 (9.6) 
118 (20.6) 
148 (25.8) 
156 (27.2) 
51 (8.9) 
5.9 ±1.3 
 
39.1±12.5 
 
 
 
105 (45.4) 
15 (6.5) 
85 (36.8) 
26 (11.3) 
 
108 (46.7) 
123 (53.3) 
 
38 (16.4) 
38 (16.4) 
46 (19.9) 
52 (22.5) 
45 (19.5) 
12 (5.1) 
5.2 ±1.6 
 
35.3± 3.3 
 
 
<0.001 
 
 
 
 
<0.001 
 
 
<0.001 
 
 
 
 
 
 
<0.001 
 
<0.001 
 
 
 
147 (83.1) 
11 (6.2) 
19 (10.7) 
0 (0.0) 
 
54 (30.5) 
123 (69.5) 
 
3 (1.7) 
8 (4.5) 
37 (20.9) 
45 (25.4) 
58 (32.8) 
26 (14.7) 
6.2±1.0 
 
46.2±12.6 
 
 
 
30 (73.2) 
3 (7.3) 
8 (19.5) 
0 (0.0) 
 
16 (39.0) 
25 (61.0) 
 
6 (14.6) 
2 (4.9) 
3 (7.3) 
12 (29.3) 
15 (36.6) 
3 (7.3) 
6.1±1.2 
 
47.0±1.9 
 
 
0.282 
 
 
 
 
0.293 
 
 
0.002 
 
 
 
 
 
 
0.633 
 
0.724 
 
Lifestyle factors  
Smoking status  
     Never  
     Former  
     Current 
  Currently on diet  
     Yes 
     No 
  Fat consumption 
     Low 
     Medium  
     High  
  Vegetable & fruit consumption  
     Low 
     Medium  
     High  
  Alcohol use  
     Yes 
     No  
  Physical activity  
     None 
     Not daily 
     Daily 
BMI  
     Underweight 
 
 
 
106 (18.5) 
126 (22.0) 
341 (59.5) 
 
87 (15.2) 
486 (84.8) 
 
247 (43.1) 
176 (30.7) 
150 (26.2) 
 
59 (10.3) 
200 (34.9) 
314 (54.8) 
 
35 (6.1) 
536 (93.9) 
 
178 (31.1) 
116 (20.2) 
279 (48.7) 
 
3 (0.5) 
 
 
 
182 (78.8) 
11 (4.8) 
38 (16.4) 
 
37 (16.0) 
194 (84.0) 
 
127 (55.0) 
77 (33.3) 
27 (11.7) 
 
25 (10.8) 
83 (35.9) 
123 (53.3) 
 
3 (1.3) 
228 (98.7) 
 
117 (50.7) 
37 (16.0) 
77 (33.3) 
 
0 (0.0) 
 
 
<0.001 
 
 
 
0.767 
 
 
<0.001 
 
 
 
0.920 
 
 
 
0.004 
 
 
<0.001 
 
 
 
0.083 
 
 
 
42 (23.7) 
105 (59.3) 
30 (17.0) 
 
39 (22.0) 
138 (78.0) 
 
85 (48.0) 
53 (30.0) 
39 (22.0) 
 
15 (8.5) 
55 (31.1) 
107 (60.4) 
 
11 (6.2) 
165 (93.8) 
 
31 (17.5) 
24 (13.6) 
122 (68.9) 
 
1 (0.6) 
 
 
 
34 (82.9) 
4 (9.8) 
3 (7.3) 
 
7 (17.1) 
34 (82.9) 
 
21 (51.2) 
17 (41.5) 
3 (7.3) 
 
3 (7.3) 
15 (36.6) 
23 (56.1) 
 
0 (0.0) 
41 (100.0) 
 
11 (26.8) 
12 (29.3) 
18 (43.9) 
 
0 (0.0) 
 
 
<0.001 
 
 
 
0.483 
 
 
0.075 
 
 
 
0.789 
 
 
 
0.100 
 
 
0.008 
 
 
 
0.230 
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     Normal weight 
     Overweight 
     Obese 
118 (20.6) 
236 (41.2) 
216 (37.7) 
39 (16.9) 
84 (36.4) 
108 (46.7) 
38 (21.5) 
87 (49.1) 
51 (28.8) 
4 (9.8) 
20 (48.8) 
17 (41.4) 
Note. Gender differences were assessed using Chi-squared and t-tests, respectively, both in patients with and 
without depressive symptoms. 
CDS=Cardiac Depression Scale, HS= High school, MI= Myocardial infarction, CHD= Coronary heart disease, 
CATH= catheterization, CABG= coronary artery bypass graft, PHQ-15= Patient Health Questionnair-15, 
QoL=quality of life, SF-12= Short-form 12 Health Survey, PCS= Physical Component Summary, SD= standard 
deviation, PTSD=Post-Traumatic Stress Disorder, PTSD-PCL-S=Post-Traumatic Stress Disorder Checklist, RS-
14=Resilience Scale-14, SISE=Single-Item Self-Esteem Scale, ESSI= ENRICHD Social Support Instrument, 
MCS=Mental Component Summary, BMI= body mass index; †=Independent t test; P values in bold are significant 
at p <0.05.                  
                                             
 
 
     Bivariate comparisons of psychosocial factors between depressed men and women revealed 
that depressed women were more likely to have higher levels of PTSD symptoms, lower social 
support, lower resilience, lower self-esteem and a lower score on the SF-12-MCS for quality 
of life than their male counterparts. 
  Regarding lifestyle factors, women with depressive symptoms were less likely to be smokers 
and have a high fat intake, while more likely to be physically inactive and to be obese than men 
with depressive symptoms.  
     In the sample without depressive symptoms, the pattern of gender differences was similar, 
but with the small sample of women without depression (n=41), significant differences were 
observed less frequently.  
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Figure 5.1. Distribution of scores for symptoms of depression (CDS score) and PTSD score, 
by gender   
 
 
Note. CDS=Cardiac Depression Scale (Possible score range: 26-182; Actual score range: 47-155); PTSD=Post-
Traumatic Stress Disorder (Possible score range: 0-85; Actual score range: 0-71) 
 
     The presence of depressive symptoms as defined by a CDS score ≥90 among the total 
sample was 78.7%. The proportion of severe depressive symptoms (CDS >100) was higher in 
women compared to men (61.4% versus 50.7%, P=0.003), while the proportion of women 
without depressive symptoms was 15.1% versus 23.6% for men (Table 5.2). Comparison of 
depressive and PTSD symptoms assessed as continuous variables (means of CDS and PTSD 
scores) by gender revealed that women had significantly higher CDS (104.6±15.9; t=4.1; 
P<0.001) and PTSD scores (29.4±10.6; t=4.4; P<0.001) (Figure 5.1).  
 
 
 
 
 
85 
Table 5.2. Frequency of levels of severity of depressive symptoms, by gender  
CDS score 
Total Population 
(n=1022) 
Men 
(n=750) 
Women 
(n=272) 
P value 
<90: no depression 218 (21.3) 177 (23.6) 41 (15.1) 
0.003 
90-100:mild-to-moderate 
depression 
257 (25.2) 193 (25.7) 64 (23.5) 
>100: severe depression 547 (53.5) 380 (50.7) 167 (61.4) 
Note. CDS=Cardiac Depression Scale  
 
5.3.2 Direct and indirect effects of gender on depression (CDS score) 
     The pooled SEM of the direct effect of gender on depression (CDS score) and the indirect 
effects when mediators were added was conducted for the overall sample. Figure 6.2 illustrates 
the pathways between gender and depression with the tested mediators. Parameters reported in 
the figure include coefficients and confidence intervals (CI). They demonstrate the associations 
of gender with each potential mediating factor and between each potential mediating factor and 
outcome variable, after adjusting for the effect of gender. Results from the SEM showed both 
positive and negative mediators, where positive mediators mediating the gender difference on 
depression are associated both with being female and higher levels of depression. In the pooled 
SEM of gender and depression, there was no direct effect of gender on CDS score (coefficient: 
0.0, 95% CI: -2.2-2.2, p=1.0). There were significant direct effects of gender on the mediators 
as shown in figure 6.2. On the one hand, female gender was positively associated with higher 
PTSD symptoms, comorbidities, somatic symptoms and income. On the other hand, female 
gender was associated with lower resilience, self-esteem, quality of life, education, less 
smoking and lower physical activity. Negative indirect effects of gender on depression were 
observed through resilience, self-esteem, quality of life, (SF-12-PCS), education, income and 
physical activity, whereas positive indirect effects of gender on depression were observed 
through PTSD, comorbidities, somatic symptoms, and smoking. Quality of life, education, and 
income were not significant mediators for the indirect effect of gender on depression. No 
evidence of moderation was found for the direct effect of gender on CDS score, the effects of 
gender on mediators and the effects of mediators on CDS score.  
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Figure 5.2. SEM of the direct and indirect effects of gender on depression (CDS score), 
(n=1022) 
Note. The pathways represented by arrows correspond to direct and indirect effects of gender on depression (CDS 
score). Solid arrows (in bold) represent statistically significant associations between variables and dashed arrows 
represent non-significant associations. Each arrow is labeled with the respective effect estimate and its 95%-
confidence interval. The effect magnitudes on the arrows are not comparable to each other because the mediators 
have different scale ranges. 
Gender was coded as 0=male, 1=female; IV=independent variable, DV= dependent variable, CDS=Cardiac 
Depression Scale, PTSD-PCL-S=Post-Traumatic Stress Disorder Checklist, RS-14=Resilience Scale-14, SISE= 
Single-Item Self-Esteem Scale, SF-12-PCS= Short-form 12 Health Survey-Physical Component Summary, PHQ-
15= the Patient Health Questionnaire-15; *p<0.05, **p<0.01, ***p<0.001 
 
     There was no indication of confounding or moderation by age. In the pooled model, age 
was not significant when a direct effect of age on CDS score was added to the model. There 
were also no significant differences between corresponding effect estimates after SEM’s were 
conducted separately for the two age groups <59 years and ≥59 years. These results are 
presented in Figure 5.S1. 
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     The SEM conducted to assess whether resilience could also be a mediator and/or moderator 
between PTSD and depression (CDS score) revealed a significant direct association between 
PTSD and depression and a small positive moderating effect of resilience on this association 
was observed. There were negative yet significant associations between PTSD and resilience 
and between resilience and depression (Figure 5.S2). Thus, in this SEM, resilience appeared 
both as a mediator of the total effect of PTSD on depression and a moderator of the respective 
direct effect.  
 
Figure 5.3. Association of PTSD and CDS stratified by level of resilience 
Note. CDS= Cardiac Depression Scale; PTSD=Post-traumatic stress disorder 
 
     Figure 5.3 illustrates the interaction between PTSD and resilience, in which the difference 
in predicted depression (CDS score) between those with low and high resilience decreases 
slightly with increasing PTSD symptoms. This suggests that resilience shows a clearer 
protective role at lower levels of PTSD, becoming less protective at higher levels of PTSD.  
     No mediation by smoking of the association between PTSD and depression (CDS score) 
was found (data not shown).  
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5.4 Discussion 
In our sample of cardiac patients, women with CVD have a higher prevalence of severe 
depressive symptoms (61.4%) compared to men (50.7%). The association of gender with 
depression was entirely explained by a number of mediators. The strongest positive mediator 
was PTSD, which was more prevalent in women and positively associated with depression. 
While resilience itself was a negative mediator of the gender-depression association, it 
mediated and moderated the PTSD-depression (CDS score) association. Besides mediation by 
psychosocial parameters, lifestyle factors such as physical activity and smoking also explained 
part of the gender-depression association. 
     Our findings that women with CVD were more likely to experience depressive symptoms 
and at higher levels than men with CVD were consistent with other studies (Kao et al., 2014, 
Frasure-Smith and Lesperance, 2005, 2006). This finding is also consistent with the respective 
sex difference observed in the general population (Nolen-Hoeksema et al., 1999).    
     Previously, there has been evidence on gender being linked to PTSD and comorbid 
depression as well as PTSD and associated outcomes in cardiac patients. However, to our 
knowledge, this is the first study to assess direct and indirect effects of gender on depression 
among a cardiac population, with a particular focus on PTSD as a mediator. Previous studies 
have found that women are at higher risk of comorbid PTSD and depression symptoms 
compared to men (Cohen et al., 2016, Horesh et al., 2015), similar to our findings which 
showed a direct significant association of female gender with PTSD and a significant indirect 
effect of gender on depression mediated by PTSD. Reasons for these gender differences could 
be attributed to the different types of traumatic or stressful situations which men and women 
are exposed to, different responses to trauma, and different symptom-related responses, all of 
which may affect the course and severity of symptoms (Nolen-Hoeksema, 1987). In addition, 
higher rates of PTSD and depression among women could be due to women’s lower social 
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position which can lead to greater exposure to trauma and stressors compared to men (Van de 
Velde et al., 2010). This could particularly be true among our sample and in the cultural context 
of Palestine, where women have much lower social positions compared to men. In the present 
study, women had more severe diagnoses, comorbidities and complicated treatment procedures 
along with other negative daily stressors, suggesting that women were more vulnerable to 
traumatic stress which arises from both PTSD and depression and their comorbidity. Dao et al., 
found increased mortality among comorbid PTSD and depression patients after CABG to be 
linked to female gender (Dao et al., 2010). These results have implications for early assessment 
of these mental health disorders, as their comorbidity is becoming more frequently observed 
and prevalent in cardiac patients.  
     Our findings also reveal that low resilience is associated with being female and higher 
depressive symptoms among our cardiac sample. This finding supports the results of a study 
by Carvalho et al. (Carvalho et al., 2016), which found that among a CVD sample, lower scores 
of resilience were associated with depressive symptoms and with female gender, compared to 
men. This finding could indicate that men tend to have more motivation to focus on problem 
solving coping strategies, whereas women tend to use emotion-focused coping strategies 
(Bazrafshan et al., 2014, Möller-Leimkühler, 2007). Additionally, another study which assessed 
for depression using the CDS found a strong association between low resilience and depression 
(CDS>95) among CVD patients (Toukhsati et al., 2017). In our further analysis assessing 
mediation of resilience between PTSD and depression (CDS score), we found a significant 
effect for the interaction by resilience of the association between PTSD and depression (CDS 
score). We also found the difference in CDS score between those with low and high resilience 
decreased with increasing PTSD symptoms, potentially meaning that higher levels of PTSD 
partly override the protective effects of resilience. These findings suggest the need for 
intervention targets such as group cardiac rehabilitation and interventions to improve coping 
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with adversities, which could ultimately reduce the risk of depression and strengthen resilience 
among cardiac patients. Furthermore, promoting physical activity among CVD patients is 
recommended as resilience also has been linked to exercise (Fleshner et al., 2011) and has been 
known to reduce the risk of depression among resilient patients with CVD (Toukhsati et al., 
2017).  
       Higher somatic symptoms were also associated with being female and higher depression 
levels in this study, consistent with previous reports which found females with major 
depression showed higher rates of somatic symptoms compared to men (Dessotte et al., 2015, 
Dekker et al., 2007).  A study conducted in Spain, which also used the PHQ-15 to assess for 
somatic symptoms, found women reported higher total scores than men and were more 
concerned in 8 out of 15 items of the PHQ-15 (Gonzalez et al., 2009). Nonetheless, these 
findings should be interpreted with caution since somatic symptom scales vary in different 
studies.  
     Our results also reveal that physical inactivity is associated with being female and higher 
depressive symptoms among our cardiac sample. It has been previously reported that female 
cardiac patients frequently engage in less exercise compared with their male counterparts, 
despite the increasing evidence to support the beneficial role of exercise among cardiac patients 
(Hunt-Shanks et al., 2009). Physical inactivity has been associated with depression and has 
been shown to mediate the relationship between depression and cardiovascular events and 
mortality (Bonnet et al., 2005, Whooley et al., 2008). A recent systematic review found that 
depression could lead to a sedentary lifestyle and lower levels of physical activity (Roshanaei-
Moghaddam et al., 2009). These data along with our findings suggest that there is need for 
exercise programs for CVD patients, especially women and those with depression.  
      Furthermore, our findings shed light on gender differences for socioeconomic factors 
among men and women with both CVD and depressive symptoms. In the present study, and 
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similar to other studies, women were more likely to be not married, unemployed, and less 
educated (Vaccarino et al., 2003, Doering et al., 2011), compared to men with CVD and 
comorbid depressive symptoms. These findings are supported by previous studies on CHD 
patients that female gender is linked to lower education, which increases the risk of onset of 
CHD (Thurston et al., 2006), whereas employment and higher education play a protective role 
against depressive symptoms (Bjerkeset et al., 2005). Those with high socioeconomic status 
have more self-esteem, more resources and social support, all of which reduce the stress that 
comes with depression compared to those with low socioeconomic status, whom have less 
access to social and personal resources, which increases stress levels. However, occupation and 
marital status were not significant in the final SEM and thus were not mediating effects of 
gender on depression (CDS score). 
     Furthermore, in our sample, women had more coexisting illnesses (i.e. diabetes and 
hypertension) compared with men with cardiac disease, a finding consistent with other studies 
(Anand et al., 2005, Doering et al., 2011, Vaccarino et al., 2003). There were no major 
differences in rates of angina as an initial cardiac diagnosis between men and women, which 
is inconsistent with results in other studies, which found higher angina rates among women 
compared with men (Daly et al., 2006) (Milner et al., 2002). 
Strengths  
This study had several strengths. First, the high participation rate decreased the likelihood of 
selection and participation bias. Second, our sample of women was relatively large, compared 
to other studies, which provided sufficient statistical power for testing gender differences. 
Third, the CDS used in the study is the only psychometric scale suitable for the comparative 
depression assessment in heart disease patients, subjected to different interventions and has 
excellent properties for the diagnosis of severe depression, a score >100 having a sensitivity of 
88% and a specificity of 84%. Finally, the findings of our study are likely generalizable as our 
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sample was recruited from four main hospitals of Nablus, Palestine, which provide cardiac care 
to a large percentage of individuals in the area.  
Limitations 
The limitations of our study are due to several sources. First, depression was not formally 
diagnosed by a psychological interview and was rather assessed using the CDS, thus we cannot 
conclude that our sample had clinical depression. However, the identification of certain 
mediating factors of gender on depression among cardiac patients can serve as a basis for 
developing the best intervention targeting depression among women and men with cardiac 
disease. Second, some patients were recruited at the time of admission and for the most part 
before receiving their intervention or diagnosis, and thus were under stress and anxiety. As 
some of the anxiety observed may have been transient, the level of depression and anxiety 
could have been overestimated. Finally, due to the cross-sectional design of the study the 
direction of associations cannot be derived with certainty and causality cannot be inferred. 
5.5 Conclusion 
This study demonstrated that, similar to the general population, the prevalence of severe 
depression is greater in female patients with cardiac disease compared to male patients. Overall, 
our findings provide new information documenting mediating factors, in particular PTSD, of 
the association between gender and depression among cardiac patients. These findings 
emphasize the need to devote more attention to identify and address potential mediating factors 
that could account for gender differences in depression. Providing supportive programs for 
female patients with CVD to improve their psychosocial well-being in cardiac rehabilitation 
seems of particular importance in conflict-prone areas, like Palestine.  
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5.6 Supplementary material 
Figure 5.S1. SEM of the direct and indirect effects of gender on depression (CDS score) for 
age groups <59 (n=500) and ≥59 (n=522). 
 
Age group <59 
Note. The pathways represented by arrows correspond to direct and indirect effects of gender on depression (CDS 
score). Solid arrows (in bold) represent statistically significant associations between variables and dashed arrows 
represent non-significant associations. Each arrow is labeled with the respective effect estimate and its 95%-
confidence interval. The effect magnitudes on the arrows are not comparable to each other because the mediators 
have different scale ranges. 
Gender was coded as 0=male, 1=female; IV=independent variable, DV= dependent variable, CDS=Cardiac 
Depression Scale, PTSD-PCL-S=Post-Traumatic Stress Disorder Checklist, RS-14=Resilience Scale-14, SISE= 
Single-Item Self-Esteem Scale, SF-12-PCS= Short-form 12 Health Survey-Physical Component Summary, PHQ-
15= the Patient Health Questionnaire-15; *p<0.05, **p<0.01, ***p<0.001 
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Age group ≥59 
 
Note. The pathways represented by arrows correspond to direct and indirect effects of gender on depression (CDS 
score). Solid arrows (in bold) represent statistically significant associations between variables and dashed arrows 
represent non-significant associations. Each arrow is labeled with the respective effect estimate and its 95%-
confidence interval. The effect magnitudes on the arrows are not comparable to each other because the mediators 
have different scale ranges. 
Gender was coded as 0=male, 1=female; IV=independent variable, DV= dependent variable, CDS=Cardiac 
Depression Scale, PTSD-PCL-S=Post-Traumatic Stress Disorder Checklist, RS-14=Resilience Scale-14, SISE= 
Single-Item Self-Esteem Scale, SF-12-PCS= Short-form 12 Health Survey-Physical Component Summary, PHQ-
15= the Patient Health Questionnaire-15; *p<0.05, **p<0.01, ***p<0.001 
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Figure 5.S2. SEM of association between resilience, PTSD and depression (CDS score) 
 
Note. CDS= Cardiac Depression Scale; PTSD=Post-traumatic stress disorder 
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Abstract 
Background: The longitudinal association of posttraumatic stress disorder (PTSD) with 
health-related quality of life (HRQL) in cardiac patients’ remains poorly studied, particularly 
in conflict-affected settings.  
Methods: For this cohort study, we used baseline and one-year follow-up data collected from 
patients 30 to 80 years old consecutively admitted with a cardiac diagnosis to four major 
hospitals in Nablus, Palestine. All subjects were screened for PTSD and HRQL using the PTSD 
Checklist Specific and the HeartQoL questionnaire. We used a generalized structural equation 
model (GSEM) to examine the independent predictive association of PTSD at baseline with 
HRQL at follow-up. We also examined the mediating roles of depression, anxiety, and stress 
at baseline.  
Results: The prevalence of moderate-to-high PTSD symptoms among 1022 patients at baseline 
was 27∙0%. Patients with PTSD symptoms reported an approximate 20∙0% lower HRQL at 
follow-up. The PTSD and HRQL relationship was largely mediated by depressive and anxiety 
symptoms. It was not materially altered by adjustment for socio-demographic, clinical, and 
lifestyle factors.  
Discussion: Our findings suggest that individuals with a combination of PTSD and depression, 
or anxiety are potentially faced with poor HRQL as a longer term outcome of their cardiac 
disease. In Palestine, psychological disorders are often stigmatized; however integration of 
mental health care with cardiac care may offer an entry door for addressing psychological 
problems in the population. Further studies need to assess the effective mental health 
interventions for improving quality of life in cardiac patients.   
Keywords: Posttraumatic stress disorder, cardiovascular diseases, health-related quality of life  
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6.1 Introduction  
Cardiovascular diseases (CVDs) account for 31% of all global deaths (Roth et al., 2017). The 
Middle East has a high burden of CVD morbidity, mortality, and premature cardiac events 
(Dugani et al., 2019), leading to a substantial proportion of patients experiencing disability 
(Lisy et al., 2018). Subsequently, there is a strong need for cardiac rehabilitation with a special 
focus on improving health-related quality of life (HRQL). There is evidence that HRQL 
predicts adverse health outcomes including mortality and hospitalizations in cardiac patients 
(Bosworth et al., 1999). 
     Targets for intervention in cardiac rehabilitation include psychosocial stressors and mental 
health disorders, which tremendously impact overall HRQL. Depression in particular is not 
only an established risk factor for CVD (Barth et al., 2004), but is increasingly recognized for 
its adverse prognostic effect in cardiac patients (Carney and Freedland, 2008). Less is known 
about the prognostic role of posttraumatic stress disorder (PTSD), a common psychiatric 
disorder in individuals who experience a traumatic event (e.g. war, natural disasters, physical 
assault, life threating illness) (2000a).  
     Numerous cross-sectional studies have found CVD and its risk factors are more prevalent 
among individuals with PTSD than those without PTSD (Pietrzak et al., 2011). This higher 
CVD prevalence can reflect both the etiological role of PTSD and the traumatic effect of a 
cardiac event. On the one hand, a recent meta-analysis has shown that PTSD is associated with 
a 55% increased incidence of cardiac disease or cardiac-related mortality, even after adjustment 
for demographic, clinical, and psychosocial factors including depression (Edmondson et al., 
2013). On the other hand, CVD events can be psychologically traumatic experiences given 
their sudden onset, unpredictable consequences and life-threatening nature: approximately 
10∙0-30∙0% of people suffer from PTSD after a cardiac event such as a myocardial infarction 
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(MI) or cardiac arrest (Gander and von Kanel, 2006, Shemesh et al., 2001, Wiedemar et al., 
2008).  
     Yet, evidence on whether and how the presence of PTSD in cardiac patients predicts the 
course of their disease and quality of life remains limited. The few existing studies suggest that 
PTSD in cardiac patients is associated with impaired psychosocial functioning, poor physical 
health (Ginzburg et al., 2003), decreased HRQL (Cohen et al., 2009), non-adherence to 
medication and treatment (Shemesh et al., 2001), as well as an increased risk of mortality, 
morbidity and recurrent cardiac events (Edmondson et al., 2011). These adverse associations 
of PTSD with HRQL may be partly mediated by other mental health symptoms (e.g. 
depression, anxiety or stress), also associated with heart disease patients’ HRQL (AbuRuz, 
2018, Stafford et al., 2007).    
     To the best of our knowledge, the longer-term impact of PTSD on HRQL among cardiac 
patients has not been conducted in the occupied Palestinian territories (oPt). The present study 
among a well-characterized cohort of cardiac patients in the Palestinian population a) 
investigates the independent predictive association of PTSD with HRQL over a one-year 
follow-up period, and b) assesses the mediating role of depression, anxiety and stress. 
 
6.2 Methods 
6.2.1 Study design and sample 
A longitudinal design was used to explore the predictive association between PTSD and HRQL 
in hospitalized cardiac patients after a 12-month follow-up. This study followed cardiac 
patients consecutively admitted to cardiology units at four major hospitals in Nablus, Palestine. 
The recruitment and procedures of the study have been described in detail elsewhere (Allabadi 
et al., 2019). To be eligible for the study, patients were required to be between 30 to 80 years 
old and have clinically diagnosed CHD, MI, angina, heart failure, or any other cardiac disease. 
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Patients were recruited for the initial baseline assessment within one week of hospitalization 
(range one-seven days) between March, 2017 and November, 2017. With a participation rate 
of 96∙0%, a total of 1053 patients were included in the study. Thirty four patients were excluded 
from the baseline analysis and follow-up due to incomplete data. A follow-up assessment was 
conducted approximately one year after enrollment in the study between June, 2018 and 
December, 2018 (Figure 6.1). Ethical approval for the study was obtained from the Ethics 
Committee of Nordwest-und Zentral Schweiz (EKNZ) in Basel, Switzerland, and the 
Institutional Review Board (IRB) committee at An-Najah National University in Nablus. All 
participants provided a written informed consent at baseline and follow-up.  
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Figure 6.1 Flowchart from baseline recruitment to longitudinal study sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2.2 Procedures 
Trained medical students from An-Najah University carried out in-person interviews using a 
structured questionnaire containing validated assessment tools. At follow-up, all assessed 
patients who provided consent at baseline were re-contacted by telephone and invited to attend 
an in-person interview at a medical facility in Nablus, Palestine. Patients refusing in-person 
interviews were asked to provide relevant information during a phone interview. In this current 
study, PTSD, depression, anxiety, stress, socio-demographic, clinical, psychosocial and 
lifestyle factors obtained from all participants at baseline assessment were the independent 
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variables of interest. HRQL was assessed as the study outcome at 12-month follow-up. An 
overview of the assessment tools has been described in detail previously (Allabadi et al., 2019).  
 
6.2.3 Assessments 
Predictor variable: Posttraumatic stress disorder (PTSD) 
PTSD was assessed by the PTSD Checklist Specific (PCL-S), a 17-item questionnaire 
corresponding to PTSD symptoms based on the Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV) criteria.  Each item in the questionnaire is scored from 1 (not 
at all) to 5 (extremely), indicating the extent to which the patient has been bothered by the 
symptom during the previous month. A total PCL-S score is determined by summing up the 
scores of all items (range 17-85).  In the present study, the total score was divided into two 
categories  of PTSD symptom severity:  “no-to-little symptoms” (PCL-S scores 17-29) and 
“moderate-to-high symptoms” (PCL-S scores ≥30; cutoff for clinically relevant PTSD) 
(Blanchard et al., 1996). In the current sample, the PCL-S demonstrated an internal consistency 
(Cronbach α) of 0∙86 for all 17 items.  
 
Mediating variables: Depression, anxiety and stress  
Depression, anxiety and stress were measured using the Depression Anxiety Stress Scale-42 
(DASS-42) by Lovibond & Lovibond (Lovibond SH, 1995). The questionnaire is divided into 
three scales (depression, anxiety and stress), with items scored on a four-point Likert scale 
ranging from 0 (did not apply to me at all) to 3 (applied to me very much) measuring the extent 
to which each state was experienced over the past week. Scores for each of the three scales are 
determined by summing up the scores and categorized into: depression 0-9 (normal), 10-20 
(mild-moderate),  ≥21 (severe-very severe); anxiety 0-7 (normal), 8-14 (mild-moderate),  ≥15 
(severe-very severe); stress 0-14 (normal); 15-25 (mild-moderate),  ≥26 (severe-very severe) 
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(Lovibond SH, 1995). Cronbach α for the three scales in our sample was 0∙92 (DASS-
depression), 0∙82 (DASS-anxiety), and 0∙89 (DASS-stress), respectively. 
 
Outcome variable: Health-related quality of life (HRQL)  
HRQL was assessed using the HeartQoL questionnaire, a 14-item ischemic heart disease 
(IHD)-specific scale which measures overall quality of life. The global HeartQoL score 
indicates how the patient perceives being bothered by their heart disease (Oldridge et al., 2012). 
In this study the total score was determined by summing up the scores of all 14 items which 
were assessed on a four-point scale from 0 to 3 (0=poor and 3=good quality of life). The overall 
score range was 0-42, with higher scores indicating better HRQL. In the present study, 
Cronbach’s α for HRQL was 0∙91. 
  
Other variables of interest  
Socio-demographics factors----Age, gender, marital status, education, employment and 
residence were assessed by interview at baseline.  
Clinical factors----Clinical data related to the cardiac disease including diagnosis, treatment 
procedure, comorbidities, duration of disease, medications at discharge and somatic symptoms, 
which were assessed using the Patient Health Questionnaire-15 (PHQ-15), were retrieved from 
medical records and by interview at baseline.  
Lifestyle factors----Information on smoking status, body-mass index (weight (kg)/height 
(m)2), and physical activity (e.g. the number of days of physical activity for at least 30 minutes 
per week) were obtained through in-person interviews at baseline. 
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6.2.4 Statistical methods  
PTSD symptoms were analyzed as the dichotomous variable (presence/absence of moderate-
high PTSD symptoms). To assess the relationship between PTSD at baseline and HRQL at 
follow-up involving potential mediators, we built a generalized structural equation model 
(GSEM), portrayed in figure 6.2. The model is based on the hypothesis that depression, anxiety 
and stress mediate the relationship between PTSD and HRQL. The analysis was adjusted for 
age, gender, occupation, education, residence, hospital, cardiac diagnosis, cardiac treatment, 
years with disease, somatic symptoms (PHQ-15), comorbidities, medications, body-mass 
index, physical activity, smoking status and duration of follow-up. We selected these covariates 
a priori, and based on evidence for association with PTSD as likely confounders of the 
association between PTSD and HRQL. All GSEM models were estimated using maximum 
likelihood in the STATA Statistical Software Release 15 (StataCorp., College Station, U.S.A.).  
 
6.3 Results 
6.3.1 Recruitment  
Of the 1022 participants included at baseline, n=622 (61∙0%) were reexamined at follow-up. 
The mean duration of the approximate one-year follow-up was 399 (SD= 93∙7) days (range: 
235-677 days). Among the patients whom we attempted to contact, 415 (40∙6%) attended in-
person interviews and 207 (20∙2%) were interviewed by phone; while 351 patients (34∙4%) 
were lost to follow-up (not reached after four telephone calls; phones disconnected). Telephone 
interviews were conducted with patients who were not able to attend in-person interviews due 
to (1) physical restrictions, (2) lack of means of transportation, or (3) no interest in attending 
the appointment. For deceased people (n=49, 4∙8%), a telephone interview with the next of kin 
was used to ascertain or confirm the cause and date of death.  
6.3.2 Sample characteristics at baseline 
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At baseline, among the 1022 patients, the mean age was 58∙9±10∙1 years (range 30-80 years). 
Of these participants, 73∙4% were male, 90∙6% were married, 37∙0% were unemployed, and 
58∙7% did not have a high school diploma. With regard to clinical variables, 39∙7% had an 
acute MI, 32.7% had established CHD, 15∙9% had stable or unstable angina, and 11∙7% had 
some other type of cardiac disease, including mitral or aortic valve stenosis, valve 
regurgitation, heart block and others. Among the category of other diagnoses, 29 (2∙8%) 
patients had heart failure. There were no major socio-demographic or lifestyle differences at 
baseline among participants included vs excluded in the follow-up assessment. However, 
depression, complicated treatments, and number of medications were slightly more common 
among non-participants at follow-up (Table 6.S1).  
 
  6.1. Socio-demographic, clinical, psychosocial and lifestyle characteristics at baseline, by 
PTSD status, n=1022 
 
 
 
 
Moderate-to-
high PTSD 
symptoms 
(PCL-S  ≥30) 
(n=279) 
No-to-low 
PTSD symptoms 
(PCL-S < 30) 
(n=743) 
Socio-demographic factors 
Age 
Gender 
     Female 
     Male 
Marital status 
     Married 
     Not married  
Residence  
     City 
     Village 
     Camp  
Education degree 
     No high school diploma  
     High school diploma  
     College degree  
Occupation 
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
 
58∙8±10∙3 
 
106 (39∙0) 
173 (23∙2) 
 
237 (25∙7) 
42 (43∙7) 
 
115 (24∙4) 
137 (29∙0) 
48 (64∙0) 
 
180 (30∙0) 
64 (24∙5) 
35 (22∙2) 
 
51 (24∙6) 
62 (20∙2) 
125 (33∙1) 
22 (27∙5) 
19 (40∙4) 
 
 
59∙1±10∙1 
 
166 (61∙0) 
571 (76∙8) 
 
689 (74∙3) 
54 (56∙3) 
 
356 (75∙6) 
339 (71∙0) 
48 (64∙0) 
 
420 (70∙0) 
197 (75∙5) 
126 (77∙8) 
 
156 (75∙4) 
245 (79∙8) 
256 (66∙9) 
58 (72∙5) 
28 (59∙6) 
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Clinical Factors  
Cardiac diagnosis 
     Coronary heart disease 
     Myocardial infarction 
     Angina  
     Other  
Years with cardiac disease  
     Less than one year  
     Two-nine years  
     10 or more years  
Cardiac treatment (at admission)       
     Catheterization/stent 
     Catheterization /coronary bypass artery graft 
     Catheterization/other & unknown  
Co-morbidities 
     None 
     One 
     Two or more 
Medications 
     None 
     One to two   
     Three to four 
Somatic symptoms 
     Minimal (PHQ  ≤ 4)    
     Low (PHQ 5-9) 
     Medium (PHQ 10-14)      
     High (PHQ ≥ 15) 
 
 
116 (34∙7) 
91 (22∙5) 
28 (17∙5) 
44 (36∙7) 
 
154 (24∙6) 
79 (31∙1) 
46 (33∙1) 
 
127 (23∙9) 
76 (31∙8) 
76 (30∙6) 
 
62 (20∙8) 
80 (26∙6) 
137 (32∙6) 
 
33 (25∙0) 
39 (25∙8) 
207 (28∙1) 
 
17 (18∙7) 
31 (13∙0) 
77 (24∙5) 
154 (41∙1) 
 
 
218 (65∙3) 
317 (77∙5) 
132 (82∙5) 
76 (63∙3) 
 
472 (75∙4) 
178 (68∙9) 
93 (66∙9) 
 
405 (76∙1) 
166 (68∙2) 
172 (69∙4) 
 
236 (79∙2) 
224 (73∙4) 
283 (67∙4) 
 
99 (75∙0) 
112 (74∙2) 
532 (71∙9) 
 
74 (81∙3) 
208 (87∙0) 
237 (75∙5) 
224 (58∙9) 
 
Psychosocial factors 
Depression 
     Depressed (DASS-Depression ≥ 10) 
     Not depressed (DASS-Depression ≤ 9) 
Anxiety 
     Anxiety (DASS-anxiety ≥8) 
     No Anxiety (DASS-anxiety ≤7) 
Stress 
     Stress (DASS-stress ≥15) 
     No stress (DASS-stress ≤14) 
 
Lifestyle factors  
Smoking status 
     Never  
     Former  
     Current 
  Physical activity 
     None 
     Not daily 
     Daily 
Body-mass index 
     Normal weight 
     Overweight 
     Obese 
 
 
213 (53∙9) 
66 (10∙6) 
 
236 (38∙5) 
43 (10∙6) 
 
258 (39∙7) 
21 (5∙7) 
 
 
 
125 (34∙3) 
47 (27∙6) 
107 (22∙1) 
 
115 (34∙3) 
53 (28∙0) 
111 (22∙4) 
 
56 (27∙4) 
111 (25∙7) 
112 (29∙2) 
 
 
185 (46∙1) 
558 (89∙4) 
 
380 (61∙5) 
363 (89∙4) 
 
395 (60∙3) 
348 (94∙3) 
 
 
 
239 (65∙7) 
123 (72∙4) 
381 (77∙9) 
 
223 (65∙7) 
136 (72∙0) 
384 (77∙6) 
 
148 (72∙6) 
321 (74∙3) 
274 (72∙8) 
Data are mean (SD) or n (%). PTSD= Posttraumatic stress disorder, PCL-S= Posttraumatic stress disorder 
Checklist Specific, PHQ=Patient Health Questionnaire, DASS=Depression, Anxiety, Stress Scale. Physical 
activity defined as the number of days of physical activity for at least 30 minutes per week. 
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6.3.3 Distribution of socio-demographic, clinical, psychosocial and lifestyle characteristics 
according to PTSD status 
The mean scores of PTSD symptoms at baseline and follow-up were 27∙3 (SD = 9∙5; range 17-
71), and 23∙5 (SD=11∙0; range 17-80), respectively and the PTSD prevalence’s were 27∙0% 
and 21∙2%, respectively. Characteristics of participants by PTSD status at baseline are shown 
in Table 6.1. Among our sample with PTSD symptoms, there were more females (39∙0% vs 
23∙2%); there were more unmarried individuals (43∙7% vs 25∙7%); housewives [40∙4% vs 
24∙6% (professional)]; individuals with severe cardiac diseases [36∙7% vs 17∙5% (angina)]; 
individuals diseased over 10 years [33∙1% vs 24∙6% (less than one year)]; patients who had a 
CABG [31∙8% vs stent (23∙9%)]; had two or more comorbidities [32∙6% vs 20∙8% (no 
comorbidities)]; and more individuals who scored high on the PHQ-15 [41∙1% vs 13∙0% (low 
somatic symptoms)]. Additionally, among those with PTSD symptoms, patients were more 
likely to be depressed [53∙9% vs 10∙6%]; stressed [39∙7% vs 5∙7%]; and anxious [38∙5% vs 
10∙6%]; more likely to be never-smokers [34∙3% vs 22∙1% (current smoker)]; and physically 
inactive [34∙3% vs 22∙4% (daily)]. None of the patients confirmed when asked at baseline that 
in the context of their cardiac care they had ever been asked about their mental health well-
being.  
 
6.3.4 Mediation analyses: direct and indirect associations of PTSD with HRQL 
The mean HRQL score at follow-up was 28∙2 (SD=12∙1). The mean HRQL score among those 
with PTSD at baseline was 24∙6 (SD=12∙8) compared to 30∙0 (SD=11∙4) among those without 
PTSD (p <0∙001). 
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Figure 6.2: GSEM: The estimation of the direct and indirect effects of PTSD on HRQL 
Covariates additionally adjusted for: Age, gender, occupation, education, residence, hospital, cardiac diagnosis, 
cardiac treatment, years with disease, somatic symptoms (PHQ-15), comorbidities, medications, body mass index, 
physical activity, smoking status. Follow-up duration was also adjusted for with no differences in the results. 
Bolded lines indicate statistically significant effects and dashed lines indicate non-significant effects. Each line is 
labeled with the respective effect estimate and its 95%-confidence intervals. Note that because the scales of the 
three mediating variables are not the same, the effect sizes cannot be compared directly. Follow-up for HRQL: 
(n=619). 
PTSD= Post-Traumatic Stress Disorder, PCL-S=Post-Traumatic Stress Disorder Checklist, DASS=Depression, 
Anxiety, Stress Scale, HRQL= Health-related quality of life, Questionnaire. *p<0∙10, **p<0∙05, ***p<0∙001 
 
     Results from the mediation analyses (Figure 6.2) report the associations of PTSD with each 
potential mediating factor (depression, anxiety, stress) and between each potential mediator 
and HRQL, after adjusting for covariates. PTSD was a positive predictor of depression (β=10∙3, 
p<0∙001), anxiety (β=6∙8, p<0∙001) and stress (β=10∙1, p<0∙001). In turn, depression (β=-0∙2, 
p=0∙025) and anxiety (β=-0∙2, p<0∙068), but not stress predicted HRQL at follow-up, implying 
depression and anxiety to be mediators for the relationship between PTSD and HRQL. 
Furthermore, the direct effect of PTSD on HRQL was not statistically significant after 
controlling for covariates and mediators (β=-0∙3, p=0∙824), indicating the predictive 
association of PTSD with HRQL at one year follow-up was largely mediated by depression 
and anxiety. Our reference model further identified treating hospital, duration of disease, 
comorbidities and physical activity as independent predictors of HRQL. These factors neither 
modified the association of PTSD with depression or anxiety, nor the association of depression 
and anxiety with PTSD. 
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     6.4 Discussion 
This is the first study on the role of PTSD on the quality of life of cardiac patients in Palestine. 
Patients with moderate and high PTSD symptoms reported lower HRQL, approximately one 
year after baseline assessment. The PTSD and HRQL relationship was largely mediated by 
depressive and anxiety symptoms. The negative effect of PTSD remained evident after 
adjusting for relevant covariates. The careful control for confounding and the longitudinal 
nature of our study strengthens the belief that this relationship may be causal. 
     There has been extensive research on the relationship between PTSD and HRQL among 
war veterans and those with various chronic illnesses, but little on the relationship of PTSD 
and HRQL, specifically among CVD patients. Our results are consistent with similar studies 
of CHD patients, which found PTSD symptoms are associated with a lower quality of life 
(Cohen et al., 2009, Stoll et al., 2000). A further study which investigated HRQL among 
patients with PTSD following cardiac arrest reported more problems in overall quality of life 
and decreased HRQL scores compared to those without PTSD (Gamper et al., 2004). 
     To our knowledge, this is the first study to assess the specific mediating role of depression, 
anxiety and stress in the relationship between PTSD and HRQL among cardiac patients. Our 
findings are similar to those of a previous study conducted among a small sample of motor 
vehicle accident survivors, in which an indirect effect of PTSD on quality of life through 
depression and anxiety was also found (Gudmundsdottir et al., 2004). Numerous studies have 
also found that approximately half of people with PTSD had major depressive disorder (MDD) 
across different sub-samples (Rytwinski et al., 2013, Kessler et al., 1995), which is consistent 
with our analyses. Moreover, a body of literature has documented the independent associations 
of depression and anxiety with poor HRQL among CVD patients (AbuRuz, 2018, Stafford et 
al., 2007). 
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     The prevalence of PTSD in our sample of cardiac patients was 27∙0%, which is considerably 
higher than the PTSD rates reported in previous studies showing associations between PTSD 
and quality of life in different groups of patients. Cohen et al., who assessed for PTSD and 
HRQL among CHD patients found a prevalence of 9∙0%.(Cohen et al., 2009) The prevalence 
of PSTD in our study  exceeds PTSD rates found among patients with trauma (Danielsson et 
al., 2018), stroke (Goldfinger et al., 2014), and hematological malignancies (Liu et al., 2015).   
     One of the major strengths of the present study is its longitudinal design which allowed 
studying the predictive association of PTSD with HRQL in a clear temporal resolution. The 
detailed characterization of the study population limited residual confounding in studying the 
independent association of PTSD with HRQL. Moreover, previous research has focused on 
only one category of cardiac patients, rather than considering a sample of diverse cardiac 
diagnoses. Further strengths of this study are the high participation rate and the use of the 
HeartQoL questionnaire, which is specifically designed to assess quality of life in cardiac 
patients.  
     The findings in this present study should be interpreted taking into consideration several 
limitations. First, we cannot exclude the possibility that depression, anxiety and stress 
symptoms measured among those with PTSD pre-dated the traumatic event itself in some 
patients.  Second, the baseline assessment was conducted shortly after admission following a 
cardiac event, when elevated stress and anxiety are to be expected, thus our estimates of the 
magnitude of effect may not be generalizable to a longer follow-up. Third, we did not assess 
HRQL at baseline. If HRQL at follow-up was correlated with HRQL at baseline, the 
association observed would suggest an association of PTSD with the persistence of decreased 
HRQL. Finally, individuals who died before the follow-up assessment, refused to participate 
in the follow-up, or could not be reached could in fact have had a very low quality of life. If 
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they were also more likely to exhibit PTSD symptoms, we may have underestimated the effect 
of PTSD on HRQL.   
 
6.5 Conclusion 
     In the conflict-affected area of Palestine, high rates of PTSD as well as depression and 
anxiety are observed among cardiac patients (Allabadi et al., 2019). The current results suggest 
that individuals with a combination of PTSD and depression or anxiety are potentially faced 
with poor HRQL as a longer term outcome of their heart disease. Despite general 
recommendations for the integration of mental health care into cardiac rehabilitation, none of 
the patients in this study reported having been assessed for psychological problems. In Middle 
East settings such as Palestine, psychological disorders are often stigmatized, however 
integration of mental health care with cardiac care may offer a unique entry door for efficiently 
addressing psychological problems in a considerable part of the population. CVDs affect a high 
percentage of the population. Patients and their family members may be particularly receptive 
for mental health interventions in a period of life where faced with disability and death. Further 
studies need to assess the culturally acceptable and effective mental health interventions for 
improving quality of life in heart disease patients.   
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6.6 Supplementary Material 
Table S6.1: Sample characteristics among patients included vs excluded at follow-up  
 
Included at follow-
up 
(n=622) 
Excluded at follow-
up 
(n=400) 
P value 
Socio-demographic factors 
Age 
Gender 
     Female 
     Male 
Marital status 
     Married 
     Not married  
Residence 
     City 
     Village 
     Camp  
Education degree  
     No high school diploma  
     High school diploma  
     College degree  
Occupation 
     Professional 
     Non-professional  
     Unemployed  
     Retired  
     House wife 
 
 
58∙1±10∙1 
 
152 (24∙6) 
470 (75∙4) 
 
566 (91∙4) 
56 (8∙6) 
 
288 (46∙5) 
292 (46∙7) 
42 (6∙8) 
 
356 (57∙5) 
169 (26∙8) 
97 (15∙7) 
 
125 (20∙2) 
206 (32∙8) 
209 (33∙8) 
51 (8∙2) 
31 (5∙0) 
 
 
60∙3±10∙0 
 
120 (30∙0) 
280 (70∙0) 
 
357 (89∙2) 
43 (10∙8) 
 
183 (45∙7) 
184 (46∙0) 
33 (8∙3) 
 
241 (60∙2) 
97 (24∙3) 
62 (15∙5) 
 
84 (21∙0) 
103 (25∙7) 
167 (41∙8) 
30 (7∙5) 
16 (4∙0) 
 
<0∙001 
 
 
0∙055 
 
 
0∙243 
 
 
 
0∙682 
 
 
 
0∙626 
 
 
 
 
 
0∙061 
Clinical Factors  
Cardiac diagnosis 
     Coronary heart disease 
     Myocardial infarction 
     Angina  
     Other  
Years with cardiac disease  
     Less than one year  
     Two-nine years  
     10 or more years   
Cardiac treatment (at admission) 
     Catheterization/stent  
     Catheterization/coronary artery bypass graft 
     Catheterization/other & unknown  
Co-morbidities  
     None 
     One  
     Two or more  
Medications  
     None 
     One-two  
     Three-four  
Somatic symptoms (PHQ-15) 
     Minimal (PHQ  ≤ 4)    
     Low (PHQ 5-9) 
     Medium (PHQ 10-14)      
     High (PHQ ≥ 15) 
 
 
 
197 (31∙8) 
249 (40∙2) 
104 (16∙3) 
72 (11∙7) 
 
388 (62∙7) 
144 (22∙8) 
90 (14∙5) 
 
340 (54∙9) 
149 (24∙1) 
133 (21∙0) 
 
193 (31∙2) 
183 (29∙5) 
246 (39∙3) 
 
94 (14∙7) 
86 (13∙9) 
442 (71∙4) 
 
52 (8∙4) 
148 (23∙9) 
209 (33∙3) 
213 (34∙4) 
 
 
 
136 (34∙0) 
156 (39∙0) 
60 (15∙0) 
48 (12∙0) 
 
239 (59∙7) 
113 (28∙3) 
48 (12∙0) 
 
192 (48∙0) 
91 (22∙7) 
117 (29∙3) 
 
105 (26∙2) 
119 (29∙8) 
176 (44∙0) 
 
40 (10∙0) 
66 (16∙5) 
294 (73∙5) 
 
38 (9∙5) 
92 (23∙0) 
108 (27∙0) 
162 (40∙5) 
 
 
 
 
 
 
0∙864 
 
 
 
0∙110 
 
 
 
0∙010 
 
 
 
0∙187 
 
 
 
0∙066 
 
 
 
 
0∙113 
 
Psychosocial factors 
PTSD (PTSD-PCL-S) 
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     Medium-high PTSD symptoms (PTSD ≥30) 
     No-low PTSD symptoms (PTSD <30) 
Depression 
     Depressed (DASS-Depression ≥ 10) 
     Not depressed (DASS-Depression ≤ 9) 
Anxiety 
     Anxiety (DASS-anxiety ≥8) 
     No Anxiety (DASS-anxiety ≤7) 
Stress  
     Stress (DASS-stress ≥15) 
     No stress (DASS-stress ≤14) 
 
Lifestyle factors  
Smoking 
     Never  
     Former  
     Current 
  Physical activity 
     None 
     Not daily 
     Daily 
Body-mass index 
     Normal weight 
     Overweight 
     Obese 
197 (31∙8) 
425 (68∙2) 
 
229 (36∙5) 
393 (63∙5) 
 
363 (58∙2) 
259 (41∙8) 
 
395 (63∙3) 
227 (36∙7) 
 
 
 
217 (34∙6) 
100 (16.1) 
305 (49∙3) 
 
194 (30∙9) 
114 (18∙4) 
314 (50∙7) 
 
124 (19∙5) 
263 (42∙5) 
235 (38∙0) 
119 (29∙8) 
281 (70∙2) 
 
169 (42∙2) 
231 (57∙8) 
 
252 (63∙0) 
148 (37∙0) 
 
259 (64∙7) 
141 (35∙3) 
 
 
 
149 (37∙2) 
70 (17∙5) 
181 (45∙3) 
 
145 (36∙2) 
74 (18∙5) 
181 (45∙3) 
 
82 (20∙5) 
167 (41∙7) 
151 (37∙8) 
 
0∙484 
 
 
0∙066 
 
 
0∙123 
 
 
0∙644 
 
 
 
 
 
0∙454 
 
 
 
0∙162 
 
 
 
0∙933 
Data are mean (SD) or n (%). PTSD= Posttraumatic stress disorder, PCL-S= Posttraumatic stress disorder 
Checklist Specific, PHQ=Patient Health Questionnaire, DASS=Depression, Anxiety, Stress Scale. †=Independent 
t-test. Physical activity defined as the number of days of physical activity for at least 30 minutes per week; P 
values in bold are significant at p <0∙05 
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7 
 
DISCUSSION 
 
7.1 Summary of main findings 
     Although the co-morbidity of mental diseases and CVDs is well documented in literature 
and in western countries, there have been no studies to examine the relationship between mental 
and cardiac health in a non-western culture and setting such as Palestine. This thesis was guided 
by five primary goals to better understand the relationship between mental disorders and 
cardiac diseases among a well-characterized cohort of patients in conflict-affected Palestine 
and to provide local evidence for the need of integrating mental health treatment into cardiac 
care. The following sections will focus on the contributions of this PhD project to the 
aforementioned aim by addressing the following specific questions: 
1) What is the prevalence of depression and anxiety among Palestinian cardiac patients?  
2) What are the associated factors which put patients at higher risk of depression and 
anxiety? 
3) Are women more likely to suffer from depression than men? What are socio-
demographic, clinical psychosocial and lifestyle characteristics which mediate the 
relationship between gender and depression? 
4) Is there a longitudinal association between PTSD and HRQL? 
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5) Are there mediating roles of depression, anxiety and stress in the relationship 
between PTSD and HRQL? Which combination of patient sub-groups is likely to 
benefit most from mental health screening and intervention? 
7.1.1 Alarming rates of depression and anxiety among cardiac patients 
The baseline cross-sectional study presented in Chapter 4 of this thesis documents for the first 
time the alarmingly high prevalence of depression and anxiety among cardiac patients in 
Palestine, with a prevalence rate of 53.5% and 33.9% for severe-to-very severe depressive and 
anxiety symptoms, respectively. The well characterized cardiac population at baseline provides 
evidence for important cross-sectional associations of depression and anxiety with socio-
demographic, clinical, psychosocial and lifestyle characteristics. The presence of factors such 
as PTSD symptoms, low self-esteem, poor somatic symptoms, smoking, physical inactivity 
among cardiac patients should be a red flag for cardiologists to identify patients at higher risk 
of depression and anxiety. In perspective of mental health screening among cardiac patients, 
focus should be given to females and less educated patients. These results point to the potential 
need for integrating mental health care into cardiology practice for early diagnosis, prevention 
and treatment of these mental disorders. The outcomes of this study have implications for 
healthcare practice in hospital settings in Palestine, where physicians do not recognize or treat 
mental disorders, there are a lack of screening tools developed for the population in context as 
well as poor and untrained health professionals to treat for mental disorders among this patient 
population.  
7.1.2 Women at greater risk of depression 
Our second study brought to light new information regarding the high prevalence of severe 
depression among female patients with cardiac disease compared to male cardiac patients. In 
addition, our findings provide new evidence of the mediating factors of the association between 
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gender and depression among cardiac patients, in particular PTSD. The results emphasize the 
need for further research on potential mediating factors that could account for gender 
differences in depression and the need to provide support programs for female patients 
specifically in a setting such as Palestine as women are more prone to chronic and daily 
stressors and are underprivileged compared to men. As a part of CR programs, specific focus 
should be given to female patients with cardiac disease to improve their psychosocial 
wellbeing.  
7.1.3 Influence of PTSD, depression, and anxiety on HRQL 
The longitudinal study in Chapter 6 of the thesis and the first to assess the role of PTSD on 
HRQL in Palestine, while assessing the mediating roles of other mental disorders, found that 
the link between PTSD and HRQL was largely mediated by depression and anxiety over a one-
year period (on average), even after adjusting for relevant socio-demographic, clinical and 
lifestyle covariates. The findings of this study also suggest that depression and anxiety strongly 
predicted poor HRQL and revealed that patients with higher levels of PTSD exhibited lower 
HRQL after one-year. Our study sample with PTSD have differences in health behaviours such 
as smoking and physical activity, which could also impact HRQL, thus PTSD could potentially 
directly and indirectly affect overall HRQL in  cardiac patients. These results indicate the need 
to treat patients with a combination of PTSD, depression and anxiety as these are patients which 
are more likely to face disability and eventually death. These findings also hold strong 
implications for cardiologists and researchers which should be made aware of the long-term 
effect PTSD could have on HRQL as well as recurrent cardiac events and cardiac mortality 
(Edmondson and Cohen, 2013). Further studies need to be conducted to 1) better characterize 
the patients at higher risk 2) examine the mechanisms underlying the relationship between 
PTSD and poor HRQL among cardiac patients, 3) identify modifiable mechanisms for the 
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association of PTSD and cardiac disease (e.g. non-traditional risk factors) and 4) determine 
methods for decreasing PTSD, especially in medical settings.  
7.2 Strengths and limitations 
The specific strengths and limitations of each of the three studies have been reported in detail 
in the previous chapters. The strengths and limitations in the following paragraph are mainly 
related to the conclusions of the overall thesis. First, this thesis had several main strengths. The 
findings of the three thesis studies should be able to generalize well within a Palestinian context 
of cardiac and other chronic disease subgroups as well as other LMICs with similar health care 
systems and cultural settings. The potential generalizability our thesis findings present can also 
be attributed to the four study hospitals which provide cardiac care for a large percentage of 
the population in the West Bank. However, since Palestine is a conflict-affected country with 
poor economic resources, these findings might not generalize well to other countries, 
particularly in the United States and European countries. Additionally, all three studies were 
strengthened by the large sample size and high participation rate both at baseline and follow-
up, resulting in 1) a strong statistical power to assess associations and 2) decreased the 
likelihood of selection bias. The designs of both the cross-sectional and longitudinal studies 
also enabled the consideration of a wide range of relevant socio-demographic, clinical, 
psychosocial and lifestyle covariates in the investigated associations. 
     There are also several limitations this thesis presents. In general, nonparticipation and loss 
to follow-up tend to be more evident among the physically unhealthy and less advantaged 
leading to cohort studies often being a relatively healthier sub-population. Thus, the loss to 
follow-up for the longitudinal study might have resulted in underestimation of those which still 
have high levels of depression, anxiety or PTSD and have poorer levels of HRQL. However, 
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several studies have demonstrated that this causes only minimal bias in some exposure-
outcome associations.  
     Another shortcoming of this thesis was the short follow-up time, which could have also 
underestimated the true effect of PTSD on HRQL among cardiac patients, as cardiac diseases 
require longer latency periods for outcomes such as quality of life. Usually, longitudinal studies 
have longer follow-up times and thus allow for the occurrence of more events, and in the case 
of our longitudinal study, probably worse quality of life.  
      Although the assessment of depression, anxiety, PTSD and other clinical covariates were 
assessed at similar time points (one week within cardiac hospitalization), we presume there 
was an overestimation in the rates of these mental disorders, as patients are likely to be more 
depressed or anxious during the period right before or after their hospitalization.  
     Finally, it is important to point out that despite the use of screening instruments with 
excellent psychometric properties; our research lacked the use of clinical structural diagnostic 
interviews based on DSM-V criteria for these mental illnesses. Thus, our sample of cardiac 
patients were not diagnosed with these mental illnesses, rather they were screened and assessed 
for presence and severity of these mental-related symptoms within a specific period of time. 
Nonetheless, those who did score high on these screening instruments need to be further 
interviewed and assessed for clinical diagnostic confirmation of these mental illnesses.  
7.3 Implications of findings  
7.3.1 Weaknesses and challenges of the mental health care in Palestine 
 Given the impact of the war and the Israel occupation over the past 70 years in Palestine, and 
the vast extent of the mental health issues that Palestinians have been enduring, there is a strong 
need to integrate mental health within primary care services, raise awareness about the stigma 
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behind mental health and strengthen the mental health staff. There is a general lack of 
awareness of mental disorders and efforts should be made to tackle the misperceptions and 
stigmatization of health professionals as well as patients with mental diseases. The mental 
health system in Palestine needs to move toward multidisciplinary care at the primary and 
secondary health care levels such as public hospitals, where patients and families should be at 
the heart of interdisciplinary care. This will require the empowerment of nurses and social 
workers as there is a lack of psychiatrists in the country. The commitment of mental health 
professionals in Palestine and the international community will also help to develop quality 
mental health care services.  
 
7.3.2 Significance of thesis findings for Palestine  
Our thesis provides evidence for the first time of the extraordinarily high depression, anxiety 
and PTSD rates among Palestinian cardiac patients. This project has implemented already 
established screening instruments for mental disorders in clinical settings and provides 
evidence for the validity of the instruments in the Palestinian context. Additionally, the findings 
of this thesis help recognize socio-cultural and disease specific subgroups of CVD patients in 
particular need of future interventions. In light of this, a substantial percentage of the 
Palestinians of all ages can benefit from the evidence generated by this project. The results 
point to the potential need for integrating mental health care into cardiology practice and CR.  
      Evidence has shown that CHD also imposes significant physical, psychological and social 
burden eliciting anxiety and stress on patient’s family members as well. Mental intervention 
during CR may be an entry door for addressing mental health issues in a broader family and 
societal context. The patient’s family commonly also experiences major distress as a result of 
comorbid CHD and psychological disorders among their loved ones. Research on depression 
and anxiety among family members has not been conducted as extensively as for the patient; 
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however it has been suggested that levels of these mental health symptoms can be as high 
among the patient’s partner/family member as the patient’s themselves. It has also been 
recommended that the patient and partner/family member should be involved in the care and 
recovery process after a cardiac event (Reid et al., 2013).  
     Systematic reviews evaluating the effectiveness of psychological interventions for patients 
with chronic diseases including CHD and their partner or family member show potential 
benefits for both the patient and partner. (Hartmann et al., 2010, Martire et al., 2010, M Martire 
et al., 2004) Potential benefits of psychological interventions for patients include improvement 
in mental health, cardiac-related health, mortality and quality of life, while benefits for the 
partner/family member include improvements in mental health and quality of life. Additionally, 
the intervention may prevent healthy family members from also developing cardiac disease. 
There is mounting evidence emphasizing the adverse effect of psychological disorders on the 
onset of heart disease, even in family members. Individuals with depression are twice as likely 
to develop MI than the general population (Chaddha et al., 2016). In order to determine which 
psychological interventions are most effective, it would be best if a psychological intervention 
trial would be tests on patients alone and on patients and their partner or family member.  
     It therefore seems pivotal to integrate mental health services and interventions into cardiac 
care for both, patients and their family members, addressing in particular stress and 
psychosocial factors (i.e. lack of social support) (Lichtman et al., 2014b). 
7.3.3 Implications for interventions: evidence from psychosocial intervention 
studies  
There is a growing interest on the influence of psychosocial interventions on CVD outcomes. 
It is known after a cardiac event, it remains challenging for healthcare providers to identify and 
treat patients with depression and anxiety. Epidemiological studies suggest that treatment of 
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mental disorders, specifically depression and anxiety as well as other psychosocial factors may 
improve CVD related symptoms and decrease adverse outcomes, hospitalizations, and overall 
quality of life in patients suffering from cardiac disease. The most effective time to screen for 
psychological problems has been either before hospital discharge or during the first sessions of 
a CR program. The European Society of Cardiology (ESC) has established a comprehensive 
CR program which includes core components such as patient assessment, physical activity 
counseling, dietary counseling, management of risk factors (e.g. hypertension, lipid profile, 
and diabetes), patient education, psychosocial management and vocational advice. Patients and 
families may be offered a range of psychological therapies including stress management, 
relaxation therapies, treatments for psychological and mood disorders, coping strategies, 
enhancing disease adjustment and specific cardiac-related rehabilitation such as diet and 
lifestyle advice, or exercise. Systematic reviews have documented CR programs which address 
medical and lifestyle factors have shown to have positive effects on behavioral changes and 
reducing the risk of recurrent cardiac events, mortality depressed mood and social isolation 
(Oldridge et al., 1988).  
     The Ischemic Heart Disease study, a unique home-based stress reduction program has 
shown that treatment has been associated with reduction in cardiac events. Among patients 
attending CR programs, a study by Dusseldorp et al. found reduction in mortality and recurrent 
MI following interventions for reduction in psychological stress (Olafiranye et al., 2011). In a 
meta-analysis of 23 randomized controlled trials that evaluated the impact of adding 
psychosocial interventions to standard cardiac rehabilitation regimens, Gellis et al. observed 
that lack of psychosocial intervention was associated with greater rates of mortality and 
recurrent MI after a two year follow-up (Gellis and Kang-Yi, 2012).  
           The first study to investigate the effectiveness of collaborative mental care for patients 
with diabetes or heart disease in the context of the primary care setting in the UK was recently 
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published. In the COINCIDE cluster-randomized trial, where patients could choose between 
different psychological and pharmacological treatments, there was a decrease in symptoms of 
depression over a four-month follow-up, however there was no improvement in quality of life 
or social support (Coventry et al., 2015). These results point to the need for additional research 
into the long-term effectiveness of collaborative mental care approaches in the setting of CVD 
patients. These types of interventions and CR programs will enable patients to receive the 
appropriate treatment to improve their cardiac health and their mental well-being.  
7.4 Public health relevance and implications  
Considering this project is a large population-based study, this will set the basis for mental 
health policies among cardiac populations across the West Bank, and ultimately in the Gaza 
Strip. Further, in terms of Palestine, to address the population at need, integrated mental health 
services should be implemented at the primary healthcare level. This step will provide easier 
access to health services, and will reduce the stigma associated with mental issues (Afana et al, 
2004). The evidence presented in this thesis points to the importance of identifying and treating 
depression, anxiety and PTSD among the cardiac population, in particular as they impact 
individual’s quality of life. As many physicians overlook depressive and anxiety symptoms in 
cardiac patients mistaking them for cardiac-related somatic symptoms as well as the high 
prevalence of depression and anxiety in cardiac populations, the AHA recommends the 
screening of all cardiac patients for depression (Lichtman et al., 2008). This could identify 
those with higher risk of morbidity, mortality and HRQL and help in reducing associated risks. 
These recommendations have implications for clinical practice on which best ways to treat 
comorbid mental disease and cardiac disease. 
      The comprehensive, representative and predetermined patient data obtained throughout the 
study period including health status, socio-demographics, mental health status, and other 
variables will help in the establishment of a heart disease registry with authentic and of good 
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quality data to monitor quality of care, record management and outcomes of cardiac diseases, 
and encourage further epidemiological research.  
     In Palestine, the results from the study will provide health policy and medical agencies with 
the needed evidence base to justify integrating mental health care into cardiac care and 
rehabilitation. Evidence abroad points to a beneficial cost-effectiveness of treating heart 
disease patients for their mental problems. Mental intervention during CR may be an entry door 
for addressing mental health issues in a broader family and societal context.  
      The rationale for integration of mental health care into other health care platforms includes 
improving access to mental health care; providing patient-centred care; avoiding fragmentation 
of health services; reducing stigma; optimising both mental health and physical health 
outcomes; and overall health system strengthening. Mental health interventions for CVD 
patients are the most promising for integration (Patel, 2013). There are at least two advantages 
to integrate treatment of common mental health problems during cardiovascular routine care. 
First, integrated treatment programs in which medical providers are supported to treat common 
mental health problems offer a better chance to treat ‘the whole patient’, as a patient-centred 
approach, which is recommended worldwide. Second, integrated care programs that can 
address patients' mental health needs in the context of general or other specialized health care 
settings are often more attractive to patients and family members who are concerned about the 
stigma that is still associated with mental health and the treatment settings that specialize on 
caring for individuals with severe mental disorders. 
7.5 Conclusion and future work   
In conclusion, the prevalence of anxiety and depression among cardiac patients was alarmingly 
high. One of the key outcomes of this thesis is the need to consider the different characteristics 
between men and women in the relationship between depression and cardiac disease. Future 
research should focus on the importance of gender-specific research when examining the 
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effects and role of depression on the onset, prognosis and recovery of heart diseases. The 
crucial prognostic influence of PTSD, depression and anxiety on overall HRQL among this 
cardiac population also calls for concern. Early diagnosis of predictors associated with 
depression, anxiety and PTSD is necessary to promote patient adherence and compliance. In 
addition, the identification and treatment of patients with these mental disorders in particular 
is an important goal for clinical practice, in both cardiac populations and the general 
population. Collaborative team work between healthcare providers and patients is needed to 
prevent worse disease outcomes. More research needs to be conducted on a national level to 
develop strategies for the prevention and control of psychological distress among patients with 
chronic diseases in Palestine.  
      Our findings in this thesis can be considered as first steps to the translational approach of 
innovation, validation and application, where we can use the current cardiac sample as an entry 
door to pursue family members of diseased patients whom also could be at risk of onset and 
progression of cardiac diseases. This could potentially lead to a national mental health program 
that could be generalizable to similar health care systems in the Middle East region. 
      To embark on this aim, the current PhD project will take the findings one step further from 
the observational setting (innovation) to the validation setting by developing a psychological 
intervention and evaluating its effectiveness in the Palestinian context. Going further, the 
intervention will integrate a strong family focus, as patient’s families commonly also 
experience major distress as a result of comorbid CHD and psychological disorders among 
their loved ones.  
     To date, no programs exist in CR that focus on comprehensive psychological interventions 
for cardiac patients and their partner/family member in Palestine. The efficacy of intervention 
on psychological and psychosocial outcomes in cardiac patients and their family members 
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remains unknown. Therefore, we intend to implement a comprehensive psychosocial 
intervention program to evaluate the effects of a comprehensive psychological intervention on 
the one-year course of mental health and well-being, coping and social support of the cardiac 
patients included in this thesis as well as their one partner/family member. The major 
components of the intervention will be 1) assessment and evaluation of risk factors, and 
indicators of need for further specific psychological intervention, and 2) psychosocial 
intervention that focuses on lifestyle/behavioral changes; support, coping strategies with 
anxiety, affect dysregulation and or depression;  psychological support with  life stressors  and 
stressors of surgery and treatment;  stress management training, and emotional as well as  social 
support for families and care givers (See Appendix IV).  
     In brief, the study will enroll (n=250) patients with a previously diagnosed CHD and at least 
moderate depression reported at the 12-month follow-up. The study will also enroll n=250 
family members identified by the patient as the family member most likely to provide 
emotional and physical support. For ethical reasons all these patients with symptoms of 
depression and their family members must obtain a psychological intervention at baseline. 
     Two additional repeat psychological interventions during a one-year follow-up at month 3 
and month 6 after the baseline intervention will be randomly assigned to half of the patients 
and their family members, while the other 50% of the patients and family members will just 
receive the intervention at baseline. To test the efficacy of the repeat intervention, all 
participants will undergo detailed interviews on mental health, well-being, social support, 
behavior and clinical characteristics at baseline before the intervention, at three months before 
the intervention, at six months before the intervention, and at 12 months to test the efficacy of 
the intervention.  
     The primary outcomes for patients/family members will include: 1) psychological well-
being (depression & anxiety & stress, 2) quality of life, and 3) satisfaction with life. Secondary 
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outcomes for patients/family members will include: social support/coping, knowledge of 
disease and treatment, satisfaction with treatment and care, lifestyle (diet; physical activity; 
smoking; weight change), treatment adherence (in patients only), attitude towards mental 
health problems, health resource use.  
      We hypothesize that this type of intervention will lead to better psychological outcomes, 
improve coping, lifestyle behaviors and reduce stress among cardiac patients and their 
partner/family member at one end as well as improve medical outcomes, treatment compliant 
behavior and overall quality of life. Ultimately, if the intervention is found to be effective, it 
can be scaled up to a national CR policy.  
     The longer-term goal of this proposed project in the future is to develop clinical guidelines 
and national policies for strengthening mental health services overall and in CR, in particular. 
With regard to the cardiac setting, the population-based studies offer the potential for the future 
setup of population-based heart disease registries. According registries could make an 
important contribution to the evaluation and promotion of effectiveness of cardiac and mental 
health care in the region.  
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Appendices 
  
I. Screening Instruments   
1. Heart Quality of Life (Heart QoL) Questionnaire  
 
  
2. Cardiac Depression Scale (CDS-26) 
This questionnaire consists of a number of statements about the way you feel at present. Next to each statement 
there is a rating scale from 1 to 7 for you to indicate how much you agree or disagree with the statement. Please 
circle one of the numbers on the scale: 
Strongly disagree 1  2  3  4  5  6  7 Strongly agree 
1 I have dropped many of interests and activities…     1        2       3       4       5       6       7 
None dropped                          All dropped 
2 My concentration is as good as it ever was…     1        2       3       4       5       6       7 
  Very poor                               Excellent 
concentration                        concentration 
3 I can’t be bothered doing anything much…     1        2       3       4       5       6       7 
Keen to do                                   Can’t be   
    things                                       bothered 
4 I get pleasure from life at present…     1        2       3       4       5       6       7 
No pleasure                        Great Pleasure 
5 I am concerned about the uncertainty of my 
health… 
    1        2       3       4       5       6       7 
     Not                                             Very 
concerned                                 concerned 
6 I may not recover completely...      1        2       3       4       5       6       7 
Will recover                                 Will not 
completely                                   recover  
 How much has your heart problem bothered you and how 
have you been feeling during the last 4 weeks.  
No 
(3) 
A little 
(2) 
Some 
(1) 
A lot 
(0) 
First, in the last 4 weeks, have you been bothered by having to:  
1 Walking indoors on level ground?     
2 Garden, vacuum, or carry groceries?     
3 Climb a hill or flight of stairs without shopping?     
4 Walk more than 100 yards at a brisk pace?     
5 Lift or move heavy objects?     
Now, in the last 4 weeks, have you been bothered by:  
6 Feeling short of breath?     
7 Being physically      
8 Feeling tired, fatigued, low on energy?     
9 Not feeling relaxed and free of tension?     
10 Feeling depressed?      
11 Being frustrated?     
12 Being worried?     
13 Being limited in doing sports or exercise?     
14 Working around the house or yard?     
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7 My sleep is restless and disturbed…     1        2       3       4       5       6       7 
Not restless                           Very restless 
8 I am not the person I used to be…     1        2       3       4       5       6       7 
Just the                                   Completely  
  same                                       different 
9 I wake up in the early hours of the morning and 
cannot get back to sleep...  
 
    1        2       3       4       5       6       7 
Never wake                           Always wake 
10 I feel like I am living on borrowed time...  
 
    1        2       3       4       5       6       7 
Unlimited                              Very much 
    time                             on borrowed time       
11 Dying is the best solution for me...  
 
    1        2       3       4       5       6       7 
No solution                            Best solution 
12 I feel in good spirits…  
 
    1        2       3       4       5       6       7 
Very poor                                   Excellent 
   spirits                                        spirits 
13 The possibility of sudden death worries me...  
 
    1        2       3       4       5       6       7 
Not at all                                 Very worried 
14 There is only misery in the future for me...  
 
    1        2       3       4       5       6       7 
No misery                                Only misery 
15 My mind is as fast and alert as always...  
 
    1        2       3       4       5       6       7 
Slow and                                    Very fast 
inattentive                                  and alert 
16 I get hardly anything done...  
 
    1        2       3       4       5       6       7 
Everything                                   Nothing 
    done                                          done 
17 My problems are not yet over...  
 
    1        2       3       4       5       6       7 
All problems                              Still major 
      over                                     problems 
18 Things which I regret about my life are bothering 
me...  
 
    1        2       3       4       5       6       7 
Absolutely                                      Great 
no regrets                                      regrets 
19 I gain just as much pleasure from my leisure 
activities as I used to...  
 
    1        2       3       4       5       6       7 
No pleasure                              Very great 
     at all                                       pleasure 
20 My memory is as good as it always was...  
 
    1        2       3       4       5       6       7 
Very poor                                   Excellent 
  memory                                     memory 
21 I become tearful more easily than before…  
 
    1        2       3       4       5       6       7 
Not at all                                   Very easily 
  tearful                                       tearful 
22 I seem to get more easily irritated by others than 
before...  
 
    1        2       3       4       5       6       7 
 Never                                       Very easily 
irritated                                        irritated  
23 I feel independent and in control of my life...  
 
    1        2       3       4       5       6       7 
      No                                     Completely 
independence                        Independent 
24 I lose my temper more easily nowadays...  
  
    1        2       3       4       5       6       7 
Never lose                                    Lose it 
  temper                                     very easily 
25 I feel frustrated...  
 
    1        2       3       4       5       6       7 
Not at all                                    Extremely   
frustrated                                   frustrated 
26 I am concerned about my capacity for sexual 
activity...  
 
    1        2       3       4       5       6       7 
No concern                                    Grave  
      At all                                       concern 
 
3. Depression Anxiety Stress Scale (DASS-42) 
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Please read each statement and select a number 0, 1, 2 or 3 which indicates how much the statement applied to 
you over the past week. This assessment is not intended to be a diagnosis.  
0= Did not apply to me at all; 1= Applied to me to some degree or for some of the time; 2= Applied to me to a 
considerable degree or for a good part of time; 3= Applied to me very much or most of the time  
1 I found myself getting upset by quite trivial things 0        1         2         3 
2 I was aware of dryness of my mouth 0        1         2         3 
3 I could not seem to experience any positive feelings at all 0        1         2         3 
4 I experienced breathing difficult (e.g. breathlessness or 
excessively rapid breathing in the absence of physical exertion  
0        1         2         3 
5 I just could not seem to get going 0        1         2         3 
6 I tend to over-react to situations  0        1         2         3 
7 I had a feeling of shakiness (e.g. legs going to give way) 0        1         2         3 
8 I found it difficult to relax 0        1         2         3 
9 I found myself in situations that made me so anxious I was most 
relieved when they ended 
0        1         2         3 
10 I felt that I had nothing to look forward to 0        1         2         3 
11 I found myself getting upset rather easily  0        1         2         3 
12 I felt that I was using a lot of nervous energy  0        1         2         3 
13 I felt sad and depressed  0        1         2         3 
14 I found myself getting impatient when I was delayed in any way 
(e.g. lifts, traffic lights, being kept waiting) 
0        1         2         3 
15 I had a feeling of faintness 0        1         2         3 
16 I felt that I had lost interest in just about everything  0        1         2         3 
17 I felt I was not worth much as a person  0        1         2         3 
18 I felt that I was rather touchy 0        1         2         3 
19 I perspired noticeably (e.g. hands sweaty) in the absence of high 
temperatures or physical exertion  
0        1         2         3 
20 I felt scared without any good reason  0        1         2         3 
21 I felt that life wasn’t worthwhile 0        1         2         3 
22 I found it hard to wind down  0        1         2         3 
23 I had difficulty in swallowing  0        1         2         3 
24 I could not seem to get any enjoyment out of things I did 0        1         2         3 
25 I was aware of the action of my heart in the absence of physical 
exertion (e.g. sense of heart rate increase, heart missing a beat)  
0        1         2         3 
26 I felt down-hearted and blue  0        1         2         3 
27 I found that I was very irritable  0        1         2         3 
28 I felt I was close to panic  0        1         2         3 
29 I found it hard to calm down after something upset me  0        1         2         3 
30 I feared that I would be thrown by some trivial by unfamiliar task  0        1         2         3 
31 I was unable to become enthusiastic about anything  0        1         2         3 
32 I found it difficult to tolerate interruptions to what I was doing  0        1         2         3 
33 I was in a state of nervous tension 0        1         2         3 
34 I felt I was pretty worthless  0        1         2         3 
35 I was intolerant of anything that kept me from getting on with 
what I was doing  
0        1         2         3 
36 I felt terrified  0        1         2         3 
37 I could see nothing in the future to be hopeful about  0        1         2         3 
38 I felt that life was meaningless  0        1         2         3 
39 I found myself getting agitated  0        1         2         3 
40 I was worried about situations in which I might panic and make a 
fool of myself  
0        1         2         3 
41 I experienced trembling (e.g. in the hands) 0        1         2         3 
42 I found it difficult to work up the initiative to do things 0        1         2         3 
 
Depression Score______ 
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Anxiety Score______ 
Stress Score_______ 
 
4. Patient Health Questionnaire (PHQ-15)- (Somatic Symptoms)  
 
During the last four weeks, how much have you been 
bothered by any of the following problems? 
Not 
bothered 
(0) 
Bothered a 
little 
(1) 
Bothered a 
lot 
(2) 
1 Stomach pain    
2 Back pain    
3 Pain in your arms, legs, or joints    
4 Feeling tired or having little energy    
5 Trouble falling or staying asleep, or sleeping too much    
6 For women: menstrual cramps or other problems with your 
period 
   
7 Pain or problems during sexual intercourse    
8 Headaches    
9 Chest Pain    
10 Dizziness    
11 Fainting spells    
12 Feeling your heart pound or race    
13 Shortness of breathe    
14 Constipation, loose bowel, or diarrhea    
15 Nausea, gas, or indigestion    
PHQ-15 Score= 
________+_______ 
5. ENRICHED Social Support Instrument (ESSI) 
Please read the following questions and circle the response that most closely describes your current situation.  
1 
Is there someone available to 
you whom you can count on 
to listen to you when you 
need to talk? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
2 
Is there someone available to 
give you good advice about a 
problem? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
3 
Is there someone available to 
you who shows you love and 
affection? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
4 
Is there someone available to 
help you with daily chores? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
5 
Can you count on anyone to 
provide you with emotional 
support (talking over 
problems or helping you 
make a difficult decision?) 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
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6 
Do you have as much contact 
as you would like with 
someone you feel close to, 
someone in whom you can 
trust and confide in? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
7 
Are you currently married or 
living with a partner? 
None of        A little         Some of        Most of         All 
the time     of the time     the time        the time     the time 
1                      2                   3                  4               5 
 
6. Resilience Scale (RS-14) 
Please read the following statements. Please circle the number which best indicates your feelings about the 
statement. The numbers range from “1” (strongly disagree) to “7” (strongly agree).  
1 I usually manage one way or another 1 2 3 4 5 6 7 
2 I feel proud that I have accomplished things in life 1 2 3 4 5 6 7 
3 I usually take things in stride 1 2 3 4 5 6 7 
4 I am friends with myself 1 2 3 4 5 6 7 
5 I feel that I can handle many things at a time 1 2 3 4 5 6 7 
6 I am determined 1 2 3 4 5 6 7 
7 I can get through difficult times because I have experienced 
difficulty before 
1 2 3 4 5 6 7 
8 I have self-discipline  1 2 3 4 5 6 7 
9 I keep interested in things 1 2 3 4 5 6 7 
10 I can usually find something to laugh about 1 2 3 4 5 6 7 
11 My belief in myself gets me through hard times 1 2 3 4 5 6 7 
12 In an emergency, I am someone people can generally rely on 1 2 3 4 5 6 7 
13 My life has meaning  1 2 3 4 5 6 7 
14 When I am in a difficult situation, I can usually find my way out 
of it 
1 2 3 4 5 6 7 
 Total        
 
7. Single-item Self-Esteem Scale (SISE) 
I have high Self-esteem. 
 
1          2          3          4           5            6           7 
Not very                                                              Very true 
true                                                                     of me 
 
 
8. Short-Form Health Survey (SF-12)  
This survey asks for your views about your health. This information will help keep track of how you feel and 
how well you are able to do your usual activities. Answer each question by choosing just one answer. If you are 
unsure how to answer a question, please give the best answer you can. 
1. In general, would you say your health is:  
 
Excellent          Very good          Good           Fair           Poor 
2. Does your health limit you in moderate activities such as moving a table, pushing a vacuum cleaner, 
bowling, or playing golf? 
 
Yes, limited a lot          Yes, limited a little          No, not limited at all 
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3. Does your health limit you in climbing several flights of stairs?  
 
Yes, limited a lot          Yes, limited a little          No, not limited at all 
4. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? Accomplished less than you would like  
 
YES          NO  
5. During the past 4 weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of your physical health? Were limited in the kind of work or other activities. 
 
YES          NO  
6. During the past four weeks, have you had any of the following problems with your work or other regular 
daily activities as a result of any emotional problems (such as feeling depressed or anxious)? Accomplished 
less than you would like?  
 
YES          NO  
7. Did work or activities less carefully than usual? 
 
YES          NO 
8. During the past four weeks, how much did pain interfere with your normal work (including work outside 
the home and housework)? 
 
Not at all          A little bit          Moderately          Quite a bit          Extremely  
These questions are about how you have been feeling during the past four weeks. 
For each question, please give the one answer that comes closest to the way you have been feeling. How 
much of the time during the past 4 weeks… 
 
                                                        All of      Most      A good      Some of      A little    None 
                                                        the time   of the       bit of        the time      bit of      of the 
                                                                         time        time                             time        time 
 
9. Have you felt calm and  
    peaceful? 
10. Did you have a lot of energy? 
11. Have you felt down-hearted  
      And blue?  
12. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered 
with your social activities (like visiting friends, relatives, etc.)? 
 
  All of     Most     A good       Some of      A little   None 
the time   of the       bit of        the time      bit of      of the 
                 time        time                             time       time 
 
9. Posttraumatic Stress Disorder- Checklist Specific Version [PTSD-CL-S] 
Below is a list of problems and complaints that individuals sometimes have in response to stressful life 
experiences. Please read each one carefully, put an “X” in the box to indicate how much you have been bothered 
by that problem in the last month. 
 
 
No. Response Not at 
all (1) 
A little 
bit (2) 
Moderately 
(3) 
Quite a 
bit (4) 
Extremely 
(5) 
1 Repeated, disturbing memories, 
thoughts, or images 
of a stressful experience from the past? 
     
2 Repeated, disturbing dreams of a 
stressful 
experience from the past? 
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3 Suddenly acting or feeling as if a 
stressful experience 
were happening again (as if you were 
reliving it)? 
     
4 Feeling very upset when something 
reminded you of 
a stressful experience from the past? 
     
5 Having physical reactions (e.g., heart 
pounding, 
trouble breathing, or sweating) when 
something 
reminded you of a stressful experience 
from the 
past? 
     
6 Avoid thinking about or talking about a 
stressful 
experience from the past or avoid 
having feelings 
related to it? 
     
7 Avoid activities or situations because 
they remind 
you of a stressful experience from the 
past? 
     
8 Trouble remembering important parts 
of a stressful 
experience from the past? 
     
9 Loss of interest in things that you used 
to enjoy? 
     
10 Feeling distant or cut off from other 
people? 
     
11 Feeling emotionally numb or being 
unable to have 
loving feelings for those close to you? 
     
12 Feeling as if your future will somehow 
be cut short? 
     
13 Trouble falling or staying asleep?      
14 Feeling irritable or having angry 
outbursts? 
     
15 Having difficulty concentrating?      
16 Being “super alert” or watchful on 
guard? 
     
17 Feeling jumpy or easily startled?      
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II. Questionnaires 
 
 
 
 
 
CARMEN I: Baseline Questionnaire 
Mental disorders among Cardiac Patients 
I. PERSONAL INFORMATION 
All questions contained in this questionnaire are optional and will be kept strictly confidential. 
 
PERSONAL/BACKGROUND INFORMATION 
Patient ID no.:  
 
(Baseline/Follow-up; hospital; department; Last 
three digits of ID) 
 
 
Date of Birth: 
(dd/mm/yy) 
 
 
Fieldworker name:    
Place of Residence: 
  
 City      Village  Camp      
  
Sex:      
 
  M      F 
 
Date of arrival (at treatment facility): 
(dd/mm/yy) 
      
Marital status: 
Single     
Married     
Separated     
Divorced     
Widowed 
     
Department: 
 
Cardiac 
Surgery    
Outpatient 
Clinic   
Cardiology   
 
Hospital:  
 An-Najah National 
University Hospital     
 Nablus Hospital     
 Arab-Specialized 
Hospital   
 Al-Watani 
Hospital   
 
Weight:  
 
Height:  Number of years of education completed:  
What is your profession?  
 
 
 
 
Highest degree of education completed: 
 
Less than high school    High school graduate 
     
Some college, no degree   2-year Diploma     
Bachelor’s  
 
Masters Ph.D. Graduate or professional 
degree  
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What is your monthly income?  
<1000 ILS 
1000-2000 ILS 
2000-3000ILS 
3000-4000ILS 
4000-5000ILS 
5000+ ILS 
II. DIAGNOSIS INFORMATION  
Current Diagnosis/condition: 
 
 Coronary 
Artery Disease 
  Heart Failure  
 Angina  
 Atrial 
Fibrillation 
 
 Myocardial 
Infarction 
  
Previous Reported Diagnosis: 
 Coronary 
Artery Disease  
 Angina 
 Atrial 
Fibrillation 
 Myocardial                           
Infarction 
 Heart Failure 
 
Year of 
first heart 
problem?  
 
Other Medical History [Check all that apply]: 
 
 Anemia     Cancer     Embolism      Diabetes   Chronic liver disease  Chronic lung disease  Chronic kidney disease 
     
 Hypertension   High blood lipids   Thyroid problems  Chronic pain   
 
Mental disorders, specify:________________________________  
 
 Other chronic conditions, specify:________________________________________________ 
         
Surgeries (related to cardiovascular health): 
Year  Procedure Hospital 
   
   
   
   
   
Other hospitalizations (related to cardiovascular health): 
Year Reason Hospital 
   
   
   
   
   
Current Medications (including contraceptives or hormones for treatment of menopause symtoms): 
Drug 
Dosage Frequency  
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WOMENS HEALTH 
No. of pregnancies:  What year of last menses?  
Last menses at least a year ag                               
o?  
Yes No  
Bleeding became more irregular?                       Yes      No 
FAMILY HISTORY 
 CARDIOVASCULAR DISEASE IF DECEASED, CAUSE OF DEATH 
 DIAGNOSIS 
AGE AT 
DIAGNOSIS 
CAUSE OF DEATH 
AGE AT 
DEATH 
MOTHER     
FATHER     
BROTHERS     
SISTERS     
OTHERS     
HEALTH HABITS 
(Think about a normal week) 
Exercise 
How many days of the week are you physically active for at least 30 minutes?  
 
 0 (never) 
 1 day 
 2 days 
 3 days 
 4 days 
 5 days 
 6 days 
 7 days  
HOW MUCH TIME DO YOU SPEND SITTING ON A TYPICAL WEEKDAY (HOURS/MINUTES) 
HOW MUCH TIME DO YOU SPEND SITTING ON A TYPICAL WEEKEND? (HOURS/MINUTES)  
 
 
Diet 
Are you dieting?  Yes  No 
Rank salt intake  Hi  Med  Low 
Rank fat intake  Hi  Med  Low 
Rank of fruit/vegetable 
intake 
 Hi  Med  Low 
How many 
caffeinated drinks 
do you drink daily? 
 Never  not daily  1-2  2-3  5+ 
Smoking 
Have you ever smoked regularly for at least one year?  
 
Yes 
Never smoked 
 
 
 
Are you a current smoker?  
 
Yes 
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No 
 
If yes, what do you smoke? 
Cigarettes 
Shisha  
Other, specify:_______________________________ 
 
If yes, how many cigarettes do you smoke a day? __________ 
How often do you smoke shisha?  
 
What age did you start smoking? _____ 
If you quit, what age did you stop smoking? _____ 
 
Alcohol 
Do you drink alcohol?  
 
Yes 
No 
 
How often do you drink alcohol?  
 
none of the time 
a little bit of the time 
some of the time  
a good bit of time 
most of the time  
all of the time  
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CARMEN II: Follow-up Questionnaire 
 One-year follow-up of participants in the CARMEN baseline assessment 
I. PERSONAL INFORMATION 
All questions contained in this questionnaire are optional and will be kept strictly confidential. 
 
PERSONAL/BACKGROUND INFORMATION 
Patient ID no.:   Fieldworker name:  
 
 
Date of interview:  
(dd/mm/yy) 
   Residence:   
camp village 
city  
 
Marital status: 
Single     Married     
Separated     Divorced     
Widowed 
      
What is your profession?  
 
Professional     Non-professional    Retired    Housewife    Unemployed 
 
 
 
II. CLINICAL INFORMATION  
 
Current Diagnosis:  
Coronary artery disease  
Angina 
Myocardial infarction 
Atrial fibrillation 
Heart Failure 
None 
Other_____________________ 
  
 
Previous diagnosis: 
Coronary artery disease  
Angina 
Myocardial infarction 
Atrial fibrillation 
Heart Failure 
None 
Other_____________________ 
Last time you visited a 
physician or were treated for 
your heart condition  
Date: 
Place:  
Name of treating physician: 
Doctor’s visits related to cardiovascular health since the last interview 
Reason of visit  Date of visit  Physicians name and hospital 
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Hospitalizations as in-patient related to cardiovascular health since the last interview 
Reason/diagnosis Procedures performed  Date of stay Duration of stay Hospital  
 
 
 
 
 
Surgeries (related to cardiovascular health) in the last year: 
Procedure Duration of stay ; date of stay Hospital 
   
   
   
   
   
   
   
   
   
   
   
Current Medications 
Name of the Medication 
Dosage 
At what times do you take the 
medication; How many tablets to 
you take at each time? 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
Medications taken since last interview,  but no longer taking 
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Medication 
Dosage 
At what times do you take the 
medication; How many tablets to 
you take at each time?  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
FAMILY HISTORY 
 CARDIOVASCULAR DISEASE IF DECEASED, CAUSE OF DEATH 
 DIAGNOSIS 
AGE AT 
DIAGNOSIS 
CAUSE OF DEATH 
AGE AT 
DEATH 
MOTHER     
FATHER     
BROTHERS     
SISTERS     
OTHERS     
HEALTH HABITS 
(Think about a normal week) 
Exercise 
How many days of the week are you physically active for at least 30 minutes?  
 
 0 (never) 
 1 day 
 2 days 
 3 days 
 4 days 
 5 days 
 6 days 
 7 days  
 
Have you increased your physical activity since the last interview?  
 
 yes 
 no 
 
Have you ever received medical advice to increase your level of physical activity?  
 
 yes 
 no 
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Diet 
Are you dieting?  Yes  
N
o 
Rank salt intake  Hi  Med  Low 
Rank sugar intake  Hi  Med  Low 
Rank fat intake  Hi  Med  Low 
Rank of 
fruit/vegetable 
intake 
 Hi  Med  Low 
 
 
Since the last interview 
 
1) Have you decreased your salt consumption? 
 
 yes no 
 
2) Have you ever received medical advice to decrease your salt consumption? 
 
                 yes  no 
 
3) Have you increased your fruit and vegetable consumption? 
 
                 yes  no 
 
4) Have you ever received medical advise to increase your fruit/vegetable consumption? 
 
                 yes  no 
 
5) Have you decreased your sugar consumption?  
 
                 yes  no 
 
6) Have you ever received medical advise to decrease your sugar consumption? 
 
                 yes  no 
How many 
caffeinated 
drinks do you 
drink daily? 
 Never  not daily  1-2  2-3  5+ 
Snoring 
Do you Snore Loudly (loud enough to be heard through closed doors or your bed-partner elbows you for 
snoring at night) 
 
 yes 
 no  
 
Sleep  
How many hours of sleep do you get a night?   
Do you often feel Tired, Fatigued, or Sleepy during the daytime (such as falling asleep during driving or 
talking to someone)? 
 
 yes 
 no 
 
Has anyone Observed you Stop Breathing or Choking/Gasping during your sleep ? 
 
 yes 
 no 
Smoking 
Have you ever smoked regularly for at least one year?  
 
Yes 
Never smoked 
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Are you a current smoker?  
 
Yes 
No 
 
If yes, what do you smoke? 
Cigarettes 
Shisha  
Other, specify:_______________________________ 
 
If yes, how many cigarettes do you smoke a day? __________ 
How often do you smoke shisha?  
 
What age did you start smoking? _____ 
If you quit, what age did you stop smoking? _____ 
 
Do you smoke less since the last interview? 
 
 yes 
 no 
 N/A  
 
Have you ever received medical advise to no smoke or smoke less? 
 
 yes 
 no 
 N/A  
 
Alcohol 
Do you drink alcohol?  
 
Yes 
No 
 
How often do you drink alcohol?  
 
none of the time 
a little bit of the time 
some of the time  
a good bit of time 
most of the time  
all of the time  
 
 
Have you consumed less alcohol since  the last interview? 
 
 yes 
 no 
 N/A  
 
Have you ever received medical advise to drink less alcohol? 
 
 yes 
 no 
 N/A  
 
Psychosocial  
  
Have you experienced one or more events in your family and social environment in the last 12 months 
that were very stressful for you, in addition to any events mentioned on your personal health? 
 yes 
 no 
 
If yes please explain:   
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IV. Description of psychosocial intervention 
Target Intervention Methodology  
Behavioral 
risk (diet, 
physical 
activity, 
medication 
adherence) 
Psycho-education 
Behavioral change/ modification  
- In groups 
- On pairs (patient/ partner) 
- Simulation , role play, charts and 
check lists, illustrative handouts 
Coping skills Psycho-education 
Behavioral change/modification 
Hands on training  
- In groups 
- On pairs (patient/ partner) 
- Simulation , role play, life style 
analysis and practicing  
Depression Assessment 
Psycho-education 
Daily life routine and activation 
behaviors 
Family and social support 
Pharmacological intervention when 
needed  
- In groups 
- On pairs (patient/ partner) 
- Group therapy sessions 
- Monitoring daily life activities 
- Activation behaviors 
- Referral for psychiatric/ medical 
support when needed 
Anxiety Assessment 
Psycho-education 
Managing physical symptoms 
Cognitive intervention 
 Pharmacological intervention when 
needed  
- In groups 
- On pairs (patient/ partner) 
- Simulation , role play, negative/ 
anxious thinking patterns modification, 
relaxation training, daily life settings 
modification  
- Referral for psychiatric/ medical 
intervention when needed  
Stress Psycho-education 
Stress management skills training 
Life style assessment and modification 
Nutrition and exercise  
- In groups 
- On pairs (patient/ partner) 
- Simulation , role play 
- Social support 
- Breathing 
- Nutrition and exercise  
- Daily life supportive activities 
Affect 
dysregulation 
Anger 
management 
Psycho-education 
Assessment of personality patterns and 
attitudes towards illness and life 
Anger management  skills training 
Affect regulation training  
 
- In groups 
- On pairs (patient/ partner) 
- Simulation , role play, charts and 
check lists, illustrative handouts 
- Mood and behaviors monitoring  
- Behavior change  
- Breathing and biofeedback  
 
 
 
 
 
 
 
